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Burkholderia pseudomallei is an intracellular bacterium that causes 
melioidosis, a severe disease in humans and animals that is endemic in Southeast 
Asia and Northern Australia. Particularly in Northeast Thailand, melioidosis is an 
emerging infectious disease and is the third most common cause of death from 
infectious diseases after HIV/AIDS and tuberculosis. This bacterium is the second 
most common cause of community-acquired bacteraemia with an average mortality 
rate of around 40%. Due to the wide range of clinical presentations associated with 
this disease, the lack of rapid diagnostic tests, the resistance of B. pseudomallei to 
common antibiotics and the absence of a suitable vaccine, research aimed at 
understanding B. pseudomallei pathogenesis is of key importance.  
This pathogen is able to invade cells and exploit host cellular actin, which is 
an abundant host cell protein that plays an important role in cell movement and 
shape. The bacteria make a protein on its surface called BimA. BimA mimics a host 
cell protein and assembles actin to form a rocket-like actin tail which it uses to propel 
itself within and between the host cells. This study aims to better understand how 
BimA harnesses the host actin-assembly machinery. It revealed that a cellular 
protein known as IQGAP1 is recruited to B. pseudomallei actin tails. IQGAP1 was 
removed from a human cell line by a genetic technique. Surprisingly, the bacteria 
could still form actin tails in these cells, but the tail length was significantly shorter. 
Moreover, the number of intracellular bacteria and the efficiency of B. pseudomallei 
spread to neighbouring cells decreased in the cells lacking IQGAP1. This indicates 
that IQGAP1 plays an important role in actin tail formation and intracellular life of B. 
pseudomallei. This study provides a better understanding of B. pseudomallei 
intracellular life and is of importance for the design of future novel therapeutic 





Burkholderia pseudomallei is a Gram-negative intracellular bacterium that 
causes melioidosis, a serious disease of humans and animals in tropical countries. 
This pathogen can subvert the host cell actin machinery by a process known as actin-
based motility, for promoting its movement both within and between cells. The 
bacterial factor required for this process is known as BimA (Burkholderia 
intracellular motility A). Intracytoplasmic bacterial pathogens use distinct 
mechanisms for actin-based motility, hijacking host cytoskeletal proteins for their 
benefit. However, the molecular mechanism by which BimA subverts the cellular 
actin machinery is ill-defined. From an affinity approach coupled with mass 
spectrometry to identify cellular proteins recruited to BimA-expressing bacteria 
under conditions that promote actin polymerisation, a group of cellular proteins that 
are recruited to the B. pseudomallei surface in a BimA-dependent manner was 
identified. A subset of these proteins was independently validated with specific 
antisera including IQ motif containing GTPase activating protein 1 (IQGAP1). IQGAP1 
is a ubiquitous scaffold protein that integrates several key cellular signalling 
pathways including those involved in actin dynamics. Previous studies demonstrated 
IQGAP1 was targeted by pathogens to regulate the actin cytoskeleton, for example 
promoting Salmonella invasion into epithelial cells or supporting cell attachment and 
pedestal formation of Enteropathogenic Escherichia coli. The aim of this study is to 
explore the roles of IQGAP1 in the intracellular life of B. pseudomallei. 
This present study revealed that IQGAP1 was recruited to B. pseudomallei 
actin tails in infected HeLa cells. This protein has not previously been associated with 
actin-based motility of other intracellular pathogens. To examine the effect on actin-
based motility of B. pseudomallei, siRNA was utilised to knockdown IQGAP1 in HeLa 
cells. After optimisation of siRNA transfection, IQGAP1 expression in HeLa cells was 
suppressed by approximately 70% as assessed by IQGAP1 immunoblotting. The 
siIQGAP1 knockdown cells were infected with B. pseudomallei. The bacteria could 
still form actin tails in the knockdown cells, however, the data showed a statistically 
significant increase in overall tail length with a concomitant decrease in actin density, 
compared with the tails formed by B. pseudomallei in control cells.  
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Actin-based motility is essential in the life cycle of several cytoplasmic 
bacterial pathogens, particularly in cell-to- cell spread. After entry into the host cell 
cytosol, B. pseudomallei polymerises actin in a BimA-dependent manner and propels 
itself within and between cells. This is accompanied by cell fusion which generates 
multi-nucleated giant cells (MNGCs), a process mediated by a Type 6 Secretion 
System that is co-regulated with BimA. To gain an understanding of the impact of 
IQGAP1 on the intracellular life of B. pseudomallei, IQGAP1 was successfully knocked-
out from HeLa cells using CRISPR-Cas9 technique. Interestingly, Burkholderia 
invasion was not affected in HeLa cells lacking IQGAP1. However, the bacteria 
showed a defect in intracellular survival in IQGAP1 knockout cells that was revealed 
after 6 hours post-infection. Moreover, there was no difference in the proportion of 
bacteria associated with actin in the control and knockout cells at 16 hours post-
infection, although the bacteria formed longer actin tails in control cells with similar 
actin density.  Consequently, the number of MNGCs decreased dramatically in the 
cells lacking IQGAP1, which was indicated by the absence of plaque formation.  
Another element of this study was to determine whether BimA and IQGAP1 
are direct interacting partners. Using either an in vitro pulldown assay or in vivo yeast 
two-hybrid system, a direct interaction between these proteins could not be 
detected. It is, therefore, likely that IQGAP1 is recruited to B. pseudomallei actin tails 
through its intrinsic ability to interact with F-actin. Despite the lack of a direct 
interaction between these two proteins, an N-terminal IQGAP1 fragment 
significantly augmented BimA-mediated actin polymerisation in vitro.   
Taken together, this study provides the first evidence of the presence of 
IQGAP1 in B. pseudomallei actin tails and presents the importance of IQGAP1 in actin-
based motility and intracellular life of this bacterium. Understanding the mechanism 
of B. pseudomallei actin-based motility is useful to gain insights into host cell actin 
dynamics and its role in pathogenesis. Targeting host cellular proteins that are 
required for the intracellular life of pathogens are a topical area of research, with the 
potential to be useful alternatives to classic antibiotic therapy. Indeed, IQGAP1 could 
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1.1   Burkholderia pseudomallei  
B. pseudomallei is a Gram-negative motile rod-shaped bacterium that causes 
melioidosis, a serious infectious disease in humans and animals. Mature colonies of 
B. pseudomallei display a wrinkled appearance on Ashdowns selective agar (Inglis 
and Sagripanti, 2006). B. pseudomallei is an environmental saprophyte, which is 
endemic in 17 countries in Southeast Asia and Northern Australia with evidence of 
acquisition of the disease from the environment, specifically from contaminated soil 
and water (Limmathurotsakul et al., 2013). Recently, the whole genome sequencing 
data from B. pseudomallei isolates from 30 countries collected over 79 years 
indicated geographic spread of this bacterium from Australia and then to Southeast 
Asia (Chewapreecha et al., 2017). The reference genome of B. pseudomallei strain 
K96243, which was isolated from a case of human melioidosis in 1996, consists of 
two chromosomes, comprising a total of 7.25 megabase pairs (Mb) with a G+C 
content of 68% (Holden et al., 2004). The large chromosome (4.07 Mb) encodes many 
core functions associated with central metabolism and bacterial growth and the 
small chromosome (3.17 Mb) contains a greater proportion of accessory genes 
associated with adaptation and survival in different niches (Holden et al., 2004).  
B. pseudomallei is classified as a Hazard Group 3 agent by the Health and Safety 
Executive (HSE) in the UK; an agent that can cause severe human disease and may 
spread to the community, but there is no effective treatment available. Additionally, 
B. pseudomallei is listed as a pathogenic agent that may be targeted or used by 
terrorists under Schedule 5 of the Anti-Terrorism Crime and Security Act 2001 
(ATCSA) in the UK. In the US, B. pseudomallei is a Tier 1 select agent, which is 
categorised by the ability to cause a mass casualty event, being easily transmitted 
with a low infectious dose, and potential use as a  weaponised agent (Wagar, 2016). 
It is also listed as a US category B bioterrorism agent because of its aerosol infectivity 
and lack of vaccine, despite many studies that have attempted to develop effective 
vaccines against melioidosis (Patel et al., 2011, Choh et al., 2013). Detailed 
understanding of the mechanisms of host-pathogen interactions is essential to 




Melioidosis, also called Whitmore's disease, can affect humans and animals 
and is caused by the facultative intracellular pathogen, B. pseudomallei. In humans, 
melioidosis is an important cause of community-acquired sepsis in Southeast Asia 
and Northern Australia.  In north-east Thailand, melioidosis has a reported mortality 
rate of 40% which is comparable to that for deaths from tuberculosis in this region. 
Melioidosis is the third most common cause of death from infectious diseases 
(Limmathurotsakul et al., 2010) and was the second most common cause of 
community-acquired bacteraemia in 2010 (Kanoksil et al., 2013). Recent computer 
modelling predicts that humans are infected with B. pseudomallei with an estimated 
165,000 cases and global mortality of melioidosis of 89,000 per year 
(Limmathurotsakul et al., 2016).  
Routes of infection are percutaneous inoculation via an open wound, 
ingestion from the contaminated water or food, or infection from inhalation 
(Reviewed in Wiersinga et al., 2012). Clinical presentation of melioidosis can mimic 
tuberculosis or cancer with a variety of severity from an acute septic illness to a 
chronic infection. A prospective database of 624 patients with culture-confirmed 
melioidosis in the top end of the Northern Territory, Australia showed that 51% of 
cases presented with pneumonia as the primary diagnosis (Meumann et al., 2012), 
whereas fever was the most common presentation with localised infection in the 
majority of melioidosis patients in Thailand (Churuangsuk et al., 2016, 
Limmathurotsakul et al., 2006). Additionally, patients may present with bacteraemia, 
internal organ abscesses and septic shock. A number of risk factors for developing 
melioidosis, such as diabetes and excessive alcohol use have been defined. Despite 
this, melioidosis is considered an opportunistic infection because it is unlikely to 
have a fatal outcome in a healthy person who is diagnosed early and treated with 
appropriate antibiotics. However, bacterial eradication is still challenging and 
requires a prolonged course of antibiotic treatment. Moreover, recurrent disease is 
common with the longest period of latency of up to 62 years being recorded 
(Reviewed in Wiersinga et al., 2012). Based on clinical presentation, patients take 
antimicrobial therapy in two separate phases, an intensive and an eradication phase 
of 6 months (Currie, 2015).  However, infections caused by B. pseudomallei are 
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difficult to treat because of the inherent antibiotic resistance of B. pseudomallei to 
many antibacterial agents (Reviewed in Schweizer, 2012). 
Melioidosis also affects a range of different animal species, both pets and 
livestock, with a variability in susceptibility between species. Sheep and goats are the 
most susceptible, compared with pigs and cattle (Choy et al., 2000, 
Limmathurotsakul et al., 2012). B. pseudomallei infection in birds, crocodiles and 
kangaroos was also reported (Choy et al., 2000). The incidence of fatal melioidosis in 
zoo animals showed an area and a seasonal correlation with the highest incidence of 
melioidosis in the rainy season in the north-east Thailand (Kasantikul et al., 2016). 
B. pseudomallei infected animals may display abscesses in many organs and acute 
illness, in a similar manner to the disease presentation of humans (Reviewed in 
Sprague and Neubauer, 2004, Limmathurotsakul et al., 2013).  
1.1.2 The closely related species 
From the large diversity of the Burkholderia genus (more than 70 species), 
Burkholderia mallei is the only member that is restricted to mammalian host cells, 
including humans, but it cannot persist in the environment outside its host. Different 
from B. pseudomallei, B. mallei is a non-motile bacterium because of the absence of 
flagella (Reviewed in Hatcher et al., 2015). B. pseudomallei and B. mallei share more 
than 90% genetic homology. The smaller genome size of B. mallei (5.8 Mb) is thought 
to underlie the adaptation of B. mallei to equine hosts and why it does not survive 
well outside the host (Nierman et al., 2004).  A whole-genome comparative analysis 
of B. mallei strains compared with B. pseudomallei strains suggested that B. mallei is 
a clone of B. pseudomallei (Losada et al., 2010).  
B. mallei causes the zoonotic disease glanders in solipeds such as horses, 
donkeys and mules. Glanders is characterised by ulcerating lesions of the skin and 
mucous membranes (Reviewed in Khan et al., 2013). This disease has been 
eradicated from developed countries, but it still remains in parts of Africa, Asia, South 
America and the Middle East. Glanders can be transmitted to humans and may 
present with similar symptoms to melioidosis. The mortality rate in humans without 
treatment is 95% and up to 40% with treatment. Additionally, it has been 
documented that B. mallei was used as a biological warfare agent during the World 
Wars (Reviewed in Van Zandt et al., 2013). Because of the lack of a vaccine, effective 
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treatment and diagnostic tools and its weaponisation potential, B. mallei is also listed 
in Schedule 5 of the ATCSA in the UK and as a Tier 1 select agent in the USA. 
Whilst B. pseudomallei and B. mallei are the causative agents for melioidosis 
and glanders, respectively, B. thailandensis was later described with over 95% of 16S 
rDNA identity with B. pseudomallei (Brett et al., 1998). B. thailandensis is generally 
considered as relatively avirulent because a significantly higher infectious dose is 
required to cause disease in animal models (Brett et al., 1997). It is also avirulent 
because it is not associated with human disease, despite being present at very high 
titres in soil and water (Smith et al., 1997). Both B. pseudomallei and B. thailandesis 
are found in soil in Thailand but the ability of B. thailandensis to assimilate L-
arabinose (Ara+) differentiates the species (Smith et al., 1997). Although B. 
thailandensis can invade cells, escape the endocytic compartment, form actin tails 
and spread from cell-to-cell in cultured human epithelial cells, it is less efficient than 
the pathogenic B. pseudomallei (Kespichayawattana et al., 2004).  
1.1.3 Intracellular lifestyle of B. pseudomallei 
In common with many other intracellular bacteria, after internalisation, B. 
pseudomallei has evolved to escape from the vacuole and survive in the cytosol of 
host cells. A key virulence factor for the early stages of B. pseudomallei infection, 
which is known to be important for escaping from endocytic vesicle and intracellular 
survival, is the Type III Secretion System (T3SS) (Reviewed in Vander Broek and 
Stevens, 2017). T3SS-3 (also known as Burkholderia secretion apparatus; Bsa), which 
is one of three of T3SS encoded by B. pseudomallei, is the best characterised and is 
required for the efficient escape into the cytosol (Stevens et al., 2003, Stevens et al., 
2002). Inside the cytoplasm, B. pseudomallei is able to induce actin polymerisation to 
propel itself for intra- and inter-cellular movement, which is mediated by BimA 
(Burkholderia intracellular motility A) (Stevens et al., 2005a).  Uniquely, this 
pathogen spreads from cell-to-cell by cell fusion leading to multinucleated giant cell 
(MNGC) formation. Figure 1.1 shows the main stages of B. pseudomallei intracellular 
life. Numerous bacterial factors involved in its life cycle have been reviewed in 
Allwood et al (2011). Numerous bacterial factors involved in the life cycle of B. 
pseudomallei have been reviewed in Allwood et al. (2011) and recently reported in 





Figure 1.1: Intracellular lifestyle of B. pseudomallei.  
Schematic representation of intracellular lifestyle of B. pseudomallei involves:  
(1) Adhesion and internalisation: The bacterium is able to invade both phagocytic and 
non-phagocytic cells. Flagella facilitate both adhesion and invasion. The bsa-T3SS system 
(pink) encodes proteins that are required for invasion.  
(2) Endosome escape: B. pseudomallei can rapidly escape from endocytic vacuoles into 
the cytoplasm  
(3) Evasion of autophagy: The cytoplasmic B. pseudomallei is able to evade autophagy 
interfere with host defense mechanisms using unknown mechanism. 
(4) Replication: B. pseudomallei can multiply intracellularly. 
(5) BimA expression for intracellular motility: In the cytosol, B. pseudomallei requires 
BimA (as shown in green) expressed at one pole of the bacterial cell to polymerise the 
cellular actin and form an actin tail for protrusion within cells.  
(6) Intercellular motility (cell-to-cell spread): The bacteria use actin-based motility to 
spread and between cells. 
(7) Cell fusion and MNGC formation: B. pseudomallei can stimulate cell fusion with 
neighbouring cells and form multinucleated giant cells (MNGCs), which are a unique 






 The first step of B. pseudomallei infection is cell adherence to the host cells. 
The attachment of B. pseudomallei to pharyngeal epithelial cells is facilitated by a thin 
capsular polysaccharide layer on the surface of B. pseudomallei (Ahmed et al., 1999). 
A previous study showed Type IV pili (fimbriae) is required for B. pseudomallei 
adherence (Essex-Lopresti et al., 2005). A pilA mutant demonstrated a decreased 
adherence to cell cultures and a delayed time to death of C. elegans nematodes 
(Essex-Lopresti et al., 2005). Adhesins also play a role in promoting the contact of B. 
pseudomallei with the host cells. BoaA and BoaB (Burkholderia Oca-like adhesin) 
share similarity with Yersinia enterocolitica autotransporter adhesin (YadA), a 
member of the oligomeric coiled-coil adhesin (Oca) family (Balder et al., 2010). The 
boaA and boaB mutants were impaired in their ability to bind to human respiratory 
epithelial cell lines, Hep2 and A549 cells (Balder et al., 2010). 
To enter host cells, B. pseudomallei is able to invade phagocytic cells passively 
or it is taken up actively into non-phagocytic cells (Harley et al., 1998, Jones et al., 
1996). Similar to other intracellular bacterial pathogens, B. pseudomallei exploits the 
arrangement of the host actin cytoskeleton to support its invasion. This is supported 
by the finding that bacterial invasion into A549 cells treated with cytochalasin D (a 
mucotoxin that binds actin filaments specifically and inhibits polymerisation) was 
greatly reduced (Jones et al., 1996). Additionally, a Bsa T3SS-secreted effector 
protein BopE, which is required for efficient invasion of B. pseudomallei into 
epithelial cells, exhibited guanine nucleotide exchange factor (GEF) activity for Rho 
GTPase that regulate the actin network promoting membrane ruffling (Stevens et al., 
2003).  
Shortly after invasion, B. pseudomallei is observed in membrane-bound 
vacuoles of infected HeLa cells at 4 hours post-infection (Jones et al., 1996). Before 
phagosome-lysosome fusion, the bacteria escape this degradation compartment by 
lysis of the endosome which is mediated by several Bsa T3SS proteins. For example, 
BsaZ and BipD that encode a structural component and needle tip protein of the T3SS 
apparatus respectively are involved in efficient endocytic escape (Stevens et al., 
2002). Approximately 90% of bsaZ and bipD mutants in J774.2 cells were observed 
to co-localise with LAMP-1 (lysosome-associated membrane protein-1), a marker of 
lysosomes, indicating that the proteins are required for vacuole lysis leading to the 
escape of the bacteria into the host cell cytoplasm (Stevens et al., 2002).  After escape 
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from the endosome, B. pseudomallei expresses a number of biosynthetic pathway 
genes to replicate and survive inside host cells (Pilatz et al., 2006).  In the cytosol, B. 
pseudomallei is able to propel itself through the cytoplasm by hijacking the cellular 
actin to generate the actin polymerisation force known as actin-based motility. B. 
pseudomallei forms actin-rich tails at one pole of the bacterium after infection of both 
phagocytic and non-phagocytic cells to facilitate its movement and cell-to-cell spread 
(Kespichayawattana et al., 2000, Breitbach et al., 2003, Stevens et al., 2002). This 
process requires BimA expression at the pole of the bacterial cells where actin 
polymerisation occurs (Stevens et al., 2005a). A bimA mutant was unable to form 
actin tails in infected cells and actin tail formation could be restored by trans-
complementation, indicated that BimA was sufficient for actin-based motility of B. 
pseudomallei (Stevens et al., 2005a) (Figure 1.2). 
 
 
Figure 1.2: BimA is required for B. pseudomallei actin-based motility  
(a) BimA is located at the bacterial pole where actin assembly takes place. B. 
pseudomallei infected J774.2 cell. Bacteria were stained green, F-actin was stained 
red and BimA was stained blue. 
(b) Mutation of bimA abolishes actin-based motility of B. pseudomallei in J774.2 cells. 
Representative confocal micrographs of J774.2 cells infected with wild-type B. 
pseudomallei 10276, the 10276 bimA::pDM4 mutant, or the trans-complemented 
BimA mutant. Bacteria were stained red and F-actin was stained green. Scale bar = 
5 µM.  











Whilst most of the B. pseudomallei is free in the cytosol, a proportion of the 
escaped bacteria have been described to be co-localised with microtubule-associated 
protein light chain (LC3), the autophagy marker protein, in both non-phagocytic and 
phagocytic cells indicating the B. pseudomallei infection induces autophagy 
(Cullinane et al., 2008). Intracellular survival of B. pseudomallei is reduced in cells 
that were treated with rapamycin, a pharmacological autophagy inducer (Cullinane 
et al., 2008).  However, the majority of bacteria is able to evade autophagy using the 
Bsa T3SS effector, BopA for efficient escape (Cullinane et al., 2008, Gong et al., 2011). 
In order to replicate intracellularly and move from cell-to-cell by avoiding 
extracellular immune responses, B. pseudomallei has a unique characteristic to 
induce cell-cell fusion leading to MNGCs. This feature is the result of direct cell-to-
cell fusion that can be assessed by plaque assay. MNGC and plaque formation were 
observed in B. pseudomallei-infected HeLa cells and J774A.1, non-phagocytic 
epithelial cells and macrophage cells respectively (Kespichayawattana et al., 2000). 
bimA mutants were not able to form plaques in A549 monolayer because of the defect 
in actin tail formation (Sitthidet et al., 2011). In a study on HEK293 cells, it was 
demonstrated that plaque formation represents cell death which is a consequence of 
cell lysis following MNGC formation (French et al., 2011). Taken together, the motility 
of B. pseudomallei facilitates the efficiency of cell fusion (Sitthidet et al., 2011, French 
et al., 2011, Benanti et al., 2015). In addition to intracellular motility, it was proposed 
that contact between B. pseudomallei and host cell membrane is a prerequisite for 
membrane fusion through a process facilitated by Type Six Secretion System (T6SS) 
(Schwarz et al., 2014, Toesca et al., 2014). A mutation of a core gene on T6SS cluster 
5, vgrG5 (valine-glycine repeat protein), impaired the ability of the bacterium to 
induce MNGCs in HEK293 cells, despite it being able to escape from endosome and 




1.2   Actin-based motility  
Actin-based motility is a complex dynamic cellular process to organise directed 
movement, change cell shape or extend protrusions in response to environmental 
signals. The process is driven by the assembly and disassembly of actin filaments. 
Pathogens hijack host actin for propulsion by inducing actin polymerisation at the 
pole of a bacterial or viral pathogen in the cytosol. Many studies have been published 
on other intracellular bacterial pathogens that display actin-based motility and 
demonstrated that the mechanism of bacterial-induced actin-based motility differs 
between bacterial species. 
1.2.1 Actin polymerisation  
Actin is a 43-kDa abundant protein and highly conserved in eukaryotic cells. 
It exists in two forms, monomeric globular actin (G-actin) and filamentous actin (F-
actin). Actin filaments are polar polymers with a right-handed helical twist and with 
different dynamic ends called barbed or plus (+) and pointed or minus (-) ends. G-
actin is an ATPase, the ATP monomers add faster at the barbed end. As the filament 
grows, the ATPase actin hydrolyses the bound ATP and releases the phosphate 
moiety. The ADP-actin monomers remain in the filament and mainly dissociate from 
the pointed end. The dynamic process of cellular motility is driven by assembly and 
disassembly of the actin filaments. 
Actin filament assembly can be triggered by spontaneous (de novo) actin 
nucleation from monomeric actin. However, this step is rate-limiting in actin 
polymerisation because the formation of dimers and trimers of monomeric actin are 
unstable. Also, most of the monomeric actin in the cytoplasm is sequestered by actin-
monomer-binding proteins such as profilin. Once an F-actin nucleus, which usually 
consists of three actin monomers in complex, forms, the elongation process is 
initiated by further monomer addition onto the nucleus trimer on both of its ends to 
produce a filament. The barbed end elongates 10 times faster than the pointed end. 
The concentration of G-actin monomers decreases as actin filaments grow until an 
equilibrium is reached at the steady state where the amount of actin filament is 
balanced with G-monomer actin addition and polymer disassembly (Reviewed in 
Carlier et al., 2015).   
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Spontaneous nucleation is an inefficient process. In cells, there are three 
major classes of actin-nucleating factors; the actin-related protein 2/3 (Arp2/3) 
complex, formins, and tandem-monomer-binding proteins (Reviewed in Firat-
Karalar and Welch, 2011). Although they form distinctive actin filament networks, 
they all contain WASP-homology 2 (WH2) domains (Reviewed in Dominguez, 2016). 
Also, most actin nucleators contain proline-rich domains to deliver actin monomers 
for actin polymerisation by interaction with an associated protein such as profilin 
(Reviewed in Holt and Koffer, 2001). The first actin nucleator that was discovered is 
the Arp2/3 complex, consisting of seven subunits; Arp2, Arp3 and ARPC1-5. Arp2 
and Arp3 have a similar homology to monomeric actin that mimics the actin dimer 
and trimer resulting in initiation of actin polymerisation, generating filaments that 
grow at their barbed ends.  
However, the Arp2/3 complex by itself is a weak nucleator, and nucleation-
promoting factors (NPFs) are required for activation. The largest group of NPFs 
include Wiskott-Aldrich syndrome protein (WASP), neural WASP (N-WASP), WASP 
family verprolin-homologous proteins or also known as SCAR (WAVE/SCAR), and 
WASP and SCAR homologue (WASH). A common characteristic of these proteins is 
that they contain a C-terminal WCA domain. This domain (also called VCA) consists 
of three conserved motifs; W: one or more WASP homology (WH2) domains (also 
known as verprolin-homology domain), C: the cofilin-homology domain (also called 
central domain), and A: the acidic domain. For activation, actin monomers bind to 
the WH2 domain and the Arp2/3 complex is recruited to the CA domain (Reviewed 
in Campellone and Welch, 2010).  The WASP family proteins are inactive in an auto-
inhibited state. The upstream Rho-family GTPases, which are small GTP-binding 
proteins; such as Cdc42 and Rac1, regulate and activate the WASP and N-WASP by 
opening the WCA domain allowing the Arp2/3 to bind (Reviewed in Spiering and 
Hodgson, 2011). 
In addition to the NPFs, the Arp2/3 complex requires the side of an existing 
actin filament to bind by joining at a 70° Y-branch angle. Thus, the Arp2/3 complex 
is a key mediator of actin polymerisation in cells, playing roles in the nucleation step 
as well as cross-linking actin filaments to form characteristic Y-branched actin 




The second group of actin nucleator includes the multidomain formin 
proteins, which initiate de novo polymerisation of actin.  In contrast to the Arp2/3 
complex and its NPFs, formin-mediated actin polymerisation leads to cross-linking 
of linear (unbranched) actin filaments in parallel arrays. Formin consists of formin 
homology 1 and 2 (FH1 and FH2) domains. The FH1 domain acts as a lasso to rope in 
profilin-actin molecules while the FH2 domain forms a doughnut- or ring-shaped 
homodimer that interacts with two actin monomers nucleating a filament at the 
barbed ends as well as protecting the filament from capping (Reviewed in Goode and 
Eck, 2007). The tandem-monomer-binding proteins such as Spire, Cordon-Bleu 
(Cobl), Leiomodin (Lmod) and Junction-mediating and regulatory protein (JMY) are 
the third group identified as an actin nucleator because of the presence of multiple 
repeating WH2 domains. The multiple WH2 domains bind monomeric actin and 
tether the molecules to form an F-actin nucleus. These tandem-monomer-binding 
proteins nucleate both branched and unbranched actin filaments. Differences in the 
number of WH2 domains and the length between them result in distinct structural 
arrangement of the resulting actin network (Reviewed in Qualmann and Kessels, 
2009, Siton-Mendelson and Bernheim-Groswasser, 2017). 
In addition to actin nucleators, actin elongators also promote actin 
polymerisation. Once nucleated, actin filament elongation provides the driving force 
for cellular movement. Elongation is rapid and can be enhanced by formin and 
Enabled/vasodilator-stimulated phosphoprotein (Ena/VASP) proteins. Formins not 
only nucleate unbranched actin filaments but remain bound to the elongating barbed 
end of the filament to promote F-actin polymerisation (Reviewed in (Paul and 
Pollard, 2009). Ena/VASP recruits both actin monomer and actin filament, as well as 
actin-profilin complex, but reduces stability of branched actin filaments generated 
by the Arp2/3 complex (Reviewed in Krause et al., 2003). A recent study shows 
Ena/VASP are required for the formation of parallel actin filaments bundled by fascin 
(Winkelman et al., 2014).  
For cell motility, actin filaments are formed in different patterns with specific 
factors for force generation. Lamellipodia and filopodia actin networks are the 
beginning step for migration. At the leading edge of lamellipodia, a sheet-like 
protrusion of plasma membrane is driven by a branched actin filament network. On 
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the other hand, filopodia formed by unbranched actin filaments bundles produce 
finger-like plasma membrane protrusions. Then the cell form adhesions connected 
to the extracellular matrix. Finally, the cell moves forward with concomitant 
disassembly of the anchor site. Apart from the functions of the actin-binding proteins 
to nucleate and elongate actin polymerisation as described above, other actin-
binding proteins are also importance factors required for different organisation of 
actin filaments with distinct dynamic properties (Reviewed in Carlier et al., 2015, 
Pollard, 2016). Actin-monomer-binding proteins such as profilin, which is an 
abundant protein, binds monomeric globular actin to inhibit spontaneous actin 
nucleation and elongation at the pointed ends. Moreover, profilin competes with 
capping protein, which is an actin-binding protein to control the free barbed ends in 
cells by blocking the addition of actin (Reviewed in(Edwards et al., 2014). The actin 
filaments can also be depolymerised by actin depolymerising factor (ADF), also 
known as cofilin, which binds to actin filaments and distort the helical twist of F-actin 
or severs actin filaments. However, the actin filaments can be protected from 
severing by cofilin with tropomyosin which is a filaments-binding protein.  Bundles 
of actin filaments are connected together by actin cross-linking proteins, for example 
fascin and filamin that are present in either bundles or networks to control cell shape, 
and α-actinin that plays role in the rate of assembly of actin networks (Courson and 
Rock, 2010). When increasing the rate of actin assembly, the formation of actin 
bundles was abolished (Falzone et al., 2012).  
To understand the process for generating the force for cell motility, two new 
models have been proposed. One model describes competition for actin monomers 
in which actin monomer availability is limiting (Suarez and Kovar, 2016), the second 
describes a global treadmilling process in which a steady-state amount of 
polymerisable actin monomers (Carlier and Shekhar, 2017) impacts actin 
cytoskeleton dynamics. Studies on actin-based motility of bacterial pathogens 
explore the molecular components necessary for this process, providing a better 
understanding of both cell biology and pathogenesis.   
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1.2.2 Actin-based motility of bacterial pathogens 
With a range of different mechanisms of actin filament organisation, cells can 
migrate by a multistep process that produces force to drive motility. Pathogens 
hijack this process for their movement within and between host cells. Bacterial 
factors have similar function as the actin-binding proteins to nucleate and assemble 
actin filaments at one pole of the bacterium. The barbed ends of actin filaments are 
towards the pole of the bacterium that propel itself forward within and between cells 
by the asymmetric actin polymerisation forming comet- or rocket-actin tail behind it 
(Gouin et al., 1999).  
Bacterial pathogens have evolved different mechanisms to manipulate the 
host actin cytoskeleton. Arp2/3 complex is a common target for pathogens to hijack 
actin for motility during infection (Reviewed in Welch and Way, 2013). ActA from L. 
monocytogenes, BimA from B. thailandensis and RickA from Rickettsia species of the 
spotted fever group (SFG) mimic a cellular NPF to activate the Arp2/3 complex. On 
the other hand, IcsA from S. flexneri recruits the host NPF N-WASP to the bacterial 
surface to promote their Arp2/3-mediated motility by activating upstream small 
GTPases (Reviewed in Stevens et al., 2006). Moreover, virulence proteins from Gram-
negative bacteria; BimA from B. pseudomallei and B. mallei and Sca2 from SFG 
Rickettsia species, act as actin nucleators which are able to nucleate actin directly 
(Reviewed in Bugalhao et al., 2015). This diversity of bacterial proteins that regulate 
cellular actin dynamics demonstrates that the bacteria hijack the host cellular actin 
regulatory machinery by distinct molecular mechanisms. This results in different 
organisation of actin filaments formed by these bacteria impact on the efficiency of 
motility (Reviewed in Lamason and Welch, 2017). 
1) Listeria monocytogenes 
L. monocytogenes is a Gram-positive food-borne pathogen that causes 
listeriosis as well as meningitis and abortions. It is a facultative intracellular 
bacterium that can invade both non-phagocytic and phagocytic host cells, and then 
replicate within the cytosol where actin is recruited and polymerised to create the 
driving force for its movement and protrusion to the neighbouring cell. Initially, the 
bacteria are surrounded with actin forming an actin cloud around the bacterial cell, 
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before displaying trails of actin comet tails used for propulsion through the 
cytoplasm (Tilney and Portnoy, 1989). The length of Listeria comet tails in HEp2 cells 
was shown to vary from 4-12 µm (Gouin et al., 1999). In different cell lines, the 
bacteria moved in a straight line leaving a long F-actin tails up to 40 µm in length, 
moving at speeds in the cytoplasm between 0.25-1.46 µm/sec in J774 cells and from 
0.12-0.35 µm/sec in PtK2 cells (Dabiri et al., 1990). Similarly, the movement rate of 
L. monocytogenes in Vero cells was recorded as 22 µm/min (Gouin et al., 1999). The 
force generated by actin-based motility supports bacterial movement until reaching 
the peripheral cell membrane, where the bacteria spread to the adjacent cells within 
a finger-like membrane protrusion containing the bacterium at the tip (Reviewed 
in Kuehl et al., 2015). The morphology of actin filaments formed by Listeria was 
observed by electron microscopy and showed that the filaments within the 
cytoplasm are short and randomly oriented with higher density at the vicinity of the 
bacterium (Gouin et al., 1999, Tilney and Portnoy, 1989). On the other hand, most of 
the actin filaments within the protrusion were long and bundled in a parallel array, 
although near the bacterial body the filament were less tightly bundled (Sechi et al., 
1997). 
The actin-based motility of L. monocytogenes requires the surface bacterial 
factor ActA, which was identified using mutants that were unable to accumulate actin 
or spread from cell-to-cell (Domann et al., 1992, Kocks et al., 1992). ActA was 
expressed and concentrated at one pole of the bacterium where actin assembly took 
place (Kocks et al., 1993, Dabiri et al., 1990). To initiate ActA-dependent actin 
polymerisation, Listeria hijacks the host Arp2/3 complex to mediate actin tail 
formation and motility (Welch et al., 1997). The N-terminal region of ActA contains 
a WCA domain that binds and activates the Arp2/3 complex to initiate nucleation of 
branched actin filaments (Welch et al., 1998, Boujemaa-Paterski et al., 2001, Welch 
et al., 1997). This demonstrated that ActA acts as a structural and functional mimic 
of NPF N-WASP to recruit Arp2/3 complex to the bacterial surface (Lommel et al., 
2001, Boujemaa-Paterski et al., 2001).  Moreover, the proline-rich repeats on the 
central domain of ActA also recruit profilin by interaction with Ena/VASP to promote 
actin-based motility (Smith et al., 1996). It has been shown that Ena/VASP in L. 
monocytogenes movement is involved in controlling speed and directionality of 
movement (Auerbuch et al., 2003). At the later stage of infection, the time-lapse live-
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cell imaging showed that VASP was not recruited to the actin tail of L. monocytogenes 
but it interacted with the host cell protein lamellipodin (Lpd) which is an Ena/VASP 
binding protein (Wang et al., 2015). In L. monocytogenes-infected HeLa cell, Lpd 
accumulated at the interface between the bacteria and the developing actin tail 
(Wang et al., 2015). L. monocytogenes infected Lpd-depleted cells showed 
significantly fewer and smaller plaques than control cells implying a role of Lpd in 
cell-to-cell spread (Wang et al., 2015). The activity of ActA is also regulated by host 
cell phosphorylation. A study demonstrated that casein kinase 2 (CK2)-mediates 
phosphorylation of the Arp2/3-binding domain (Chong et al., 2009).  This ActA 
modification regulates the affinity of ActA for the Arp2/3 complex and is required for 
proper actin tail formation and cell-to-cell spread (Chong et al., 2009).  
The use of in vitro reconstitution experiments uncovered a core set of host 
cell proteins that acts as the minimal requirements for actin assembly and 
disassembly, which are necessary for actin-based motility, consisting of actin, 
Arp2/3, capping protein and ADF/cofilin (Loisel et al., 1999). Consistently, in the 
Listeria-actin comet tail, the Arp2/3 complex, capping protein and cofilin have been 
detected (David et al., 1998). Despite this, a large number of host proteins 
participating in tail formation of L. monocytogenes was isolated from cell extracts in 
vitro, including actin-binding proteins and components of upstream signalling 
cascades (Van Troys et al., 2008). This suggested that actin tail formation was 
regulated by specific multicomponent regulatory complexes (Van Troys et al., 2008). 
Studies on numerous protein components localised in Listeria-comet tails 
demonstrated that the dynamic interaction of host cell proteins was exploited and 
involved in the characteristic actin filaments formed by this bacterium. Only actin 
and the Arp2/3 complex are essential for actin tail formation containing highly 
branched filaments (Brieher et al., 2004). Recently, a collapsin response mediator 
protein-1 (CRMP-1), which binds to both ActA and F-actin, was identified as a novel 
host cellular factor facilitating actin network formation by increasing Arp2/3-
dependent actin filament branching (Yu-Kemp and Brieher, 2016).  Nexilin, an actin-
associated protein that localises to the leading edge and focal adhesion in motile cells, 
was identified as a crucial component for efficient comet tail formation of L. 
monocytogenes (Law et al., 2012). This protein accumulated at the point of comet tail 
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formation origin with less co-localisation along the length of the actin tail (Law et al., 
2012). This implied that nexilin stabilised the actin-rich structure (Law et al., 2012).  
The difference in actin filament networks between the bacteria within the 
cytoplasm and in the protrusion, implies certain host factors contribute to these actin 
polymerisation process. The Arp subunit p34 was enriched along with the comet tail 
in the cytosol but reduced levels of this protein were found in the Listeria-induced 
protrusion (Fattouh et al., 2015). Whereas α-actinin was contained in the Listeria-
actin tail in the cytosol but it was not in the protrusions (Dabiri et al., 1990), and ezrin 
was detected in the Listeria-induced protrusion but not in the comet tail (Sechi et al., 
1997, Fattouh et al., 2015 ).  
Apart from the Arp2/3-dependent actin assembly, ActA also induced actin 
polymerisation in vitro in a VASP-dependent manner, but independent of the Arp2/3 
complex, similar to the host zyxin-mediated actin polymerisation (Fradelizi et al., 
2001). Interestingly, bundling proteins including fascin, fimbrin, and filamin, which 
were localised to the comet tail, were required for Listeria motility in the Arp2/3-
independent elongation phase (Brieher et al., 2004). In the absence of Arp2/3 
complex, the bacteria move faster with fascin-mediated propulsion (Brieher et al., 
2004).  The comet tail organisation that was generated in this stage was bundled 
parallel to the bacterial direction movement, differing from the branched filament of 
Arp2/3 nucleation (Brieher et al., 2004).  
2) Shigella flexneri 
S. flexneri is a Gram-negative enteropathogenic bacterium that causes 
bacillary dysentery, an intestinal disease in humans. After invasion, the bacterium is 
contained in a membrane-bound vacuole within the infected cells. Then, the vacuole 
is lysed and the pathogen is free in the cytosol where actin is recruited to the bacteria 
before forming an actin tail at one pole of the bacterium (Bernardini et al., 1989). The 
length of comet tail formed by S. flexneri in HEp2 cells varied from 5 to 15 µm with 
an average length of 7 µm (Gouin et al., 1999). Comparing movement rate with L. 
monocytogenes, S. flexneri moves faster with the highest speed recorded in Vero cells 
at 26 µm/min (Gouin et al., 1999). The force generated by actin polymerisation 
propels the bacteria within the cytosol until they eventually reach the peripheral 
membrane forming a large and long membrane protrusion (Monack and Theriot, 
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2001). This structure (5-30 µm in length and 0.5 µm width) contains the bacterium 
at the tip which is engulfed by adjacent cells leading to cell-to-cell spreading (Bishai 
et al., 2013). 
The ultrastructure of the S. flexneri comet tail was observed by electron 
microscopy and showed that the actin filments were oriented with the barded ends 
towards the pole of the bacterium (Gouin et al., 1999). Similar to L. monocytogenes, 
the density of the filaments was higher in the vicinity of the bacterium, compared to 
the rest of the tails (Gouin et al., 1999). The actin filaments were cross-linked and 
formed a branching network which is a characteristics of Arp 2/3 complex nucleated 
filaments (Gouin et al., 1999, Tilney and Portnoy, 1989), but the filament along the 
sides of S. flexneri tails was shorter than those in L. monocytogenes tails (Gouin et al., 
1999). Actin filament organisation formed by S. flexneri in membrane protrusions 
were more bundled towards the end of the tails, compared to those in the comet tail 
presented in the cytosol (Gouin et al., 1999). 
 The bacterial factor required for actin-based motility of S. flexneri is IcsA (also 
called VirG) (Makino et al., 1986). Expression of IcsA on the surface of Escherichia 
coli is sufficient to allow the bacterial actin-dependent movement in cytoplasmic 
extracts, with the same rate of S. flexneri in infected cells (Goldberg and Theriot, 
1995, Kocks et al., 1995). IcsA is a member of the type V autotransporter family which 
are secreted across the cytoplasmic membrane to be presented on the outer 
membrane of S. flexneri (Brandon et al., 2003). IcsA is targeted at the pole of the 
bacteria before being secreted (Charles et al., 2001, Goldberg et al., 1993) and 
recruiting N-WASP (Suzuki et al., 1998).  
Whilst ActA acts as an NPF mimic and directly activates Arp2/3 complex, the 
host NPF N-WASP is recruited to the Shigella pole and in turn activates Arp2/3 
complex for initiation of actin nucleation and polymerisation (Egile et al., 1999). IcsA 
specifically interacts with N-WASP but it does not interact with other WASP family 
proteins (Suzuki et al., 2002). In N-WASP-defective fibroblasts, Listeria was able to 
form an actin tail but Shigella failed to induce actin tail formation (Lommel et al., 
2001). Consistently, overexpression of a dominant-negative N-WASP mutant inhibits 
actin assembly on Shigella but has no effect on the formation of actin tail by Listeria 
(Suzuki et al., 1998). Without significant sequence similarity to ActA, a glycine-rich 
repeat domain on IcsA is required for recruitment of N-WASP (Suzuki et al., 1998). 
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The interaction between IcsA and N-WASP activates an auto-inhibited conformation 
of N-WASP opening up the WCA domain to recruit the Arp2/3 complex and initiate 
actin assembly (Egile et al., 1999, Mauricio et al., 2017). This ability is similar to the 
cellular signalling molecules (Cdc42 or PIP2), suggesting that IcsA is a functional 
mimic of these molecules that recruit and activate N-WASP. This could explain why 
this pathogen was able to form actin tail in Cdc42-deficient cells (Shibata et al., 2002).  
However, both Cdc42 and PIP2-induced actin polymerisation require Toca-1 
(Transducer of Cdc42-dependent actin assembly) to interact with N-WASP to 
promote actin nucleation (Ho et al., 2004). Toca-1 was transiently recruited to the 
surface of S. flexneri at the stationary phase and dissociated from the bacteria when 
the bacteria begin to move (Leung et al., 2008). In Toca-1 depleted cells with 
expression of a constitutively open N-WASP, S. flexneri was able to assemble an actin 
tail, demonstrating that Toca-1 acts as a cellular cofactor for relief of N-WASP 
autoinhibition and efficient actin tail formation by S. flexneri (Ho et al., 2004, Leung 
et al., 2008). N-WASP-dependent actin polymerisation is also regulated by 
phosphorylation. In fibroblast cells, the Abl tyrosine kinase phosphorylates N-WASP 
(Burton et al., 2005). S. flexneri was able to restore the length of actin tail and the size 
of plaques in cells lacking Abl kinase when an activated N-WASP mutant was 
introduced, suggesting that Abl kinase was required for elongation of the Shigella 
actin tail as well as cell-to-cell spread (Burton et al., 2005). Similarly, in intestinal 
cells, Bruton’s tyrosine kinase (Btk) played a role in actin tail formation and 
dissemination of S. flexneri by regulation of N-WASP phosphorylation (Dragoi et al., 
2013). 
Several cytoskeleton proteins found in the Listeria-actin tail are also present 
in the Shigella-actin tail (Gouin et al., 1999). Actin, Arp2/3 complex, actin 
depolymerisation factor and capping protein were the minimal requirement for 
Shigella movement in vitro, the same as for Listeria in vitro actin-based motility 
(Loisel et al., 1999).  To fine-tune actin assembly dynamics, pathogens evolved their 
specific strategies to manipulate the host cell proteins differently. For example, VASP 
was present in both actin tail of L. monocytogenes and S. flexneri (Gouin et al., 1999) 
but this protein was essentail for motility rate of  L. monocytogenes  (Geese et al., 
2002), but not in S. flexneri (Ally et al., 2004). Whilst a cytoskeleton protein, spectrin 
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was not recruited to L. monocytogenes actin tail, this protein was localised within 
comet tail of S. flexneri (Ruetz et al., 2011, Ruetz et al., 2012). 
3) Rickettsia 
 Rickettsia are Gram-negative obligate intracellular bacteria that cause 
diseases such as typhus and spotted fever, transmitted to their mammalian host by 
arthropod vectors including ticks, lice and fleas. Whilst the spotted fever group (SFG) 
rickettsiae, such as R. conorii, R. parkeri and R. rickettsia, display long actin tails, the 
typhus group rickettsiae including R.  typhi forms a very short actin tail with a hook 
shape, and no actin tail formation is displayed by R. prowazekii in infected Vero cells 
(Van Kirk et al., 2000, Heinzen et al., 1993). Different from the branched actin tails-
mediated by Arp2/3 complex formed by Listeria and Shigella (Gouin et al., 1999), R. 
conorii actin tails are long and composed of helical bundles of actin filaments (Gouin 
et al., 1999). Similarly, the ultrastructure of R. rickettsia actin tails was observed by 
transmission electron microscopy and showed that the individual F-actin filaments 
are long and oriented with the fast-growing barded end towards the bacterial pole 
(Van Kirk et al., 2000). Using laser scanning confocal microscopy revealed that the 
SFG R. rickettsia actin tail is formed of bundles of actin filaments twisted around each 
other (Heinzen et al., 1999, Van Kirk et al., 2000). Despite a longer actin tail length 
with an average length of 16.7 µm of R. rickettsia (Van Kirk et al., 2000), the motility 
rate of SFG rickettsia in the cytoplasm of Vero cells was 2.5-3 times slower than that 
of L. monocytogenes (Heinzen et al., 1999, Van Kirk et al., 2000, Gouin et al., 1999). 
On the other hand, Rickettsia protrusions were shorter than those in Listeria infected 
cells (Gouin et al., 1999, Van Kirk et al., 2000). 
Whilst L. monocytogenes and S. flexneri express a single surface protein to 
activate the Arp2/3 complex to exploit the host cell actin polymerisation pathway to 
drive actin-based motility, Rickettsia requires two bacterial factors function as an 
actin nucleator to initiate actin polymerisation in distinct phases. The early phase of 
motility within an hour after infection requires an Arp2/3 complex-activating 
protein called RickA and at 24 hours later requires a bacterial surface protein, Sca2 
(Surface Cell Antigen 2) to facilitate cell-to-cell spread (Reed et al., 2014). The 
bacterial surface RickA was discovered through the similarity region with the WCA 
region of WASP protein in the SFG Rickettsia (Jeng et al. 2004). In contrast, RickA was 
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absent in the typhus group R. prowazekii that did not display actin-based motility 
(Gouin et al., 2004, Jeng et al., 2004). Interestingly, R.  typhi was able to form a short 
actin tail despite lacking RickA (Heinzen et al., 1993). RickA stimulates Arp2/3-
dependent actin polymerisation in vitro which generated branched actin networks 
(Gouin et al., 2004, Jeng et al., 2004). Despite this, the Arp2/3 complex was not 
detected in the actin tail and was not required for actin tail formation of the SFG R. 
rickettsia (Gouin et al., 2004, Serio et al., 2010). This led to the identification of the 
autotransporter protein Sca2 using transposon mutagenesis (Kleba et al., 2010). A 
Sca2 mutant of SFG R. rickettsia was unable to induce actin tail formation and 
displayed a small-plaque phenotype indicating that Sca2 was required for actin tail 
formation and cell-to-cell spread (Kleba et al., 2010). The N-terminal domain of Sca2 
shares secondary structure similarity with the FH2 domains of formins (Haglund et 
al., 2010, Madasu et al., 2013).  
 Morphology of Rickettsia actin tail generated at different times during 
infection was also observed. After invasion, short and curved actin tails with slow 
movement were found in the early phase when the bacteria expressed RickA and the 
Arp2/3 complex as well as cofilin were recruited into the actin tail (Reed et al., 2014). 
Instead, the formin mimic, Sca2 was later expressed and the bacteria displayed long 
and straight actin tails leading to a faster motility (Reed et al., 2014).  The molecular 
mechanism of Rickettsia actin-based motility in the early and late phase is also 
distinguishable. Early actin tail formation by SFG R. parkeri was impaired in the cells 
treated with an Arp2/3 inhibitor but there was no effect in the late actin tail 
formation (Reed et al., 2014). Indeed, a core set of host factors for SFG R. parkeri 
actin-based motility was identified as profilin, fimbrin/T-plastin, capping protein 
and cofilin (Serio et al., 2010). These proteins were localised throughout the actin 
tails and played a role in controlling actin tail length, morphology of the actin tail and 
motility rate (Serio et al., 2010). 
4) Mycobacterium marinum   
 Mycobacterium tuberculosis causes the human disease tuberculosis. M. 
marinum is a waterborne pathogen of macrophages that causes a systemic 
tuberculosis-like disease in its natural hosts, e.g. fish and frogs, and in 
immunocompromised humans. M. marinum is closely related to M. tuberculosis with 
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a similar mode of pathogenesis and genetics (Stamm and Brown, 2004, Tobin and 
Ramakrishnan, 2008). However, M. marinum is the only mycobacterial species that 
displays actin tail formation (Stamm et al., 2003). The bacterium is able to escape 
from the Mycobacterium-containing vacuole (MCV) and enter the cytoplasm of the 
infected macrophage where it induces actin polymerisation to facilitate direct cell-
to-cell spread. A number of M. marinum were motile within bone-marrow-derived 
macrophages (BMDM) at an average rate of 11 µm/min (Stamm et al., 2003). 
Additionally, M. marinum was able to form actin tails in the free-living amoeba, 
Acanthamoeba castellanii  (Kennedy et al., 2012). M. marinum actin tails were also 
found in murine and fish macrophage cell lines, as well as in cell-free extract when 
using the bacterium isolated from the infected BMDM (Stamm et al., 2003). Electron 
microscopy showed that the actin filaments behind M. marinum were polymerised in 
a branched pattern (Stamm et al., 2003). A few of M. marinum  formed the actin tail 
at the side of a bacterium, whereas most of them formed actin tails at the pole 
(Stamm et al., 2003). Phase contrast time-lapse microscopy showed that M. marinum 
moved beyound the cell membrane to the adjacent cell directly (Stamm et al., 2003). 
Focal growth of intracellular GFP-labeled M. marinum in the presence of antibiotics 
was also detected, indicating that the role of actin-based motility was in direct cell-
to-cell spread (Stamm et al., 2003). 
 Actin filaments formed by M. marinum were in a branched pattern which is a 
characteristic of the Arp2/3 complex-mediated actin polymerisation (Stamm et al., 
2003). Consistently, subunits of the Arp2/3 complex was detected in the M. marinum 
actin tail (Stamm et al., 2003). Whilst VASP was also found throughout the actin tail, 
WASP and N-WASP localised specifically to the bacterial pole (Stamm et al., 2003). 
M. marinum motility was shown to require only WASP and N-WASP from the 
WASP/WAVE family because the bacteria restored actin tail formation in fibroblasts 
lacking N-WASP with transient expression of either WASP and N-WASP but not 
WAVE2 proteins (Stamm et al., 2005).  The mechanism of actin polymerisation of M. 
marinum is similar to Shigella which hijacks signalling for Arp2/3 complex-
dependent actin polymerisation through activation of the WASP family proteins 
(Stamm et al., 2005).  
Until now, the bacterial factor involved in M. marinum actin-based motility 
has not been defined. It has been reported that mutations in the type VII secretion 
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system ESX-1 impaired plaque formation in an A549 cell monolayer by M. marinum 
(Gao et al., 2004). This system was important for the M. marinum to escape from the 
vacuole, in turn, ESX-1 was required for actin tail formation because the bacterium 
initiated actin polymerisation only when it entered the cytosol (Smith et al., 2008). 
Similarly, ESX-1-deficient bacteria were not able to form actin tails in amoebae 
(Kennedy et al., 2012).  
5) B. pseudomallei 
B. pseudomallei is another intracellular pathogen that can invade host cells 
and replicate inside the cytosol where it can move inside and between cells using 
actin-based motility. Actin is polymerised at one pole of the bacterial cells (Breitbach 
et al., 2003, Kespichayawattana et al., 2000, Stevens et al., 2005a).  Among the 
Burkholderia species, B. mallei and B. thailandensis also showed this feature (Stevens 
et al., 2005b). From genome sequence analysis, bpss1492 encoding BimA was 
identified as a proline-rich autosecreted protein, which is a key feature of IcsA that 
is required for actin-based motility of S. flexneri (Breitbach et al., 2003, 
Kespichayawattana et al., 2000, Stevens et al., 2005a). BimA belongs to the family of 
Type V autotransporter proteins which is a large and diverse family of secreted and 
outer membrane proteins that play role in pathogenesis and immunity (Reviewed in 
Lazar Adler et al., 2011). Localisation of BimA was present at the polar of one 
daughter cell during cell division (Stevens et al., 2005a).  
Similarly, to other intracellular pathogens that exploit the Arp2/3 complex, 
the components of this complex were recruited to B. pseudomallei-actin tails in 
infected cells (Breitbach et al., 2003). However, in vitro studies showed that BimA 
directly interacts with actin and stimulates actin polymerisation in an Arp2/3-
independent manner (Stevens et al., 2005a, Benanti et al., 2015). Over-expression of 
a dominant negative domain of the cellular NPF Scar1, which inhibits Listeria, 
Shigella and SFG R. conorii motility, did not block B. pseudomallei tail formation, 
implying that Arp2/3 complex was not functionally required for B. pseudomallei 
actin-based motility (Breitbach et al., 2003).  Furthermore, N-WASP and Ena/VASP 
proteins were not required for actin-based motility of B. pseudomallei (Breitbach et 
al., 2003).  
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BimA homologues from related Burkholderia species can compensate for the 
actin tail formation defect of the B. pseudomallei bimA mutant, suggesting that actin 
assembly is a common function among these proteins (Stevens et al., 2005b). 
Comparison of the B. pseudomallei BimA with BimA from B. mallei and B. 
thailandensis demonstrates that the carboxyl-terminal regions are conserved but the 
amino-terminal regions are different. B. thailandensis BimA differs greatly in primary 
amino acid sequence to the B. pseudomallei BimA with the inclusion of an 
amphipathic central and acidic (CA) domain between the amino-terminal WH2 
domain and the proline-rich region as shown figure 1.3 (Stevens et al., 2005b). 
Interestingly, all BimA homologues bind directly with actin but only B. thailandensis 
BimA interacts with the Arp2/3 complex (Stevens et al., 2005b). Consistently, a 
recent study using Arp3 knockdown cells showed that B. pseudomallei and B. mallei 
were able to form actin tails in contrast to B. thailandensis which failed to form any 
actin tails in the knockdown cells (Lu et al., 2015a). Moreover, B. thailandensis BimA 
displays Arp2/3-dependent actin polymerisation in vitro (Stevens et al., 2005b, 
Sitthidet et al., 2010, Benanti et al. 2015). This indicated that B. thailandensis has a 
distinct mechanism for actin-based motility from B. pseudomallei and B. mallei. 
 
 
Figure 1.3: Domain organisation of the BimA proteins from Burkholderia 
pseudomallei, B. mallei and B. thailandensis  
The putative domains are shown drawn to scale where: SP, predicted signal peptide; 
NIPV, repeat sequence in B. pseudomallei BimA with homology to human diaphanous 1 
(hDia1); PRM, proline-rich motif 1 (IP7) with similarity to that found in hDia1, mouse 
formin and zyxin; WH2, WASP homology domain-2; PDAST, repeat sequence in B. 
pseudomallei BimA; TM, transmembrane anchor; Pro-rich, proline-rich regions; CA, 
central and acidic domains. (Figure taken with permission from Stevens et al., 2005b).  
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Studies on the functional regions of B. pseudomallei BimA demonstrated that 
the WH2 domains, but not a 13-amino acid repeat or proline-rich motif (PRM) 
domain, were required for actin binding, actin assembly, and plaque formation 
(Sitthidet et al., 2011). The predicted casein kinase II phosphorylation site (PDASX) 
domain was not required for actin binding, but deletion of PDASX repeats reduced 
the rate of actin polymerisation in vitro (Sitthidet et al., 2011). However, in-frame 
motif deletion mutants that lacked WH2 domains or a 13-amino acid repeat or PRM 
or PDASX domains did not impair BimA expression at the bacterial pole (Sitthidet et 
al., 2011). Expression of BimC was required for BimA-mediated B. thailandensis 
actin-tail formation as well as in B. pseudomallei and B. mallei (Lu et al., 2015a). In 
the same way, B. mallei bimA, bimB, bimC, bimE mutants could not form actin tails in 
infected cells (Schell et al., 2007).  Similarly, a B. mallei virG mutant was unable to 
induce actin polymerisation (Schell et al., 2007). Overexpression of the B. mallei 
VirAG two-component regulatory system, encoded adjacent to the bimA-E genes on 
chromosome 2, up-regulated transcription of the bimA-containing gene cluster 
suggesting that virAG was essential for transcription of bim genes (Schell et al., 2007). 
The unique mechanism of actin-based motility for Burkholderia species was 
revealed later and showed that B. pseudomallei BimA mimics host Ena/VASP 
proteins that can nucleate actin and promote actin filament elongation and bundling, 
generating a long and loosely bundled F-actin filament (Benanti et al., 2015) which 
agreed with our finding (Jitprasutwit et al., 2016). This actin filament organisation 
resulted in a long actin tail with straight paths of motility (Benanti et al., 2015). 
Similarly, BimA from B. mallei also mimics Ena/VASP showing the same actin tail 
morphology (Benanti et al., 2015). On the other hand, B. thailandensis BimA 
interacted and activated the Arp2/3 complex (Sitthidet et al., 2010, Stevens et al., 
2005b), generated branched actin filaments displaying curved and dense actin tails 
with a shorter length compared to B. pseudomallei- and B. mallei-actin tails (Benanti 
et al., 2015).  This characteristic suggested that B. thailandensis BimA was an NPF 
(Benanti et al., 2015). 
B. pseudomallei uses a unique strategy to induce actin tail formation 
independently of the Arp2/3 complex. Our laboratory has previously performed a 
proteomic analysis similar to the previous studies that found new actin-binding 
proteins in the comet tails of L. monocytogenes (David et al., 1998, Van Troys et al., 
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2008).  From the list of host cell proteins recruited to bacteria expressing BimA, the 
minimal requirements for actin polymerisation in vitro including actin, Arp2/3 
complex, actin-depolymerising factors and capping proteins were detected 
(Jitprasutwit et al. 2016) in agreement with the previous study (Loisel et al., 1999). 
Localisation of the Arp2/3 complex in the B. pseudomallei actin tail was previously 
described (Breitbach et al., 2003). Similarly, vinculin and α-actinin that were 
detected in actin tail of B. pseudomallei and also found in those of L. monocytogenes 
and S. flexneri (Breitbach et al., 2003), but not in R. rickettsia (Van Kirk et al., 2000), 
were also isolated from our in vitro system (Jitprasutwit et al., 2016). Interestingly, 
the host proteins that were identified in our previous work did not include 
microtubule components, intermediate filaments and myosins, which were 
previously detected in the actin tails of L. monocytogenes (Van Troys et al., 2008). 
Additionally, VASP and profilin that were recruited into Rickettsia actin tails (Van 
Kirk et al., 2000) were not found in our experiment (Jitprasutwit et al., 2016). While 
the molecular mechanism of the Arp2/3-mediated actin-based motility by L. 
monocytogenes and S. flexneri are well known (Reviewed in Welch and Way, 2013), 
the mechanism of actin-based motility displayed by B. pseudomallei and B. mallei are 
poorly characterised. Discovery of host factors that are involved in this process 
would be important in the further understanding of how pathogens exploit the actin 




1.3   BimA plays roles in intracellular survival and virulence  
Actin-based motility impacts intracellular life cycle of several bacterial 
pathogens, particularly in cell-to-cell spread (Reviewed in Lamason and Welch, 
2017). The force generated from actin-based motility is sufficient for the bacterium 
to create a membrane protrusion into the adjacent cell (Monack and Theriot, 2001). 
Dissemination defects are observed by mutants that cannot form actin tails. A S. 
flexneri icsA transposon mutant lacking an F-actin tail did not spread between host 
cells (Bernardini et al., 1989). Similarly, a transposon insertion in the actA gene of L. 
monocytogenes could not form plaques on a fibroblast monolayer (Kocks et al., 1992). 
In the same way, the Sca2 R. rickettsii mutant that did not produce an actin tail 
formed a smaller plaque phenotype than the wild-type (Kleba et al., 2010). 
In addition to cell-to-cell spread, bacterial pathogens induce actin-based 
motility to manipulate autophagy or avoid lysosomal killing (Reviewed in Mostowy 
and Shenoy, 2015). In L. monocytogenes, ActA recruits Arp2/3 complex to the 
bacterial surface in order to escape autophagic recognition (Yoshikawa et al., 2009). 
Alternatively, IcsA from S. flexneri recruits N-WASP and then activates Arp2/3 
complex for actin polymerisation, but at the same time, IcsA also binds to an 
autophagy protein forming septin cage-like structures to prevent actin tail formation 
(Mostowy et al., 2010). For evasion of autophagy recognition by S. flexneri, the type 
3 secretion system effector IcsB is expressed to prevent the recruitment of autophagy 
proteins to the bacterial surface (Ogawa et al., 2005) (Reviewed in Krokowski and 
Mostowy, 2016).  
Moreover, actin-based motility influences the virulence of bacterial pathogens 
(Reviewed in Choe and Welch, 2016). For example, the actA deletion mutant of L. 
monocytogenes that was defective to induce actin tail formation in tissue culture cells 
showed a decrease in virulence in mice (Brundage et al., 1993). Similarly, the R. 
rickettsia sca2 mutant displayed reduced virulence in a guinea pig model of infection 
(Kleba et al., 2010).  
Studying BimA explores the importance of actin-based motility in intracellular 
life of B. pseudomallei. A bimA mutant showed a reduction of net intracellular 
replication in J774.2 macrophage-like cells (Lazar Adler et al., 2015). BimA mutants 
with a defect in actin tail formation could not induce plaque formation (Benanti et 
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al., 2015, French et al., 2011, Sitthidet et al., 2011). Similarly, B. oklahomensis, an 
avirulent related species, which was not able to display actin tail formation during 
infection despite the presence of a gene encoding a ‘BimA-like’ protein with 40% 
identity to the B. pseudomallei BimA, showed a low virulence in Galleria mellonella 
larvae. (Wand et al., 2011). BimA is also required for full virulence in a murine model 
of infection. A bimA mutant showed a 10-fold increase in median lethal dose, 
compared to the isogenic parent strain B. pseudomallei in BALB/c mice, 
demonstrating attenuated virulence (Lazar Adler et al., 2015). This finding agreed 
with the result in our laboratory, a bimA mutant had a defect in intracellular survival, 
plaque formation and virulence in mice (Figure 1.4; Stevens, unpublished data). 
Immunisation with either recombinant B. mallei BimA increased survival percentage 
of mice after challenging with B. mallei and B. pseudomallei (Whitlock et al., 2010). 
Virulence of B. pseudomallei, and the requirement of the bimA gene in virulence, in 
the Galleria mellonella model was also observed by Vander Broek and Stevens 
(Unpublished observations). 
The impact of BimA was also studied in human cases of melioidosis and 
animal models of infection and showed that it is a potent B-cell antigen (Felgner et 
al., 2009) and is recognised by T-cells in recovering melioidosis patients 
(Suwannasaen et al., 2011). A survey in the endemic area showed the bimA gene was 
present in 99 B. pseudomallei isolates having a high degree of conservation, 12% 
showed a geographically restricted subset of B. pseudomallei isolates from the 
Australian Northern Territory harbouring a B. mallei-like bimA allele (Sitthidet et al., 
2008). This bimA variant had a significant association with neurological melioidosis 
(Sarovich et al., 2014).  
Collectively, these evidences point to a role of BimA in intracellular life and 








Figure 1.4: BimA is required for intracellular survival, cell-to-cell spread and 
virulence in mice (Unpublished data from Jo Stevens and Mark Stevens (UoE), and Greg 
Bancroft (LSTHM)) 
(a) Intracellular survival of B. pseudomallei 10276 WT (blue line), bimA mutant (red 
line) and bimA mutant trans-complemented with bimA (green line) in A549 cells.  
(b) Plaque formation in A549 cell monolayers by B. pseudomallei 10276 WT, bimA 
mutant and bimA mutant trans-complemented with bimA (green line) at 24 hours 
post-infection. 
(c) Percentage of survival of mice challenged with B. pseudomallei 10276 WT (blue 
line), bimA mutant (red line) and bipD mutant (a T3SS mutant used as an avirulent 
control) in an intranasal model of infection. 
  









1.4   IQGAP1 
IQ motif containing GTPase activating protein 1 (IQGAP1) is a member of the 
IQGAP family which is conserved in eukaryotes. This cytoplasmic scaffold protein 
contains an N-terminal calponin homology domain (CHD), a polyproline binding 
region (WW), an IQ domain (IQ), a Ras GTPase-activating protein-related domain 
(GRD) and Ras GAP C-terminus (RGCT). The 190-kDa Homo sapiens IQGAP1 is well-
studied, performing an array of biological functions by binding and regulating 
several interacting proteins (Reviewed in Hedman et al., 2015). It is established as a 
regulator of the cytoskeleton playing roles in the organisation of the actin 
cytoskeleton (Reviewed in Watanabe et al., 2015). Several proteins associated with 
the cytoskeleton have been demonstrated to bind to IQGAP1. Figure 1.5 illustrates 
some partners that bind to a specific domain of IQGAP1. For instance, IQGAP1 binds 
F-actin directly and crosslinks the filaments (Bashour et al., 1997). The actin 
filaments are cross-linked by oligomerisation of IQGAP1 (Fukata et al., 1997). 
Regulation of IQGAP1 depends on free intracellular Ca2+ that promotes binding of 
calmodulin to IQGAP1, which in turn inhibits IQGAP1 binding actin of filaments 
(Mateer et al., 2002).  IQGAP1 also plays a role in cell motility and invasion in a Cdc42- 
and Rac1-dependent manner (Mataraza et al., 2003). In addition, IQGAP1 enhances 
actin polymerisation in vitro and mediates actin assembly by forming complexes with 
N-WASP and Arp2/3 complex (Bensenor et al., 2007, Le Clainche et al., 2007). In 
migrating cells, IQGAP1 was identified as a binding partner of the Diaphanous-
related formin (Dia1) which nucleates actin polymerisation to regulate cell motility 
and is required for the localisation of Dia1 for phagocytic cup formation (Brandt et 
al., 2007).   
IQGAP1 is also a key regulator of cell adhesion and directional migration, 
which is controlled by these small Rho-family GTPases (Reviewed in Noritake et al., 
2005). Cadherins comprise a major group of cell-cell adhesion molecules that 
mediate intercellular adhesion by engaging in Ca2+-dependent manner (Takeichi, 
1995). By forming cis homodimers, cadherins are clustered with their intracellular 
domains anchored to the actin cytoskeleton through α-catenin and β-catenin. 
Anchorage of cadherins to the actin cytoskeleton and their clustering are pivotal for 
the strong and rigid adhesion (Kuroda et al., 1998). The inhibition of IQGAP1 by RNAi 
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reduces the accumulation of actin filaments, E-cadherin and β-catenin at sites of cell-
cell contact that leads to weak cell adhesion, indicating the important of IQGAP1 for 
cell-cell adhesion (Noritake et al. 2004). 
IQGAP1 is also important in type I IFN production through the interaction 
with NLRC3, which is a nucleotide binding domain, leucine rich repeat CARD 
(caspase activation and recruitment domain) containing protein 3 (also known as 
CLR16.2 or NOD3), is a member of the NLR family of proteins. The nucleotide-binding 
domain and leucine-rich repeat containing (NLR) family is one of major familied of 
pattern recognition receptors (PRRs) that are an essential component of the host 
immune system (Tocker et al., 2017, Davis et al., 2017). NLRC3 is a negative regulator 
in response to bacterial and viral infection and expressed at high levels in various 
immune cell lines, but only at low levels in epithelial cell lines. NLRC3 regulates the 
type I IFN pathway by inhibiting subcellular redistribution and effective signalling of 
stimulator of IFN genes (STING), thus blunting the transcription of type I IFNs. A 
yeast two-hybrid screen using an amino terminal fragment of NLRC3 suggests that 
IQGAP1 associates with NLRC3 and can disrupt the NLRC3–STING interaction in the 
cytosol of human epithelial cells. A stable knockdown of IQGAP1 in THP1 human 
monocytic cell line and epithelial HeLa cell causes significantly more IFN-β 
production in response to cytosolic nucleic acids suggested a role of IQGAP1 in 
inhibition of production of type 1 IFN (Tocker et al., 2017). Localisation of NLRC3 
and IQGAP1 to the cell cortex in human epithelial cells, possibly via interactions with 
RGCT domain on IQGAP1, was also shown in the previous study (Tocker et al., 2017).  
Also, in the absence of IQGAP1, human monocytic cells are hyperactive in response 
to cytosolic nucleotides (Davis et al., 2017). 
In mammals, there are three IQGAP isoforms with a high level of amino acid 
sequence homology to IQGAP1, 62% and 59% for IQGAP2 and IQGAP3, respectively. 
They contain the same domain structure and each domain on IQGAP2 and IQGAP3 
exhibits more than 70% similarity to IQGAP1 as shown in Figure 1.5. Since the 
domains found among the IQGAP family are highly conserved, they share some 
binding partners. Both IQGAP2 and IQGAP3 are involved in cytoskeleton interactions 





In addition to binding partners, IQGAPs display specific expression patterns 
and different subcellular localisation in mammalian tissues. IQGAP1 is ubiquitously 
expressed in most cell types and distributed throughout the cytoplasm and cell 
membrane accumulating at cell-cell junctions and express. IQGAP2 is expressed 
predominantly in the liver (Wang et al., 2007) and IQGAP2 in rabbit gastric glands in 
primary culture localised in the nucleus and at sites of cell-cell contact (White et al., 
2009). IQGAP3 is reported to be expressed mainly in lung, brain, testis, small 
intestine and colon (Wang et al., 2007). In rat adrenal gland phaeochromocytoma 
cells, IQGAP3 is diffusely distributed in the cytoplasm and it is also found at cell-cell 
junctions in mouse epithelial cells (White et al., 2009). 
Intensive studies showed the importance of IQGAP1 in an array of biological 
functions. The finding of the role of IQGAP2 and IQGAP3 also have been accumulating 
and growing continuously. However, understanding the molecular mechanism of 
their functions is still poor. To gain insight into the involvement of IQGAPs in 
physiology and disease, further studies are required. 
 
Figure 1.5: Domain structure of IQGAP isoforms and binding partners of 
IQGAP1 that associate with the actin cytoskeleton 
Schematic presentation of domain organisation of IQGAP1 with 1657 amino acid, 
IQGAP2 with 1575 amino acid and IQGAP3 with 1631 amino acid length. The domain 
structures are indicated: CHD; calponin homology domain, WW; polyproline binding 
region, IQ; calmodulin-binding IQ motifs, GRD; Ras GTPase-activating protein-related 
domain, RGCT; Ras GAP C-terminus. The binding regions of IQGAP1 showing the regions 
of the interaction with its binding partners. Each domain of IQGAP2 and IQGAP3 was 
marked with the percentage of similarity with IQGAP1 analysed using pairwise sequence 
alignment (LALIGN). Italic shows the binding partners of IQGAP1.  
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1.4.1 IQGAP1 and bacterial pathogenesis  
A number of pathogen-derived IQGAP1 interaction partners have been 
discovered, indicating that IQGAP1 may be a common target for pathogens to 
regulate the actin cytoskeleton during attachment or invasion of host cells (Reviewed 
in(Kim et al., 2011b). IQGAP1 was identified as a component of Salmonella invasion. 
It co-localised with the SopE and SopE2 effector proteins, and interacts with Rac, 
Cdc42 and actin to form phagocytic cups (Brown et al., 2007). Another Salmonella 
protein Ssel has been identified as an IQGAP1 binding partner that binds directly to 
IQGAP1 in vitro and co-localises with IQGAP1 during infection of macrophages 
(McLaughlin et al., 2009). Enteropathogenic E. coli (EPEC) also targets IQGAP1 
through the bacterial Tir protein, an injected protein which manipulates the actin 
cytoskeleton by associating with calmodulin to induce actin pedestal formation 
(Brown et al., 2008). Moreover, Ibe is a novel bacterial effector of E. coli that interacts 
with IQGAP1 to induce pedestals and actin-rich membrane ruffles (Buss et al., 2009). 
IQGAP1 is also required for innate immune defence against pathogens. It interacts 
with YopMKIM, an outer protein of Yersinia pestis KIM, and regulates inflammasome 
function in macrophages (Chung et al., 2014). Recently, OspB, a Shigella effector 
protein was identified as a binding protein of IQGAP1. During early Shigella infection, 
OspB triggers cell proliferation by activation of mTORC1. IQGAP1 interacts with both 
OspB and mTORC1 leading to restriction of the area of spread of S. flexneri (Lu et al., 
2015b).  
The interaction of IQGAP1 and selected bacterial proteins is not only utilised 
by the pathogens to support the infection but also exploited for manipulating other 
binding partners of IQGAP1. For example, in S. enterica serovar Typhimurium that 
usurps Rac1 and MAPK signalling to facilitate its internalisation, IQGAP1 is used as a 
scaffold to integrate these two different pathways to achieve invasion into mouse 
embryonic fibroblasts (Kim et al., 2011a). When IQGAP1 lacking Rac1 or MEK and 
ERK binding site, the percentage of Salmonella invasion reduced by 45%. Whilst 
IQGAP1-null MEFs reconstituted with the IQGAP1 without a Rac1 binding site into 
the cells pre-treated with MEK1 inhibitor, the invasion efficiency decreased by 75% 
(Kim et al., 2011a).  However, Rac1 was not required for non-invasive EPEC to 
promote actin pedestal and bacterial adherence (Brown et al., 2008) Similarly, 
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invasion of E.coli K1 into human brain microvascular endothelial cells (HBMEC), 
requires IQGAP1 interaction with -catenin, but not Rac1, to support its dissociation  
from the adherence junction causing actin rearrangement showing co-localisation of 
IQGAP1 with polymerised actin beneath the bacterial binding site (Krishnan et al., 
2012). IQGAP1 also plays a role in promoting vascular smooth muscle cell adhesion 
and migration after Chlamydia pneumoniae infection-induced atherosclerosis (Zhang 
et al., 2012).   
Moreover, IQGAP1 was identified as an essential component in the 
communication between bacteria and human epithelial cells causing changes in the 
cytoskeleton network. A quorum-sensing molecule N–acylhomoserine lactone 
produced by Pseudomonas aeruginosa interacts and co-localises with IQGAP1 which 
functions as an integrator of Rac1 and Cdc42 to trigger cytoskeleton organisation 
(Karlsson et al., 2012). Also, IQGAP1 is required with Cdc42 to inhibit cell migration 
of the opportunistic pathogenic bacterium Legionella pneumophila infected cells 
(Simon et al., 2015).  When A549 cells were treated with LAI-1 (3-
hydroxypentadecane-4-one), a quorum sensing compound employed by this 
bacterium, Cdc42 was inactivated and IQGAP1 re-localised from the cytoplasm to 
accumulate at the cell cortex (Simon et al., 2015).  
The current literature shows the role of IQGAP1 binding partners seems to be 
specific for different pathogens. However, there is no publication that demonstrates 
the role of IQGAP1 in bacterial actin-based motility. For this reason, the role of 
IQGAP1 as a novel protein involved in this process was investigated in this study.  
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1.5   Aims and Objectives 
Aims 
To explore the mode of action and functional significance of IQGAP1 in the 
intracellular life of Burkholderia pseudomallei.  
 
Objectives 
1) To determine the localisation of IQGAP1 in B. pseudomallei-infected cells and 
study the role of IQGAP1 in actin-based motility of B. pseudomallei in siRNA-
mediated IQGAP1 knockdown cells.  
2) To generate IQGAP1 knockout cells by CRISPR-Cas9 genetic engineering to 
examine the importance of IQGAP1 in the intracellular life of B. pseudomallei. 
3) To determine whether IQGAP1 and BimA interact directly using an in vitro pull-
down assay and in vivo yeast two-hybrid system and test the effect of IQGAP1 on 






Materials and Methods 
2.1 Maintenance of cell line, bacteria, and yeast  
 Cell maintenance 
HeLa cells were maintained in a modified Dulbecco's Modified Eagles Medium 
containing high glucose, L-glutamine and sodium pyruvates (Gibco) and 
supplemented with 10% v/v heat-inactivated foetal calf serum (10% DMEM). 
Additionally, penicillin and streptomycin (P/S) were added at a concentration of 100 
units/ml and 100 µg/ml respectively. To passage, cells were washed with Dulbecco's 
phosphate-buffered saline (D-PBS; Gibco) and detached with 1X Trypsin-EDTA 
(0.025% trypsin and 0.01% EDTA) (Gibco).  
To store cells, the number of cells and viability were determined using 0.4% 
w/v Trypan Blue (Lonza). A final concentration of viable cells of 1 x 106 cells/ml in 
Recovery™ Cell Culture Freezing Medium (Gibco) was aliquoted into cryovials and 
kept in an ultra-low temperature freezer (~-140 C). 
 Preparation of bacterial glycerol stock 
Bacteria were cultured at 37°C on LB agar or LB broth (10 g/L Tryptone, 10 
g/L NaCl and 5 g/L g yeast extract with or without 15 g/L bacto-agar, pH 7.4). An 
overnight culture from a single colony of bacteria in LB broth containing appropriate 
antibiotics was harvested by centrifugation.  The cell pellet was re-suspended in LB 
broth and then mixed with 50% v/v glycerol in LB broth in a ratio of 1:1. The 
bacterial glycerol stock tubes were frozen at -80 °C.  
 Preparation of yeast glycerol stock 
For long-term storage of Saccharomyces cerevisiae, a fresh colony of S. 
cerevisiae was scraped from either a yeast extract peptone dextrose (YPD) agar (10 
g/L yeast extract, 20 g/L peptone, 2% w/v glucose, 20 g/L agar, pH 6.5) or synthetic 
defined (SD) plate (6.7 g/L yeast nitrogen base without amino acids, 20 g/L agar 
(Invitrogen), 2% w/v glucose, with amino acid supplements (Clontech), pH 5.8). The 
amino acids were added at the concentrations of 20 mg/L L-adenine hemisulfate salt, 
20 mg/L L-arginine HCl, 20 mg/L L-histidine HCl monohydrate, 30 mg/L L-




mg/L L-phenylalanine, 200 mg/L L-threonine, 20 mg/L L-tryptophan, 30 mg/L L-
tyrosine, 20 mg/L L-uracil, 150 mg/L L-valine. Tryptophan, adenine and histidine 
were excluded from SD media where appropriate. The yeast colony was suspended 
in 200 µl of sterile water using a vortex.  Next, the cell suspension was mixed with 
200 µl of sterile 50% v/v glycerol in Phosphate-buffered saline (PBS). For Pichia cells, 
a single colony was cultured in 5 ml of YPD overnight. Then the cells were harvested 
and re-suspended in 1 ml of YPD containing 15% v/v glycerol. The stocks were 
stored at –80 °C. 
2.2 SDS-Polyacrylamide gel electrophoresis (SDS-PAGE) 
Proteins were separated by sodium dodecyl sulphate polyacrylamide gel 
electrophoresis (SDS-PAGE). Protein samples were mixed in 2X SDS-PAGE loading 
buffer (100 mM Tris-HCl pH 6.8, 4% w/v SDS, 0.2% w/v bromophenol blue and 20% 
v/v glycerol and supplemented with 2% v/v β-mercaptoethanol). For analysis under 
non-reducing conditions, the β-mercaptoethanol was omitted. After that, samples 
were heated at 99 °C for 5 minutes, loaded onto suitable SDS-polyacrylamide gels, 
submerged in running buffer (25 mM Tris base, 192 mM glycine, and 0.1% w/v SDS) 
or Tris Glycine SDS PAGE Buffer (National Diagnostics) and subjected to 
electrophoresis to the proteins. The following solutions were used for preparing gels: 
 
Table 2.1: Volumes of components for preparing acrylamide resolving gel 
Solution Components 
% v/v acrylamide resolving gel 
6% 8% 10% 
ProtoGel 30% w/v (National Diagnostics) 2 ml 2.67 ml 3.33 ml 
1.5 M Tris-HCl, pH 8.8 2.5 ml 2.5 ml 2.5 ml 
10% w/v SDS 0.1 ml 0.1 ml 0.1 ml 
Deionised water 5.29 ml 4.62 ml 3.96 ml 
10% w/v ammonium persulphate 0.1 ml 1.0 ml 1.0 ml 
TEMED 0.01 ml 0.01 ml 0.01 ml 
  
Table 2.2: Volumes of components for preparing acrylamide stacking gel 
Solution Components 
5% v/v acrylamide stacking gel 
(10 ml) 
ProtoGel 30%  w/v (National Diagnostics) 2.4 ml 
1.5 M Tris-HCl, pH 6.8 1.26 ml 
10% w/v SDS 0.1 ml 
Deionised water 6.3 ml 
10% w/v ammonium persulphate 0.025 ml 




A protein dual colour standard (Bio-Rad) or a three-color protein standard 
(Abcam) that was used as a molecular weight marker was also included. 
 Preparation of HeLa cell lysate for SDS-PAGE 
HeLa cells were grown to confluency in a 24-well plate. Cells were washed 
with PBS before lysing with 100 µl of BugBuster Master Mix (Novagen). Protein 
concentration was determined using a Direct detect spectrophotometer (EMD 
Millipore). The same amount of total protein was then suspended in 2X SDS-PAGE 
loading buffer containing 2% v/v β-mercaptoethanol. Occasionally, cells were 
harvested using 1X Trypsin-EDTA.  
 Preparation of E. coli cell lysates for SDS-PAGE 
Total protein from E. coli cells were prepared using BugBuster Master Mix 
reagent. For small scale extractions, cells were harvested by centrifugation at 1,811 
x g for 10 minutes. The pellet was re-suspended with 200 µl of BugBuster Master Mix 
per 1 ml of culture and then incubated at room temperature on a rocker for 10 
minutes. Total cell lysate was subjected to SDS-PAGE as described above.  
 Preparation of yeast cell lysates for SDS-PAGE 
For a rapid method to examine protein expression in P. pastoris or S. 
cerevisiae, cell lysates were prepared following a protocol described previously 
(Matsuo et al., 2006). Briefly, the optical density (OD) of an overnight culture was 
adjusted to 0.5 at OD600 and 1 ml pelleted by centrifugation at 16,060 x g for 1 
minute. The cell pellet was washed with 1 ml of water and centrifuged. The washed 
pellet was re-suspended with 150 µl of water. Then 150 µl of 0.6 M NaOH was added 
to the cell suspension and incubated for 10 minutes at room temperature. The 
treated cells were harvested by centrifugation and the pellet was re-suspended with 
30 µl of yeast sample buffer (60 mM Tris-HCl pH 6.8, 4% v/v β-mercaptoethanol, 4% 
w/v SDS, 0.01% w/v bromophenol blue, and 5% v/v glycerol), heated at 99 C for 5 
minutes and subjected to SDS-PAGE. 
2.3 Coomassie blue staining 
After proteins were separated by SDS-PAGE, protein bands were visualised by 
Coomassie blue staining. Gels were rinsed in water and then submerged in 




10% v/v acetic acid) for 1 hour at room temperature. After that, gels were washed 
twice in de-staining solution (45% v/v methanol, 10% v/v acetic acid) for 15 minutes 
each. Next, gels were further de-stained in water overnight. Occasionally, gels were 
stained with Bio-Safe Coomassie Brilliant Blue G-250 stain (Bio-rad) or InstantBlue 
Protein Stain (Expedeon) following manufacturers instruction. 
2.4 Silver staining 
To detect proteins in low amounts after SDS-PAGE, silver staining was 
performed using a Pierce™ Silver Stain Kit (Thermo Fisher Scientific) and following 
manufacturers instruction. Briefly, the gel was washed in ultrapure water and fixed 
in fixing solution (30% v/v ethanol, 10% v/v acetic acid).  Next, the gel was washed 
in ethanol wash (10% v/v ethanol) and then in ultrapure water. After that, the gel 
was incubated in sensitiser working solution and then in stain working solution. The 
gel was rinsed with ultrapure water. Then developer working solution was added 
immediately and incubated until protein bands appeared. Finally, the gel was 
incubated with stop solution (5% v/v acetic acid) for 10 minutes. 
2.5 Western blotting 
After SDS-PAGE, proteins were transferred to a nitrocellulose membrane using 
Trans-Blot Turbo Transfer System (Bio-Rad) with a condition of 25 V and 1.0 A for 
60 minutes in transfer buffer containing 1X transfer buffer (BioRad) and 20% v/v 
methanol followed by standard western blotting techniques.  In brief, the membrane 
was washed with PBS (137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4, 1.47 mM KH2PO, 
pH 7.4) or Tris-buffered saline (TBS) containing 150 mM NaCl,20 mM Tris-HCl, pH 
7.5, and then incubated with blocking buffer (5% w/v non-fat milk in PBS or TBS) for 
30 minutes at room temperature. To detect specific proteins, primary antibodies 
were diluted in PBS or TBS supplemented with 0.1% v/v Tween-20 (PBST or TBST). 
The membrane was probed with primary antibodies at 4 °C overnight using a 
concentration described in table 7.4. After that, species specific secondary antibodies 
were added at an appropriate dilution and incubated for 45 minutes at room 
temperature. The membrane was washed with PBST or TBST and then washed with 




 Quantitative Fluorescent Western Blotting 
After blots were imaged using an infrared imager, fluorescent signals were 
quantified using ImageStudio software (LI-COR Biosciences). In each lane, the signal 
of each protein band of interest, for example IQGAP1, was divided by the signal of the 
internal loading protein control (either actin or GAPDH). The ratio of IQGAP1/actin 
or IQGAP1/GAPDH was compared to the ratio obtained from control cells, which was 
taken as 100%. 
2.6 IQGAP1 siRNA knockdown  
 Cell preparation 
One day before transfection, HeLa cells were detached by trypsinisation and 
then cells were harvested by centrifugation at 500  g for 5 minutes. The media was 
removed and cell pellet was re-suspended in 10%DMEM (antibiotic-free). The 
number of cells was counted and then diluted to a concentration 6 x 104 cells/ml. 
Next, HeLa cells were plated in a 24-well plate using 500 µl of cell suspension to 
obtain 3 x 104 cells per well. 
 IQGAP1 siRNA transfection 
HeLa cells were transfected using the optimised condition following method 
to achieve the lowest level of IQGAP1 expression. First, RNAi duplex (siRNA IQGAP1, 
ID S16837; Silencer Select, Ambion) and Lipofectamine RNAiMAX (Invitrogen) were 
diluted with Opti-MEM™ I reduced serum medium (Gibco) in a separate micro-
centrifuge tube. To prepare RNAi duplex, 0.3 µl of 20 µM siRNA working stock was 
mixed with 99.7 µl of Opti-MEM. For Lipofectamine, 2 µl of RNAiMAX was diluted 
with 98 µl of Opti-MEM. Then the reagents were combined and incubated for 15 
minutes at room temperature. HeLa cells were transfected with 200 µl containing 6 
pmol of siRNA to obtain a final concentration of RNAi duplex at 30 nM. Transfected 
cells were incubated in a CO2 incubator at 37 C for 48 hours before infection. 
2.7 Double nickase plasmid transfection 
 Cell preparation  
One day before transfection, the number of HeLa cells were counted and 




3 ml of cell suspension were seeded in a 6-well plate to obtain 4.8 x 105 cells per well. 
HeLa cells were approximately 80% confluent at transfection.  
 Cell transfection with double nickase plasmid 
IQGAP1 double nickase plasmid (sc-400597-NIC; Santa Cruz Biotechnology) 
was utilised to knockout IQGAP1 in HeLa cells. The mixture containing 3.5 g of 
plasmid diluted in 175 l of Opti-MEM and 12 l of  Lipofectamine 2000 (Invitrogen) 
diluted in 175 l of Opti-MEM was prepared. The plasmid-Lipofectamine complex 
was incubated at room temperature for 5 minutes. Next, HeLa cells were transfected 
with 2.5 g of plasmid by adding 250 l of the complex into each well. The transfected 
cells were incubated in a CO2 incubator at 37 C for 24 hours. To determine 
transfection efficiency, transfected cells on a cover slip were washed with PBS and 
fixed with 4% w/v PFA in PBS for 1 hour at room temperature before staining nuclei 
with DAPI. GFP-expressing cells were observed under a Leica DMBL fluorescent 
microscope (Leica Biosystems). 
 Selection of transfected cells 
At 24 hours post transfection the media was removed and replaced with 
10%DMEM containing P/S and supplemented with 3 g/ml of puromycin 
dihydrochloride (Sigma-Aldrich). Cells were incubated at 37 C for 48 hours with the 
antibiotic selection. After that, the media was removed and replaced with the fresh 
medium supplemented with 3 g/ml of puromycin and incubated further for 24 
hours. After puromycin selection, the medium was removed and replaced with 
10%DMEM containing P/S without puromycin and incubated for 4 days to allow 
expansion of the cells. 
 Isolation of clonal cell lines by dilution 
The viable cells after transfection and selection were dissociated with 1X 
Trypsin-EDTA. The number of cells was counted and calculated to obtain the cell 
concentration as 1 cell/100 l by making a serial dilution in 10%DMEM containing 
P/S. Then, 200 l of cell suspension was plated into each well of five 96-well plates. 
On the 8th day after isolation, cells were inspected for a clonal appearance with cells 
radiating from a central point.  Wells with multiple colonies or without any live cells 




media was replaced every 2-3 days until cells were more than 60% confluent. The 
cells were dissociated with 1X Trypsin-EDTA and replica-plated. Cells were passaged 
until the number of cells was enough for storage and validation by immunoblotting 
using anti-IQGAP1. 
 Detection of mutations by PCR  
Genomic DNA (gDNA) was extracted from control and selected clonal cell 
lines followed a protocol by Strauss (2001). In brief, HeLa cells were harvested by 
centrifugation at 500 × g for 5 minutes.  The supernatant was discarded. Cells were 
washed with ice-cold PBS twice. Then the cell pellet was re-suspended in 0.5 ml of 
digestion buffer (100 mM NaCl, 10 mM Tris-HCl pH 8, 25 mM EDTA pH 8, 0.5% w/v 
SDS and 0.1 mg/ml proteinase K (Sigma-Aldrich) and incubated with shaking at 50 
°C. Next, the samples were extracted with an equal volume of 
phenol/chloroform/isoamyl alcohol (Sigma-Aldrich) and centrifuged at 1,700 × g for 
10 minutes. The top (aqueous) layer was transferred to a new tube and a ½ volume 
of 7.5 M ammonium acetate and 2 volumes of absolute ethanol were added. DNA was 
recovered by centrifugation at 1,700 × g for 2 minutes and the pellet was washed 
with 70% v/v ethanol before air-drying. The DNA pellet was re-suspended in TE 
buffer (100 mM Tris-HCl pH 8.0, 10 mM EDTA pH 8.0). 
To detect mutation within exon 13 of human IQGAP1, 200 ng of gDNA was 
used as template for amplification of a flanking region of exon 13 by Q5® High-
Fidelity DNA Polymerase (New England Biolab) using the oligonucleotides described 
in Table7.3. Conditions of PCR were as follows: 98 °C for 1 minute and 35 cycles of 
95 °C for 10 seconds, 67 °C for 20 seconds and 72 °C for 30 seconds, with a final 
extension step at 72 °C for 2 minutes. The PCR products were visualised by agarose 
gel electrophoresis before DNA purification and DNA sequencing (Source 
BioScience) using the same primers used for amplification. The nucleotide sequence 
of the control or wild-type (WT) HeLa cell line was analysed using Homo sapiens 
(human) Nucleotide BLAST (https://blast.ncbi.nlm.nih.gov/Blast.cgi) for 
verification. To detect mutations in the clonal cell lines, the DNA sequences of 
selected clones was aligned with WT using Clustal Omega 
(http://www.ebi.ac.uk/Tools/msa/clustalo/). The amino acid sequences of the 






Approximately 108 HeLa cells were dissociated from a tissue culture flask 
using 1X Trypsin-EDTA. Cells were centrifuged at 500 × g for 5 minutes and washed 
with PBS twice. The pellet was lysed with 1 ml of lysis buffer (50 mM Tris-HCl pH 7.5, 
150 mM NaCl, 1% v/v Triton X-100, 1 mM PMSF, 50 mM NaF, 1 mM Na2VO3, 1 mM 
EGTA) and the suspension was incubated on a tube rotator at 4 C for 2 hours. Cell 
lysates were centrifuged at 14,000 × g for 15 minutes. The supernatant was pre-
cleared by adding 100 µl of 50% v/v Protein A agarose bead slurry (Sigma-Aldrich) 
and incubated at 4 C for 2 hours.  Protein A agarose beads were removed by 
centrifugation. Total protein concentration in supernatant was determined using a 
direct detect spectrophotometer. 1.2 mg total protein was mixed with 4 µg of anti-
IQGAP1 and incubated at 4 C overnight. Next, the immune-complex was captured by 
adding 100 µl Protein A agarose bead slurry and gently rocking for 4 hours at 4 C. 
The agarose beads were collected by pulse centrifugation and washed extensively 
with ice-cold lysis buffer.  After removing the supernatant, the agarose beads were 
re-suspended in 30 µl of 2X SDS-PAGE loading buffer omitting β-mercaptoethanol to 
avoid breaking di-sulphide bond of the antibodies and heated at 70 C for 10 minutes. 
The supernatant was subjected to SDS-PAGE in non-reducing condition followed by 
Coomassie blue staining and Western blot analysis. 
2.8 In vitro cell infection  
 HeLa cells infection with B. pseudomallei 
HeLa cells were infected with B. pseudomallei as described previously 
(Sitthidet et al., 2011). Briefly, a single colony of B. pseudomallei 10276 was 
inoculated into LB broth and incubated at 37 C overnight with shaking. The bacterial 
culture was harvested by centrifugation at 1,811 x g for 10 minutes, washed with PBS 
twice and diluted in 10%DMEM. HeLa cells in a 24-well plate were washed with pre-
warmed PBS before infected with B. pseudomallei at multiplicity of infection (MOI) of 
approximately 100. The bacteria were brought into contact with the cells by 
centrifugation at 300 × g for 5 minutes and then incubated at 37 °C for 30 minutes. 
Then, the medium was removed and replaced with fresh media containing 250 µg/ml 




the infected HeLa cells were washed twice with PBS before either fixation, 
preparation of cell lysates or enumeration of intracellular bacteria. 
 Infection of HeLa cells with Salmonella 
HeLa cells were infected with Salmonella enterica serovar Typhimurium 
4/74, a nalidixic acid-resistant (NalR) strain described by Brown et al., (2007). An 
overnight bacterial culture was harvested by centrifugation. HeLa cells (2 x 105 cells) 
were infected with the bacterium at MOI of approximately 20 and centrifuged at 500 
× g for 5 minutes. The infected cells were incubated at 37 C for 40 minutes. The 
media containing extracellular bacteria was removed and replaced with 10%DMEM 
containing 50 µg/ml gentamycin and incubated until the specified time point. 
 Invasion and intracellular survival assay 
For invasion assay, the internalised bacteria were observed at 2 hours post-
infection.  Infected cells were washed with PBS twice before lysis with 500 µl of 0.1% 
v/v Triton X-100 in PBS. The suspension was transferred into a new micro-centrifuge 
tube containing 500 µl of PBS. Then, 100 µl of bacterial suspension was plated onto 
3 separate LB plates. Plates were incubated at 37 C and the number of bacteria was 
counted when the colonies appeared.  
To determine intracellular survival over a time course of up to 48 hours post-
infection, the intracellular bacteria were harvested at specific time points as 
described above. The bacterial suspension was serially diluted in PBS and plated on 
LB agar plates and incubated at 37 C for 24-48 hours until the colonies appeared. 
 Plaque assay 
At 24, 48 and 72 hours post-infection, the media in the wells of the infected 
cells was removed. Cells were washed gently with PBS. The wells were filled with 
crystal violet stain (1% w/v crystal violet, 20% v/v methanol) and incubated at room 
temperature for 1 hour before aspirating the staining solution. The fixed monolayers 
were washed with distilled water until plaques could be observed. The plates were air-
dried and plaques counted upon visual inspection. 
2.9 Immunofluorescence staining and confocal microscopy 
At the specified time points, cells were washed twice with PBS before fixing 




fixed at 4 C for at least 24 hours. Otherwise, uninfected cells were fixed at room 
temperature for 1 hour. After that, cells were washed with PBS and then 
permeabilised with 0.5% v/v Triton X-100 for 15 minutes. Then, primary antibodies 
were diluted in BSA/PBS (0.5% w/v bovine serum albumin (BSA) in PBS with 0.02% 
w/v sodium azide and filtered through a 0.2 µm filter) at a concentration described 
in table 7.4. Coverslips were covered with the primary antibodies and incubated at 4 
C overnight. After washing, secondary antibodies were added to the coverslips and 
incubated at 37 C for 1 hour. Cells were washed, and then filamentous actin was 
stained using Alexa Fluor488 or Alexa Fluor568 phalloidin (Molecular Probes). 
Occasionally, 0.66 µg/ml of DAPI (Sigma-Aldrich) was used for nuclei staining.  
Coverslips were washed with PBS followed by water and then mounted with Prolong 
Gold (Molecular Probes) prior to microscopy. The samples were imaged using an 
LSM710 laser confocal microscope and images captured using Zen software (Zeiss). 
 Image analysis 
The images captured by confocal scanning microscopy and Zen 2011 
software (Zeiss) were analysed for actin density and actin tail length using ImageJ 
software (http://imagej/nih.gov/ij/).  For each sample set, each tail was randomly 
selected by choosing a tail that did not overlap with another. Actin density was 
calculated from the corrected total cell fluorescence (CTCF) using the formula: CTCF 
= Integrated Density – (Area of selected cell x Mean fluorescence of background 
readings). To measure the length of a straight actin tail, Feret's Diameter parameter 
was used to obtain the value of the longest distance between any two points along 
the selection boundary (caliper length), as shown in figure 2.1a. For curved tails, the 
length of the tail was measured by drawing a segmented line along the tail with spline 










Figure 2.1: Actin tail analysis using ImageJ 
Fluorescent images on green channel showing actin tail formation by B. pseudomallei 
were analysed for actin density and actin tail length using ImageJ software.  
(a) Actin density was measured by corrected total cell fluorescence (CTCF) using the 
value of integrated density at the area of actin tail and subtracted from the average 
fluorescent signal of two regions next to the tail (background). For actin tail length, 
a straight tail can be measured using Feret's measurements that is the longest 
distance between any two points along the selection boundary (yellow dash line). 
(b) For a curve tail, a segmented line (red) was drawn along the tail and then measured 
the length. 
  




2.10 Cell cytotoxicity assay 
At a specific time after transfection or infection, samples of the media 
overlaying the cells were collected to assess LDH release using CytoTox 96 Non-
Radioactive cytotoxicity assay kit (Promega), following manufacturer’s instruction. 
Briefly, 25 μl media was transferred to a 96-well assay plate. Next, 25 μl of 
reconstituted substrate mix was added into each well. The plate was covered to 
protect it from light and incubated for 30 minutes before adding 25 μl of the stop 
solution and reading absorbance at 490 nm using a FLUOstar OPTIMA (BMG 
Labtechnologies). Untreated medium was used as a blank control. Percentage of 
cytotoxicity was calculated by comparing values with maximum LDH release from 
non-transfected HeLa cells lysed with 0.1% v/v of Triton X-100, which was set as 
100%.  
2.11 DNA manipulation 
 Agarose gel electrophoresis 
UltraPure™ agarose (Invitrogen) was used at 0.8% w/v or 1% w/v in TAE 
buffer (40 mM Tris, 20 mM acetic acid, 1 mM EDTA) supplemented with 1X SYBR™ 
Safe DNA Gel Stain (Invitrogen) for resolution of DNA fragment larger than 1 kb, or 
2% for smaller fragments. DNA samples were mixed with 1/6th volume of 6X agarose 
loading dye buffer (0.25% w/v Bromophenol blue, 40% w/v sucrose). For small 
fragments (less than 1 kb), DNA samples were diluted with 5X Orange G loading dye 
(0.2% w/v Orange G Dye, 1.5% v/v glycerol in 0.6 M EDTA pH 8.0). Electrophoresis 
was performed at a constant voltage (150 V) for 30 minutes to 1 hour. DNA was 
visualised by exposure to ultraviolet light on a transilluminator using the G:BOX 
image capture system (Syngene) or FluorChem™ HD2 system (ProteinSimple). 
2.12 Polymerase chain reaction (PCR) procedures 
 Polymerase chain reaction 
Polymerase chain reactions (PCR) were performed in 25 µl volume, 
containing variable amounts of DNA template, 0.5 µM oligonucleotide primers, each 
deoxynucleotide (dNTPs) at 200 µM and 0.5 units of polymerase. The buffer provided 
with the enzyme was added to a final concentration of 1X. Occasionally, 3% v/v 




Conditions for amplification were set as described in each of the relevant method 
section. 
 Colony PCR 
To screen E. coli colonies for the presence of plasmids, a single colony was 
patched on a fresh LB agar plate supplemented with appropriate antibiotics using a 
sterilised pipette tip.  After patching, the remaining cells on the tip was suspended 
directly into a PCR mixture containing all relevant reaction components. The thermo-
cycling conditions were specific for amplification of each individual gene.  
 For screening of Pichia pastoris harbouring a plasmid, a sterile tip was use to 
pick up individual colonies and re-suspended in 20 µl of 20 mM NaOH. The cell 
suspension was boiled at 99 C for 10 minutes. The sample was briefly centrifuged 
to pellet the cell debris and the supernatant (1 µl) was subjected to PCR amplification. 
2.13 Plasmid construction 
In this study, PCR amplification was performed using high-fidelity DNA 
polymerases. To amplify full-length, N-terminal and C-terminal of IQGAP1 and β-
actin, HeLa cell cDNA (BioChain) was used as a template by Advantage 2 PCR Kit 
(Clontech). The fragments were cloned into pGEM-T Easy vector (Promega) using T4 
DNA ligase (Promega) following the manufacturer’s instructions. The ligation 
mixture was then transformed into E. coli XL-1 Blue by heat shock method. 
Transformants were selected by plating on LB agar plates containing ampicillin at 
100 µg/ml and incubating at 37 C overnight. Then the insertion was screened by 
colony PCR. Clones showing the expected sized of PCR product were cultured for 
plasmid extraction using a MiniPrep Kit (Qiagen). Restriction enzyme digestion was 
performed to confirm the presence of the desired insert before sequencing. After that 
the insertions were sub-cloned into pMAL-p2X vector (New England Biolabs) for 
expression in E. coli. In addition, full-length IQGAP1 was sub-cloned into pPICZ for 
expression in P. pastoris and into pGADT7 for yeast two-hybrid assay. Also, β-actin 
was sub-cloned into pGADT7 for expression in yeast. The fragments were purified by 
gel extraction kit (Qiagen) and then ligated into the plasmids with T4 DNA ligase 
(Promega). The ligation reaction mixture was cleaned up before taking the 
supernatant to transform into E. coli XL-1 blue by heat shock method. Clones 




appropriate antibiotics. The inserts were confirmed by restriction enzyme digestion 
and DNA sequencing. 
 To express B. pseudomallei 10276 BimA (from amino acid residues 54 to 470), 
pME6032-BimA (Stevens et al., 2005) was used as a template for PCR amplification 
using two-step cycling. The resulting DNA fragment was cloned into pET-21b(+) via 
BamHI (Promega) and SacI (Promega) sites incorporated in the primers and then 
transformed into E. coli XL-1 blue competent cells using heat shock method. 
Transformants that grew on LB agar supplemented with 100 µg/ml ampicillin were 
screened for the bimA gene by colony PCR. A selected clone was cultured for plasmid 
extraction and then subjected to DNA sequencing. The sequencing result verified that 
the bimA gene fragment encoding amino acids 54-470 was inserted into the vector 
in the correct reading frame and in the correct orientation. To construct pMAL-p2X 
expressing BimA54-470, BimA54-470 was sub-cloned from pET-21b(+)BimA54-470 into 
pMAL-p2X via BamHI (Promega) and HindIII (Promega) sites. As above, the ligation 
reaction was transformed into E. coli XL-1 blue competent cells. Then, the plasmid 
was extracted for DNA sequencing to confirm the presence of the bimA gene in-frame 
with the gene encoding maltose-binding protein in pMAL-p2X.  
2.14 Site directed mutagenesis 
The sequencing result of the full-length IQGAP1 gene cloned into pGEM-T 
Easy vector showed 3 substitutions (A602C, T2130C and A3731G) when aligned 
against the human IQGAP1 sequence (NCBI Reference Sequence: NP_003861.1). 
These mutations that encode 2 different amino acids, K201T (lysine is changed to 
threonine) and D1244G (aspartic Acid is changed to glycine). In order to correct 
these mutations, QuikChange lightning site-directed mutagenesis kit (Agilent 
Technologies) was utilised, following the manufacture’s instruction. This technique 
is based on PCR allows mutagenesis at a single site using two synthetic 
oligonucleotide primers that contain the desired mutation. IQGAP1 mutagenesis was 
performed in two rounds where A602C was mutagenized first and then A3731G. 
Briefly, pGEM-T-FL3D-IQGAP1, was used as a template with using primers described 
in table 7.3. PCR mutagenesis was performed using control primers and cycling 
condition following the manufacturer’s instructions. Then DpnI was added directly 




DpnI-treated DNA sample was transformed into E. coli XL10-gold ultracompetent 
cells by heat-pulse at 42 °C. Then preheated (42 °C) NZY+ broth (10 g/L of NZ amine 
(casein hydrolysate), 5 g/L of yeast extract, 5 g/L of NaCl, pH 7.5 After autoclaving, 
added the filter-sterilised supplements, 12.5 ml of 1 M MgCl2, 12.5 ml of 1 M MgSO4, 
20 ml of 20% w/v glucose) was added into the reaction and the tubes incubated at 
37 °C for 1 hour before plating on LB agar plates supplemented with 100 µg/ml 
ampicillin. A transformant was cultured and plasmid extracted for sequencing using 
M13F, M13R, F802 R-IQ-N F2201 F-IQ-C and F3323 primers to cover the full-length 
of IQGAP1. The plasmid from the first round of mutagenesis was used as a template 
for the second round. The plasmid (pGEM-T-IQGAP1) that was generated from the 
second round of mutagenesis showed 100% identity with the database sequence. 
This plasmid was used as a template for IQGAP1 amplification by PCR to generate 
pPICZ B-IQGAP1 and pGADT7-IQGAP1. 
2.15 Transformation of E. coli 
 Preparation of electrocompetent cells 
Electrocompetent cells were prepared according to the protocol from Choi 
and colleagues (Choi et al., 2006). Briefly, 3 ml of E. coli overnight culture was 
pelleted and washed twice with 1 ml of 300 mM sucrose. And then, the pellet was re-
suspended with 100 μl of 300 mM sucrose. For transformation, 50 μl of 
electrocompetent cells was mixed with 2 μl of plasmid and transferred to a pre-
chilled cuvette gap with a gap width of 1 mm for electroporation. 
 Transformation of plasmid DNA into E. coli by electroporation 
E. coli were electroporated with a single pulse of 25 μF, 1.8 kV and 200 Ω. 
After electroporation, 1 ml of LB broth was added immediately into the cuvette and 
then the contents were transferred to a new culture tube. The transformed cells were 
incubated at 37 C with shaking for 1 hour. Clones were selected on LB agar plate 
containing relevant antibiotic selection and incubated at 37 C overnight. 
 Transformation of plasmid DNA using heat shock method 
A commercial competent cell, E. coli XL-1 Blue (Agilent Technologies) was used 
in some instances following the manufacturer’s protocol. Ligation reactions were 




was subjected to transformation. 10 μl of the reaction was mixed with thawed E. coli 
cells on ice for 30 minutes. The mixture was then heat-pulsed in a 42 °C water bath 
for 45 seconds. After that, the tube was placed on ice for 2 minutes and 0.45 ml of 
preheated SOC medium (2% w/v tryptone, 0.5% w/v yeast extract, 10 mM NaCl, 2.5 
mM KCl, 10 mM MgCl2, 10 mM MgSO4, and 20 mM glucose) added. The cells were 
transferred into a new 15-ml tube and incubated at 37 °C for 1 hour with shaking. 
Transformation mixture was plated on appropriate LB agar and incubated at 37 °C 
overnight. For transformation control, pUC18 was used in every transformation 
experiment. 
2.16 Transformation of Pichia 
 Preparation of Pichia for electroporation 
Pichia transformation by electroporation was performed following the 
manufacturer’s instructions of the EasySelect™ Pichia Expression Kit (Invitrogen). In 
brief, a single colony of Pichia pastoris GS115 or KM71H was inoculated into 10 ml of 
YPD and incubated at 30 °C with shaking. 100 µl of the overnight culture was 
inoculated into 125 ml of fresh medium and incubated at 30 °C with shaking to an 
OD600 ~ 1.3 to 1.5. Cells were pelleted at 1,500  g for 5 minutes and re-suspended 
with 125 ml of ice-cold sterile water. Next, cells were centrifuged and re-suspended 
with 62.5 ml of ice-cold sterile water. Then, cells were harvested by centrifugation 
and re-suspended in 5 ml of ice-cold 1 M sorbitol. Finally, the cells were centrifuged 
and the pellet was re-suspended in 250 µl of ice-cold 1 M sorbitol. These competent 
cells were kept on ice and used on the day of preparation. 
 Linearisation of pPICZ B  
The plasmid pPICZ B-QGAP1 and pPICZ B, which was used as a control were 
linearised before transformation into Pichia. The plasmid was digested with MssI 
(Thermo Scientific). The reaction was incubated at 37 C overnight and then 
linearised plasmid was purified using a PCR purification kit (Qiagen). Eluted DNA 
was concentrated with 1/10 volume of 3 M sodium acetate pH 5.2 and 2 volume of 
ice-cold absolute ethanol. The DNA sample was stored at -20 C for at least 1 hour 
and pelleted by centrifugation at 16,060 x g for 20 minutes. The supernatant was 




re-suspended with 10 µl of nuclease-free water and the concentration measured 
using a Nanodrop spectrophotometer (Thermo Fisher Scientific). 
 Transformation of Pichia by electroporation  
Pichia competent cells (80 μl) were mixed with 5 ng of linearised pPICZ B or 
pPICZ B-IQGAP1. The reaction was transferred into an ice-cold 0.2 cm 
electroporation cuvette and incubated on ice for 5 minutes. The cells were pulsed 
using 25 µF, 2 kV and 200   and then 1 ml of ice-cold 1 M sorbitol was immediately 
added to the cuvette. Contents in the cuvette were transferred into a sterile 15 ml 
tube and incubated at 30 °C for 2 hours without shaking. Cells were plated on YPDS 
agar plates (1% w/v yeast extract, 2% w/v peptone, 2% w/v glucose, 1 M sorbitol 
and 2% w/v agar) supplemented with 100 µg/ml of Zeocin™ (Thermo Fisher 
Scientific) and incubated at 30 °C for 4 days. A few colonies were picked and streaked 
for single colonies on fresh YPDS plates containing 2,000 µg/ml Zeocin™. The 
colonies that were able to grow on that high concentration of Zeocin™ were subjected 
to colony PCR to detect the plasmid containing the IQGAP1 gene insert. 
 Additionally, transformant of P. pastoris GS115 strains were confirmed to be 
of the Mut+ phenotype (Methanol utilisation plus) which is the ability of strains to 
metabolise methanol as the sole carbon source. A colony was picked and patched on 
an MMH plate (13.4 g/L yeast nitrogen base, 4 x 10–5% v/v biotin, 0.04 g/L histidine, 
0.5% v/v methanol and 15 g/L agar) first. After growth on the MMH plate, the strain 
was patched onto an MDH plate (13.4 g/L yeast nitrogen base, 4 x 10–5% v/v biotin, 
0.04 g/L histidine 2% g/L dextrose, and 15 g/L agar). The controls, GS115(MutS) 
albumin and GS115 pPICZ-lacZ (Mut+) were also patched onto the MDH and MMH 
agar plates. Plates were incubated at 30 °C for 2 days. Colonies that grew on both 
plates were Mut+ strains and were further screened for protein expression. Whereas 
MutS strains (that grew on the MDH plate but not on the MMH plate) were discarded. 
2.17 Protein expression and purification 
 MBP-IQGAP1 fusion proteins 
To express full-length IQGAP1 fused with maltose-binding protein (MBP); 
MBP-FL-IQGAP1 and C-terminal IQGAP1-MBP fusion protein (MBP-C-IQGAP1), a 
glycerol stock of E. coli Rosetta 2 (DE3) pLysS harbouring pMAL-p2X-FL-IQGAP1 or 




antibiotics and incubated at 37 °C overnight with shaking. For induction of MBP-FL-
IQGAP1, IPTG was added into the overnight culture to a final concentration of 0.3 mM 
and then incubated at room temperature for 6 hours with shaking. With the same 
concentration of IPTG, MBP-C-IQGAP1 was induced for 3 hours at 37 °C with shaking. 
For E. coli Rosetta 2 (DE3) pLysS harbouring N-terminal half of IQGAP1 (MBP-
N-IQGAP1) and pMAL-p2X, overnight cultures were sub-cultured in a ratio of 1:10 
into fresh medium. After 3 hours of incubation at 37 °C with shaking, IPTG was added 
to 0.1 mM final concentration and then incubated at room temperature overnight.  
Induced E. coli cells were harvested by centrifugation and pellets were stored at -20 
°C. 
Pellets of induced E. coli were re-suspended with BugBuster Master Mix using 
1/5 of the original culture volume and incubated on a rocker at room temperature 
for 10 minutes. Crude cell extract was then subjected to centrifugation at 16,060 x g 
for 3 minutes to separate the soluble (supernatant) and insoluble (pellet) fractions. 
Soluble protein was incubated with pre-washed amylose resin (New England 
Biolabs) at room temperature on a rocker for 15 minutes. The supernatant was then 
removed after centrifugation at 16,060 x g for 1 minute. The amylose resin was 
washed profusely with 20 mM Tris-HCl pH 7.5. MBP-fusion protein bound to amylose 
resin was kept at 4 °C. Alternatively, the protein was eluted at room temperature 
with 20 mM Tris-HCl pH 7.5 containing 50 mM maltose. Eluted MBP-fusion full-
length, N-terminal and C-terminal IQGAP1 proteins were concentrated using 
centrifugal concentrators at a molecular weight cut-off (MWCO) 100 kDa (GE 
Healthcare).  
 N-IQGAP1 purification 
E. coli Rosetta 2 (DE3) pLysS harbouring pMAL-p2X-N-IQGAP1 was 
inoculated into 50 ml of LB broth containing 100 µg/ml ampicillin and 34 µg/ml 
chloramphenicol and incubated at 37 C overnight with shaking. The overnight 
culture was washed with PBS twice. The bacterial cells were re-suspended in 50 ml 
of LB broth and sub-cultured in a ratio of 1:100 into 4 litres of LB broth supplemented 
with the antibiotics and incubated at 37 C for 3 hours. The culture was cooled down 
on ice and then IPTG was added at a final concentration of 0.1 mM. IPTG induction 
was conducted at 16 C overnight with shaking. Bacterial cells were harvested by 




To purify MBP-N-IQGAP1, every 1 gram of bacterial cell paste was re-
suspended with 5 ml of lysis buffer (1% w/v Octylthioglucoside (OTG) in 20 mM Tris 
pH 7.5, 200 mM NaCl, 1 mM EDTA, 1 mM DTT and 0.1% v/v Triton X-100). Lysonase™ 
Bioprocessing Reagent (Novagen) was also included in the cell suspension using 10 
µl per 1 gram of cell paste and incubated on a rocker at room temperature for 30 
minutes. The insoluble fraction was separated by centrifugation at 16,000 × g for 20 
minutes at 4 C. The supernatant was cleared with a 0.45-µm filter. Next, the soluble 
protein was purified by affinity chromatography on an MBPTrap™ HP column (GE 
Healthcare) coupled to an ÄKTApurifier system. Then the column was washed with 
washing buffer (20 mM Tris pH 7.5, 200 mM NaCl, 2 mM CaCl2). MBP-tag was cleaved 
while bound to the amylose resin by injection of 50 µg of FactorXa (New England 
Biolabs) into the column and incubation at 4 C for 48 hours.  The digested protein 
was removed from the column by washing with washing buffer. Each fraction was 
examined for the presence of protein using Bradford reagent (Sigma-Aldrich) and 
confirmed by SDS-PAGE with Coomassie blue staining. Fractions showing the 
presence of protein were pooled and subjected to gel filtration using HiPrep 16/60 
Sephacryl S-100 HR (GE Healthcare) to separate N-IQGAP1 from MBP. The proteins 
were collected in washing buffer. Two microliters from each fraction were subjected 
to dot blot on a nitrocellulose membrane to detect IQGAP1. Positive fractions were 
pooled and concentrated using an Amicon® Ultra-4 centrifugal filter device at 3 kDa 
MWCO (Merck Millipore). The concentration of purified N-IQGAP1 protein was 
measured by Nanodrop spectrophotometry before snap-freezing and storage of 
aliquots at −70°C.  
 IQGAP1-6xHis expression in Pichia and purification 
A recombinant strain with the highest expression of IQGAP1, 
GS115/IQGAP1#15, was cultured from a single colony in 25 ml of Buffered Glycerol-
complex Medium (BMGY; 1% w/v yeast extract, 2% w/v peptone, 100 mM potassium 
phosphate, pH 6.0, 1.34% w/v YNB, 4 × 10-5% w/v biotin, and 1% v/v glycerol). Cells 
were pelleted and re-suspended in Buffered Methanol-complex Medium (BMMY; 1% 
w/v yeast extract, 2% w/v peptone, 100 mM potassium phosphate, pH 6.0, 1.34% 
w/v YNB, 4 × 10-5% w/v biotin, and 0.5% v/v methanol) to an OD600 of 1.0. The 
induction was conducted at 30 C with shaking. Methanol was added to the culture 




post-induction, cells were harvested every 24 hours for 4 days. Total protein was 
analysed for IQGAP1 expression by Western blotting. 
 To purify 6xHis-IQGAP1, the strain was cultured in 400 ml media at 30 C for 
3 days by adding methanol to a final concentration of 0.5% v/v every 24 hours. Cells 
were re-suspended with Pichia lysis buffer (1 mM PMSF, 5% v/v glycerol, 50 mM 
sodium phosphate, pH 7.4) in a ratio of 1 gram of cell paste weight to 4 ml of Pichia 
lysis buffer. Cells were lysed using a One-Shot Model cell disruptor (Constant 
Systems) at 16,000 psi for 2 passes. Total cell lysate was centrifuged at 16,000 × g for 
30 minutes at 4 C. The supernatant was cleared with a 0.45-µm filter and diluted in 
binding buffer (500 mM NaCl, 1% v/v TritonX-100, and 5% v/v glycerol, 50 mM 
sodium phosphate, pH 7.4) in a ratio of 1:2. Then the protein was purified by affinity 
chromatography on a HiTrapTalon Crude column (GE Healthcare) coupled to an 
ÄKTApurifier system. After washing the column with washing buffer (500 mM NaCl, 
1% v/v TritonX-100, 5% v/v glycerol and 5 mM imidazole, 50 mM sodium phosphate, 
pH 7.4), the 6xHis-tagged protein was eluted in the elution buffer (50 mM sodium 
phosphate, pH 7.4, 500 mM NaCl and 500 mM imidazole). Each fraction was 
examined for the presence of protein using Bradford reagent (Sigma-aldrich) and 
subjected to SDS-PAGE with Coomassie blue staining and Western blot analysis. 
 GST and GST-BimA54-455 expression and purification 
A construct for the expression of amino acid residues 54 to 455 of B. 
pseudomallei strain 10276 BimA with a GST fusion protein was described in the 
previous study (Sitthidet et al., 2010). A single colony of E. coli harbouring pGEX-
BimA and pGEX-4T-1, which expressed GST-BimA54-455 and GST protein respectively, 
was inoculated in LB broth containing 100 μg/ml ampicillin and 10 μg/ml 
chloramphenicol and incubated overnight. One millilitre of overnight culture was 
sub-cultured in 100 ml LB containing appropriate antibiotics. After 3 hours of 
incubation with shaking, IPTG was added to a final concentration of 0.25 mM and 
then incubated for a further 3 hours at 37 C. The induced E. coli cells were pelleted 
and re-suspended in BugBuster Master Mix (Novagen) and incubated on a rocker for 
10 minutes at room temperature. Insoluble debris was separated by centrifugation 
at 16,060 x g for 3 minutes. The supernatant was transferred to a new tube 
containing 200 μl of prewashed glutathione sepharose 4B beads (GE Healthcare) and 




4 times with 1 ml of PBS and kept at 4 C. Otherwise, the protein was eluted with 
elution buffer. The eluted solution was cleared by a 2-ml spin filter column 
(Novagen) and equilibrated into 50 mM Tris-HCl, pH 7.5 by using centrifugal 
concentrators at MWCO 3 kDa (Sartorius).  
 For a large-scale production, 1 litre culture of induced E. coli cells was lysed 
using 1% w/v OTG in PBS in a ratio of 1 gram of cell paste per 5 ml of lysis buffer 
supplemented with 10 µl Lysonase™ Bioprocessing Reagent (Novagen). The cell 
suspension was incubated on a rocker at room temperature for 20 minutes. Insoluble 
debris was separated by centrifugation at 16,000  g for 20 minutes at 4 C. The 
supernatant was cleared using a 0.45-µm filter and then purified by affinity 
chromatography on a GSTrap™ 4B column (GE Healthcare) coupled to an 
ÄKTApurifier system. The column was washed with PBS and then the protein was 
eluted with elution buffer (10 mM reduced glutathione in 50 mM Tris-HCl pH 8.0). 
The eluted solution in each fraction was determined the presence of protein using 
Bradford reagent. The fractions that turned the reagent to blue were pooled and 
equilibrated into 50 mM Tris-HCl, pH 7.5 by dialysis using D-Tube Dialyzers Maxi, 
MWCO 3.5 kDa (Novagen) at 4 C. The protein concentration was measured using 
Nanodrop spectrophotometer and subjected to SDS-PAGE with Coomassie blue 
staining. 
 BimA54-470 -6xHis expression and purification 
A few colonies of E. coli Rosetta 2 (DE3) pLysS harbouring pET-21b 
(+)/BimA54-470 were screened for protein expression. A single colony was inoculated 
into 5 ml of LB broth supplemented with 100 µg/ml ampicillin and 34 µg/ml 
chloramphenicol and incubated at 37 C overnight with shaking. Then the overnight 
culture was subcultured in a ratio of 1 in 100 to a fresh media and incubated at 37 C 
for 3 hours with shaking. IPTG was added to a final concentration at 0.5 mM and 
induced at 37 C for 2 hours. Total cell lysate was subjected to SDS-PAGE with 
Coomassie blue staining and Western blot analysis. 
 A selected colony was cultured in a large-scale production (2 litres) and 
induced protein expression at 16 C overnight with shaking. After harvesting, 
bacterial cells were re-suspended with lysis buffer (1% w/v OTG in 50 mM sodium 




temperature for 20 minutes on a rocker. The soluble protein was collected by 
centrifugation at 16,000 g for 20 minutes at 4 C. The supernatant was cleared using 
a 0.45 µm-filter and diluted with 2 volumes of the binding buffer (50 mM sodium 
phosphate pH 7.4, 500 mM NaCl, 1% v/v Triton X-100, and 5% v/v glycerol) then 
subjected to affinity chromatography on a HiTrap TALON crude column (GE 
Healthcare) coupled to an ÄKTApurifier system. After washing the column with 
washing buffer (50 mM sodium phosphate pH 7.4, 500 mM NaCl, 1% v/v Triton X-
100 and, 10% v/v glycerol, 1 mM DTT and 5 mM imidazole), the protein was eluted 
in elution buffer (500 mM NaCl, 500 mM imidazole, 50 mM sodium phosphate pH 
7.4) and determined the presence of protein using Bradford reagent. The protein was 
then dialysed using D-Tube™ Dialyzers with molecular weight cutoffs (MWCO) 3.5 
kDa (Novagen). 
 MBP-BimA54-470 expression and purification 
To determine protein expression in E. coli Rosetta 2 (DE3) pLysS harbouring 
pMAL-p2X-BimA54-470, a few colonies were cultured in 10 ml of LB supplemented 
with appropriate antibiotics at 37 °C for 3 hours and induced with IPTG at a final 
concentration of 0.3 mM at 37 °C for 2 hours. The cell lysate was subjected to SDS-
PAGE with Coomassie blue staining and BimA expression was confirmed by Western 
blot analysis. A colony showing BimA expression was selected for a pilot experiment 
of protein purification as described below. One millilitre of overnight culture was 
inoculated into 100 ml of LB supplemented with 0.2% w/v glucose and incubated at 
37 °C with shaking to an OD600 of 0.5. IPTG was added to a final concentration of 0.3 
mM and incubation continued at 37 °C for 2 hours. Cells were harvested by 
centrifugation at 3,200 x g for 15 minutes. Cells were re-suspended in 5 ml of 1% w/v 
OTG in column buffer (200 mM NaCl and 1 mM EDTA, 20 mM Tris-HCl pH 7.4). The 
cell lysate was centrifuged at 16,000 × g for 20 minutes at 4 °C. The supernatant was 
cleared using a 0.45 µm-filter.  Pre-washed amylose resin (~200 µl) was added to the 
supernatant and incubated on a rocker at room temperature for 2 hours. The resin 
was washed with column buffer extensively and the fused protein was eluted in 200 
µl of 50 mM maltose in column buffer. After incubation at room temperature for 10 
minutes, the resin and eluted protein were separated by centrifugation. The 
supernatant was incubated with FactorXa (New Biolabs) following the 




12 hours. The protein samples were subjected to SDS-PAGE with Coomassie blue 
staining and Western Blot analysis. 
2.18 Pull-down assay 
 GST pull-down  
Immobilised fusion-tagged protein, GST and GST-BimA54-455 (Sitthidet et al., 
2011) bound to glutathione sepharose 4B beads were blocked with 5% w/v BSA in 
PBS at room temperature for 30 minutes and washed twice with PBS. The 
immobilised protein was incubated with 1 µg of purified MBP-fusion protein for 2 
hours at room temperature in 1X polymerisation buffer (500 mM KCl, 20 mM MgCl2, 
10 mM ATP, 100 mM Tris-HCl pH 7.5) containing 500 µM ATP and 100 µM CaCl2. The 
beads were washed with PBS extensively and the supernatant was removed as much 
as possible. Then the beads were suspended in 2X SDS-PAGE loading buffer 
containing 2% v/v β-mercaptoethanol. The samples were heated at 99 °C for 5 
minutes and separated by SDS-PAGE. The interaction of GST-BimA and IQGAP1 was 
determined by anti-MBP Western blot analysis. 
 MBP pull-down  
Non-specific binding sites of immobilised MBP-tagged proteins, MBP, MBP-
FL-IQGAP1, MBP-N-IQGAP1 and MBP-C-IQGAP1 bound to amylose resin were 
blocked with 5% w/v BSA in PBS at room temperature for 30 minutes. The resin was 
washed with PBS twice and then incubated with 5 µg of purified GST-fusion protein 
for 2 hours at room temperature in 1X polymerisation buffer containing 500 µM ATP 
and 100 µM CaCl2. After stringent washing steps with PBS, the supernatant was 
removed. Beads were re-suspended in 2X SDS-PAGE loading buffer containing 2% 
v/v β-mercaptoethanol. The samples were heated at 99 °C for 5 minutes and proteins 
in the supernatant were separated by SDS-PAGE. The interaction of GST-BimA and 
IQGAP1 was examined by anti-GST Western blot analysis. 
2.19 Yeast two-hybrid 
 Yeast transformation 
Saccharomyces cerevisiae AH109 containing pGBKT7-BimA54–455 (AH109 
pGBKT7-BimA) was generated previously in our laboratory.  To test the interaction 




transformed into S. cerevisiae AH109 expressing BimA on the bait plasmid (pGBKT7-
BimA54–455) by the LiAc/SS Carrier DNA/PEG method (Gietz and Woods, 2002). A 
single colony (~2 mm in size) of the S. cerevisiae AH109 harbouring pGBKT7-BimA54–
455 was inoculated into 5 ml of SD medium lacking tryptophan (SD/–Trp) and 
incubated on a shaker at 30 °C with shaking. The overnight culture was harvested at 
1,000 × g for 10 minutes and some of the supernatant was removed. Cells were re-
suspended before transferring to a new micro-centrifuge tube and pelleted at 16,060 
x g for 30 seconds. The supernatant was discarded. The reagents were added to the 
cells in the following order: 240 µl of 50% w/v filter sterilised PEG BioUltra 3,500 
(Sigma), 36 µl of 1.0 M LiAc, 10 µl of 10 mg/ml chilled Herring Testes Carrier DNA, 
denatured (Clontech), 2 µl of plasmid DNA (~1 µg) and 72 µl of sterilise water. The 
tube was incubated in a water bath at 42 °C for 3 hours. After that, the transformation 
mixture was pelleted by centrifugation at 16,060 x g for 30 seconds. One millilitre of 
sterile water was added to the pellet to re-suspend the cells, by pipetting and vortex 
mixing vigorously. 100 µl samples were inoculated onto SD agar plates lacking 
leucine and tryptophan (double dropout media; DDO) plates and incubated at 30 °C 
for 3-4 days to generate the strains AH109 pGBKT7-BimA pGADT7-IQGAP1 and 
AH109 pGBKT7-BimA pGADT7-actin.  
 Yeast two-hybrid assay 
Colonies of yeast strains AH109 pGBKT7-BimA pGADT7-IQGAP1 and AH109 
pGBKT7-BimA pGADT7-actin from DDO agar plates were suspended in 20 μl of 
water. Then 5 μl of cell suspension was dotted onto SD agar plates lacking leucine, 
tryptophan, adenine, and histidine or quadruple drop out (QDO) supplemented with 
20 μg/ml of X-α-galactosidase. Plates were incubated at 30 °C for 24 hours before 
observing the appearance of the colonies until 72 hours. Interaction controls 
supplied with the Matchmaker GAL4 Two-Hybrid System 3 (Clontech) were included 
using pGADT7-T antigen pGBKT7-p53 as a positive control and pGADT7-T antigen 
pGADT7-Lamin C as a negative control.  
2.20 Pyrene-actin assembly assay  
Pyrene-actin polymerisation assay conditions were described previously 
(Stevens et al., 2005a) using the commercial actin polymerisation Biochem kit™ 




manufacturer's instructions with some modification. In brief, an aliquot of pyrene-
actin (1 mg) was suspended in 50 µl water and diluted with 2.450 ml of ice-cold G-
buffer (10mM Tris pH 7.5, 0.2 mM CaCl2, 0.2 mM ATP and 1 mM DTT). After vortexing, 
the pyrene-actin was incubated on ice in the dark for 1 hour and then centrifuged at 
100,000 × g for 2 hours at 4C. The supernatant (2 ml) was transferred to a chilled 
tube and kept on ice and in the dark. The concentration of this G-actin stock was 
measured using a NanoDrop spectrophotometer. 
Assays were performed in the FLUOstar OPTIMA (BMG LABTECH) and set up 
in black opaque 96-well plates. To study the effect of IQGAP1 on actin polymerisation 
mediated by BimA, 200 nM GST or GST-BimA protein (with or without 50 nM N-
IQGAP1) were added into test wells and incubated with 1X polymerisation buffer. 
Next, test reactions were initiated by the addition of 1 µM G-actin and run with a 
kinetic cycle with the emission of fluorescence at 407 nm data (after excitation at 365 
nm) collected every 1 minute up to 1 hour. Rates of polymerisation were calculated 
as the rise in fluorescence units per second during the linear phase of polymerisation. 
 
Table 2.3: Molecular weight of proteins in this study 
 
Protein Relative Molecular weight; Rmw (Da) 





2.21 Statistical Analysis 
Data from at least three individual experiments from each condition were 
analysed using an unpaired two-sample Student’s t-test in GraphPad Prism software. 






Dissecting the role of IQGAP1 in B. pseudomallei actin tail 
formation using siRNA-mediated knockdown 
3.1 Introduction 
B. pseudomallei requires BimA, a bacterial protein which is located at the pole 
of the bacterial cell, to move within and between host cells by actin-based motility 
(Stevens et al., 2005a). The mechanism by which BimA subverts the cellular actin 
machinery is ill-defined. Following previous studies to identify host cell proteins 
required for actin-based motility of L. monocytogenes (David et al., 1998, Van Troys 
et al., 2008), our laboratory has previously performed a proteomic analysis in a 
similar manner.  
Prior to this present thesis, the Stevens laboratory generated bacteria 
expressing BimA by electroporation of pBHR2-virAG plasmid (Schell et al., 2007) into 
B. pseudomallei strain 10276 wild-type and bimA mutant (Stevens et al., 2005a). This 
resulted in constitutive expression of BimA protein in the wild-type strain in vitro 
(10276 pBHR2-virAG; BimA+) and a lack of expression in a bimA insertion mutant 
(10276 bimA::pDM4 pBHR2-virAG; BimA-). The bacterial strains were subjected to 
an affinity purification in murine splenic lysate supplemented with a buffer that 
promotes BimA-mediated actin polymerisation (Stevens et al., 2005a). By affinity 
purification, interacting proteins were isolated and eluted. Protein samples were 
separated by SDS-PAGE and stained. Bands were excised and subjected to LC-MS/MS. 
Of the thirty proteins identified in the eluted proteins from BimA+ compared to 
BimA-, collected for three independent experiments. Several cytoskeleton proteins 
that have previously been found in the tails of other bacterial pathogens, for example, 
α-actinin and cofilin, were identified. Some host cell proteins that were identified in 
2 and 3 experiments were validated by immunoblotting. The data set of host cellular 
protein identified has now been published following peer-review (Jitprasutwit et al., 
2016) and the experimental workflow that had been done before this thesis is shown 
in Figure 3.1.  
 Comparison of the affinity purification results to proteins involved in Listeria 
or Shigella actin-based motility identified HSP90 and IQGAP1 as novel proteins 




previously been shown to be involved in the actin-based motility of any intracellular 
bacterial pathogen studied to date, but also, since IQGAP1 is a key regulator of 
cellular actin dynamics. Moreover, the presence of IQGAP1 in B. pseudomallei actin 
tail had been seen from a preliminary observation by Stevens laboratory. It was 
hypothesised that IQGAP1 was required for B. pseudomallei actin-based motility. 
Thus, this thesis aimed to confirm the IQGAP1 localisation and explore the function 
of IQGAP in B. pseudomallei actin-based motility using siRNA technique. Results from 
the study of the interaction between IQGAP1 and BimA presented here (Chapter 5) 
have been included in a peer-reviewed publication, a copy of which is included as an 
appendix in Chapter 7. 
From the previous study using an RNAi screen targeting cytoskeleton 
proteins uncovered a core set of proteins that play roles in Rickettsia actin-based 
motility, demonstrated that the host cell proteins which were localised in the 
bacterial actin tails could be functionally important for actin-based motility as well 
as the efficiency of infection (Serio et al., 2010). The roles of IQGAP1 in the actin-








Figure 3.1: Schematic diagram illustrating the method to identify host cell 
proteins recruited to bacteria expressing BimA  
pBHR2-virAG was introduced into B. pseudomallei 10276 to obtain bacteria over-
expressing BimA (BimA+). Interacting host cell proteins from murine splenic lysate were 
isolated by affinity purification under conditions supporting actin polymerisation. After 
washing, interacting proteins were eluted and then separated by SDS-PAGE. Each protein 
band was excised from the gel for identification by mass spectrophotometry. Identified 
proteins were validated with a specific antibody by immunoblotting. (Data from 






Small or short interfering RNA (siRNA) is a non-coding RNA involved in a 
mechanism called RNA interference (RNAi) for silencing gene expression. RNAi is an 
innate defence mechanism against foreign nucleic acids such as invading viruses. 
This biological process occurs naturally in eukaryotic organisms by introduction of a 
double-stranded RNA (dsRNA), such as viruses, resulting in degradation of mRNAs 
with complementary RNA targets. RNAi is triggered by the presence of double-
stranded RNA (dsRNA) in the cytoplasm. Then this dsRNA is cleaved by Dicer, a 
ribonuclease (RNase)-like enzyme, into a 21–23 nucleotides RNA which is known as 
siRNA. The siRNA duplex is taken up by the RNA-induced silencing complex (RISC) 
that requires endonuclease Argonaute 2 (AGO2) to catalyse the unwinding of the 
siRNA duplex. The central AGO2 cleaves the sense strand of the siRNA while the 
antisense strand (guide strand) remains associated with the RISC. The guide strand 
only binds to mRNA by Watson-Crick base pairing and the active RISC targets specific 
mRNA targets for cleavage by AGO2, resulting in specific gene silencing. The 
activated RISC-siRNA complex can then be recycled to destroy additional mRNA 
targets. As a result, the gene silencing process continues.  
RNAi-mediated mechanisms are a powerful tool to explore the function of 
target genes. In experimental approaches, siRNA can be synthetically produced and 
introduced into cells directly to suppress gene expression (Reviewed in Shan, 2010). 
An RNAi screen identified a core set of host factors that were important for R. parkeri 
actin tail formation (Serio et al., 2010). Besides, many groups have succeeded in 
repressing IQGAP1 expression and explored its function in bacterial infection. For 
example, a previous study using siRNA knockdown investigated the role of IQGAP1 
in Salmonella cell invasion. IQGAP1 expression was decreased by 75% leading to 
reduced host cell invasion. It revealed that IQGAP1 was required for invasion by 
regulating actin polymerisation in the phagocytic cup (Brown et al., 2007). 
It was hypothesised that IQGAP1 may be a key mediator of BimA-dependent 
actin polymerisation. The aim of this chapter was to investigate the role of IQGAP1 





 Co-localisation of IQGAP1 with B. pseudomallei actin tails in host 
cells 
From the proteomic experiment using bacteria expressing BimA, IQGAP1 was 
detected and validated by Western blot analysis with specific antibodies, confirming 
the association with BimA-expressing bacteria in vitro (Figure 3.1, Jitprasutwit et al., 
2016). Hence, IQGAP1 was identified as a putative component of B. pseudomallei 
actin tails. In this study, localisation of IQGAP1 in B. pseudomallei-infected cells was 
investigated using immunofluorescence confocal microscopy. Firstly, a series of 
antibody dilutions in a titration experiment was performed to determine the 
optimum concentration with the best staining and minimum background 
(Supplemental figure 7.1). Sub-cellular localisation of IQGAP1 in control HeLa cells 
was observed in the cytoplasm and the cell membrane. Microscopy showed an 
overlap in the fluorescence signals of IQGAP1 (red) and F-actin, which is selectively 
labelled by phalloidin (green) in yellow, representing co-localisation of IQGAP1 with 
actin filaments (Figure 3.2a).  
Next, the localisation of IQGAP1 in B. pseudomallei infected cells was observed 
at different time points (8, 16, 24, and 32 hours post-infection). At each time point, 
the presence of IQGAP1 in B. pseudomallei actin tails were detected. At 16 hours post-
infection showed the greatest number of bacteria displayed actin tails. Figure 3.2b 
showed the localisation of IQGAP1 throughout the B. pseudomallei actin tail implied 
that this protein may be required for actin tail formation. From this promising result, 






Figure 3.2: IQGAP1 localises with actin tails of B. pseudomallei   
Representative confocal laser scanning micrographs of uninfected HeLa cells (a) and 
HeLa cells infected with the B. pseudomallei 10276 at 16 hours post-infection (b). 
Bacteria (blue) were stained using mouse monoclonal anti-B. pseudomallei 
lipopolysaccharide antibody that was detected with anti-mouse Ig-Alexa Fluor 405. F-
actin (green) was stained with Alexa Fluor 488-conjugated phalloidin. IQGAP1 (red) was 
stained with a rabbit polyclonal antibody and detected with anti-rabbit Ig-Alexa Fluor 
568. Arrows denote actin tails where IQGAP1 was recruited. 

















 Optimisation of IQGAP1 knockdown in HeLa cells 
To study the function of IQGAP1 in B. pseudomallei actin tail formation, siRNA 
technique was used to repress IQGAP1 expression in HeLa cells.  The efficiency of 
siRNA transfection was maximised by optimisation of the amount of siRNA and 
transfection reagent. A commercial siRNA targeting exon 31 (from a total of 39 
exons) of the Homo sapiens IQGAP1 gene was available from Ambion (siRNA IQGAP1, 
ID S16837; Silencer Select). The siRNA duplex was delivered into HeLa cells using 
the cationic-lipid transfection reagent Lipofectamine RNAiMAX, following the 
manufacturer's protocol. Optimisation of RNAi induction was validated by 
immunoblotting to detect IQGAP1 protein in total cell lysates. Figure 3.3 shows a 
workflow of siRNA transfection performed in this study. Briefly, one day before 
transfection, HeLa cells (diluted in DMEM without antibiotics) were plated into a 24-
well plate at a low confluency. The cells were transfected with siRNA IQGAP1 duplex 
and Lipofectamine RNAiMAX in Opti-MEM. At a specific time post-transfection, the 
cells were washed with PBS and lysed with BugBuster. Total cell lysate was subjected 
to Western blotting. For each sample, the level of protein expression was acquired 
by measuring the band intensity of IQGAP1 and actin on the blot using an Odyssey 
infrared imager. The signal value was obtained using Image studio software and the 
level of IQGAP1 expression normalised with actin in each sample. The percentage of 
IQGAP1 expression was calculated by comparing with non-transfected control 







Figure 3.3: Workflow for siRNA transfection into HeLa cells using Lipofecta-
mine RNAiMAX  
A low density of HeLa cells was seeded into a 24-well plate one day before transfection. 
For transfection, RNAi duplex and Lipofectamine RNAiMAX were diluted in Opti-MEM 
and combined. The RNAi duplex-Lipofectamine RNAiMAX complex was added into each 
well and cells incubated at 37°C in a 5% CO2 incubator. At a specific time point, HeLa cells 
were washed and lysed with BugBuster to obtain a total cell lysate. IQGAP1 protein 





Initially, several siRNA concentrations and amount of transfection reagent 
were employed to optimise conditions for knockdown of IQGAP1 in a pilot 
experiment analysing single samples from each treatment. At 48 hours post-
transfection, immunoblotting analysis (after normalisation of the IQGAP1 signal with 
that of actin) showed that increasing the siRNA concentration (3, 15, and 24 pmol) 
did not result in an improvement in IQGAP1 knockdown (Figure 3.4a). Although the 
level of IQGAP1 knockdown was more efficient with the lower concentration of 
transfection reagent (Figure 3.4b). This was followed by comparing the level of 
knockdown achieved between a single or double transfection method. For single 
transfection, HeLa cells were transfected with siRNA by Lipofectamine RNAiMAX 
only once. On the other hand, for the double transfection method, HeLa cells were 
transfected twice with the same amount of siRNA duplex and Lipofectamine 
RNAiMAX, at a 24 hours interval. A pilot experiment was set up where the efficiency 
of each condition was determined from one sample. In contrast, when the siRNA 
IQGAP1 concentration was increased by the use of a double transfection technique, 
IQGAP1 expression was lower than cells that had only been transfected once (Figure 
3.4c and 3.4d). From the quantitative immunoblotting results shown in figure 3.4, we 
decided to further optimise the double transfection method with a total amount of 6 
pmol siRNA IQGAP1 and 2 l transfection reagent to determine the time point post 








Figure 3.4: IQGAP1 expression was suppressed in a siRNA dose-dependent 
manner 
HeLa cells were transfected with a range of siRNA IQGAP1 and Lipofectamine RNAiMAX 
concentrations. Cells were incubated for 48 hours and cell lysates immunoblotted for 
IQGAP1 and actin. Quantitation of IQGAP1 expression was calculated by measuring the 
intensity of the IQGAP band normalised with the actin band in each lane. Control sample 
that was treated with the same volume of Lipofectamine RNAiMAX was taken as 100%.  
Total volume of Lipofectamine RNAiMAX was either 0.5 µl (white bar), 1 µl (grey bar) or 
2.0 µl (black bar) in each sample. The data were obtained and calculated from one 
individual sample (n=1). 
(a) Western blot analysis of IQGAP1 and actin in transfected HeLa cells from single 
transfection. 
(b) The expression level of IQGAP1 in HeLa cells from single transfection was analysed 
from the immunoblot in (a) using an Odyssey infrared imager and Image Studio 
software. 
(c) Western blot analysis of IQGAP1 and actin in transfected HeLa cells from double 
transfection.  
(d) The expression level of IQGAP1 in HeLa cells from single transfection was analysed 















 Further optimisation of IQGAP1 silencing  
To further optimise the transfection conditions for efficient silencing of 
IQGAP1 expression, a range of incubation times were tested.   From the previous 
result in section 3.2.2, HeLa cells double-transfected with 6 pmol siRNA IQGAP1 
duplex and 2 µl of Lipofectamine RNAiMAX, and incubated for 48 hours, showed the 
lowest level of IQGAP1 expression. The protocol for double transfection was 
modified in this experiment by adding the second transfection reagent at 6 hours 
after the first transfection. For this pilot experiment, only one sample was collected 
per condition at 24, 48 and 72 hours post-transfection. In this experiment, single and 
double transfections with the same amount of total siRNA IQGAP1 duplex (6 pmol) 
and Lipofectamine (2 µl) were compared once again. Controls for this experiment 
included cells treated with only Opti-MEM (no Lipofectamine or siRNA IQGAP1) to 
examine the basal levels of IQGAP1 expression. Total cell lysate from each condition 
was subjected to Western blotting, probing with anti-IQGAP1 and anti-actin 
antibodies. Cells treated with Opti-MEM and Lipofectamine showed similar signal 
intensities of actin and IQGAP1 (Figure 3.5a and 3.5b). This implies that 
Lipofectamine did not affect the baseline actin and IQGAP1 protein levels at the 
concentration used. From this result, the percentage of IQGAP1 expression was 
calculated by comparing with Lipofectamine-treated control samples which were 
taken as 100%. 
Comparing the different methods for transfection of siRNA IQGAP1 into HeLa 
cells, showed that the level of IQGAP1 expression gradually decreased over time from 
approximately 50% at 24 hours post-transfection to below 20% at 72 hours post-
transfection by both protocols, whether by single or double transfection. (Figure 
3.5c). In particular, the single transfection method was more efficient than using 
double transfection to suppress IQGAP1 expression. Therefore, in the following 
experiments, HeLa cells were transfected with 6 pmol of siRNA IQGAP1 duplex and 
2 µl of Lipofectamine RNAiMAX by the single transfection method and incubated for 









Figure 3.5: The level of IQGAP1 expression in siRNA transfected cells reduced 
over time  
HeLa cells were transfected with siRNAs targeted to IQGAP1 with 6 pmol of siRNA 
IQGAP1 and 2 µl of Lipofectamine RNAiMAX (R). Cells were incubated for a range of time 
points before lysis and immunoblotting for IQGAP1 and actin (which was used as a 
protein loading control). Quantitation of IQGAP1 level was calculated by measuring the 
intensity of the IQGAP band normalised with the actin band in each sample. For negative 
controls, HeLa cells were treated with Opti-MEM (O) or Lipofectamine (L). IQGAP1 
expression of mock transfection control was considered as 100%. The data was 
calculated from one individual sample (n=1).  
(a) Western blot analysis of IQGAP1 and actin in transfected HeLa cells from single 
transfection. 
(b) Western blot analysis of IQGAP1 and actin in transfected HeLa cells from double 
transfection. 
(c) The expression level of IQGAP1 in HeLa cells was analysed using an Odyssey 
infrared imager and Image Studio software. From the immunoblot in (a), the level of 
IQGAP1 expression using single transfection method is shown in grey bar. From 
double transfection (b) the level of IQGAP1 expression using double transfection 
method is shown in the black bar.  
  










 Confirmation of efficient IQGAP1 knockdown in HeLa cells 
To validate IQGAP1 expression in siRNA-mediated IQGAP1 (siIQGAP1) 
knockdown cells and determine if the siRNA IQGAP1 was having any non-specific 
effect, such as cell death, a siRNA with a sequence that does not target a known gene 
was included as a non-silencing siRNA control. A commercial negative control siRNA 
was utilised for assessing any ‘off-target’ effect associated with siRNA transfection. 
HeLa cells were transfected with 6 pmol of siRNA IQGAP1 duplex or siRNA negative 
control with the same amount of Lipofectamine RNAiMAX and incubated for 72 
hours.  
 From three individual experiments, it was clear that the level of IQGAP1 
expression in siIQGAP1 knockdown cells was decreased (Figure 3.6a), and the signal 
intensity of IQGAP1 from siIQGAP1 knockdown cells was lower than those from 
siRNA negative control cells (Figure 3.6b). IQGAP1 expression was reduced by 70%, 
a highly statistically significant difference from the negative siRNA control (Student's 
t-test, p = 0.0007) (Figure 3.6b). In addition to immunoblotting, suppression of 
IQGAP1 expression in siIQGAP1 cells was validated compared with control HeLa cells 
(Lipofectamine-treated cells) by confocal laser scanning microscopy. The cells were 
stained to detect IQGAP1 and actin. The result showed cytoplasmic and membrane 
localisation of IQGAP1 in the control cells, whereas siIQGAP1 knockdown cells 
showed only weak IQGAP1 expression (Figure 3.6c). The morphology of siRNA 
IQGAP1-transfected HeLa cells and control cells were not obviously different, 
indicating that IQGAP1 knockdown by siRNA IQGAP1 did not affect gross cellular 







Figure 3.6: Characterisation of IQGAP1 knockdown cells 
IQGAP1 knockdown at 72 hours post-transfection with 6 pmol of siRNA IQGAP1 and 2 µl 
of Lipofectamine RNAiMAX.  
(a)  Equal total whole cell lysate from negative siRNA control (siNeg) and siRNA-IQGAP1 
(siIQGAP1) transfected HeLa cells from 3 independent experiments were resolved 
by SDS-PAGE. Western blot was probed with anti-IQGAP1 (red) and anti-actin 
(green) antibodies.   
(b) IQGAP1 expression was quantified by signal intensity using Image Studio and 
normalised with actin expression. Data show the mean ± SEM from three 
independent experiments (n=3), with negative siRNA control-transfected cells 
considered as 100%. p = 0.0007 (Student's t-test).  
(c) Representative confocal laser scanning micrographs of HeLa non-transfected cells 
(NT) and siIQGAP1 knockdown cells. F-actin (green) was stained with Alexa Fluor 
488-conjugated phalloidin. IQGAP1 (red) was stained with a rabbit polyclonal 
antibody and detected with anti-rabbit Ig-Alexa Fluor 568. Scale bar= 10 m.  












 Cytotoxicity of siRNA transfected HeLa cells 
With an efficiency of IQGAP1 knockdown of more than 70% achieved by using 
6 pmol of siRNA IQGAP1 and 2 µl of Lipofectamine RNAiMAX at 72 hours post-
transfection, the potential effect of cytotoxicity was assessed by a colorimetric assay. 
When cells die they release lactate dehydrogenase (LDH) into the culture medium 
that can be quantified by a coupled enzymatic reaction and measured using a 
spectrophotometer. LDH catalyses lactate to pyruvate by reduction of NAD+ to NADH. 
Then the catalyst (diaphorase) uses NADH to reduce a tetrazolium salt to a red 
formazan product that can be absorbed by a visible wavelength (490 nm). To 
examine the effect of IQGAP1 knockdown on cell viability, cytotoxicity was evaluated 
after 72 hours of transfection compared to the maximum LDH released from lysed 
control cells taken as 100%.  The value of maximum LDH was determined from HeLa 
cells cultured in DMEM without antibiotics and lysed with BugBuster to break the 
cells. Cell debris was separated by centrifugation. The supernatant was diluted in the 
same growth media which was used as a blank control for spectrophotometry.  As 
shown in figure 3.7a, there was little difference in cytotoxicity between non-
transfected controls, siRNA negative control and siIQGAP1 knockdown cells. 
However, negative siRNA control transfected cells showed slightly higher 
cytotoxicity than siRNA IQGAP1-treated cells but with no statistical significance 
(Student's t-test, p = 0.1774). Notably, the three independent experiments involved 
the use of HeLa cells of increasing passage number. Cytotoxicity continually 
increased with passage number from set 1 to set 3, though at a low rate (Figure 3.7b). 
From this finding, HeLa cells at early passage (not more than 25 passages) were used 
in this study. 








Figure 3.7: Cytotoxic effect of siRNA transfection 
Cytotoxic effect of siRNA on the HeLa cells after 72 hours incubation with 6 pmol of 
siRNA and 2 µl of Lipofectamine RNAiMAX. The percentage of cytotoxicity was calculated 
from OD 490 nm measuring LDH release from cells into the supernatant. The value of 
maximum LDH released from control cells (Max) taken as 100%, compared with those 
from Opti-MEM-treated cells (Opti), Lipofectamine-treated cells (Lipo), siRNA negative 
control-treated cells (siNeg) and siRNA IQGAP1-treated cells (siIQGAP1). 
(a) Data shown are mean  SD representative of triplicate independent experiments 
(n=3) with no statistical significance (Student's t-test, p = 0.1774).  
(b) The same samples in (a) showing individual data from three independent 
experiments in cells of increasing passage number.  













 Actin-based motility of B. pseudomallei in IQGAP1 knockdown cells 
To assess if IQGAP1 is necessary for actin-based motility of B. pseudomallei, 
IQGAP1 knockdown cells and control cells were infected and assessed for actin tail 
formation by confocal microscopy. In this preliminary observation, after transfection 
of siRNA IQGAP1 into HeLa cells for 48 hours, the treated cells were infected with B. 
pseudomallei 10276. Actin tail formation of B. pseudomallei 10276 at 8, 16, 24 and 32 
hours post-infection in cells transfected with negative siRNA control and siRNA 
IQGAP1 were observed and compared with non-transfected cells. At the specific time 
point, cells were washed twice in PBS before fixation with 4% PFA/PBS overnight. 
After permeabilisation with 0.5% Triton X-100 in PBS for 15 minutes, cells were 
stained with phalloidin and anti-IQGAP1, while the bacteria were stained with anti-
LPS antibody. The z-stack images were acquired with identical laser settings using 
an LSM710 confocal laser scanning microscope. At each of the time points IQGAP1 
co-localised with the actin tail of B. pseudomallei in non-transfected cells and 
negative siRNA control-transfected cells. In contrast, some actin tails of B. 
pseudomallei in the IQGAP1 knockdown cells showed a lack of IQGAP1 co-localisation 
(Figure 3.8 – 3.11). This suggested that B. pseudomallei was able to form an actin tail 
without IQGAP1.  
 Furthermore, it was noticeable that there was a decrease in cell viability of 
the B. pseudomallei infected negative siRNA control-treated HeLa cells. This is 
consistent with the previous result of cytotoxicity in the previous section (3.2.5). 
Negative siRNA control-treated cells showed a higher level of cytotoxicity than other 
controls and siRNA IQGAP1-transfected cells (Figure 3.7). In spite of the fact that 
there was no statistical difference of cytotoxicity between the controls, HeLa cells 








Figure 3.8: Actin tail formation by B. pseudomallei in control cells and IQGAP1 
knockdown cells at 8 hours post-infection 
Confocal micrographs of HeLa cells infected with wild-type B. pseudomallei 10276. The 
left-hand panel shows a merged image of three channels. Bacteria were stained with anti-
LPS antibody in blue and cellular proteins, actin and IQGAP1 were stained in green and 
red respectively. The right-hand panel shows the bacteria and IQGAP1 localisation.  
indicates IQGAP1 co-localised with actin in an actin tail.  shows actin tail formation 






Figure 3.9: Actin tail formation by B. pseudomallei in control cells and IQGAP1 
knockdown cells at 16 hours post-infection 
Confocal micrographs of HeLa cells infected with wild-type B. pseudomallei 10276. The 
left-hand panel shows a merged image of three channels. Bacteria were stained with anti-
LPS antibody in blue and cellular proteins, actin and IQGAP1 were stained in green and 
red respectively. The right-hand panel shows the bacteria and IQGAP1 localisation.  
indicates IQGAP1 co-localised with actin in an actin tail.  shows actin tail formation 






Figure 3.10: Actin tail formation by B. pseudomallei in control cells and IQGAP1 
knockdown cells at 24 hours post-infection 
Confocal micrographs of HeLa cells infected with wild-type B. pseudomallei 10276. The 
left-hand panel shows a merged image of three channels. Bacteria were stained with anti-
LPS antibody in blue and cellular proteins, actin and IQGAP1 were stained in green and 
red respectively. The right-hand panel shows the bacteria and IQGAP1 localisation.  
indicates IQGAP1 co-localised with actin in an actin tail.  shows actin tail formation 






Figure 3.11: Actin tail formation by B. pseudomallei in control cells and IQGAP1 
knockdown cells at 32 hours post-infection 
Confocal micrographs of HeLa cells infected with wild-type B. pseudomallei 10276. The 
left-hand panel shows a merged image of three channels. Bacteria were stained with anti-
LPS antibody in blue and cellular proteins, actin and IQGAP1 were stained in green and 
red respectively. The right-hand panel shows the bacteria and IQGAP1 localisation.  
indicates IQGAP1 co-localised with actin in an actin tail.  shows actin tail formation 




 IQGAP1 expression after B. pseudomallei infection 
To give an assurance that IQGAP1 expression was suppressed when HeLa 
cells were infected with B. pseudomallei 10276, the infected HeLa cells were analysed 
by immunoblotting to examine IQGAP1 expression in control cells and siIQGAP1 
knockdown cells. Remarkably, quantification of IQGAP1 expression by signal 
intensity, using actin expression as a loading control, showed that the level of IQGAP1 
expression in infected cells was statistically greater than in uninfected cells at 24 
hours post-infection (Students t-test, p = 0.0299) and at 32 hours post-infection 
(Students t-test, p = 0.0288), as shown in figure 3.12a. The same samples were 
subjected to Western blotting with anti-IQGAP1 and anti-GAPDH antibodies. Figure 
3.12b shows that IQGAP1 expression normalised with GAPDH in uninfected siRNA 
knockdown cells was not significantly different compared to infected cells (Students 
t-test p = 0.2086 and 0.7935 at 24 and 32 hours post-infection respectively). This is 
an intriguing finding implying that infection of HeLa cells with B. pseudomallei alters 
the total cellular levels of actin.  
 Next, an experiment was performed to determine the optimal time point 
post-infection to study B. pseudomallei actin tail formation. HeLa cells were 
transfected with siRNA IQGAP1 and then infected with B. pseudomallei for 8, 16, 24 
and 32 hours. At each of these time points, the cells were lysed and the level of 
IQGAP1 knockdown assessed by Western blotting, normalising IQGAP1 levels with 
the housekeeping protein GAPDH. The initial data showed the lowest expression of 
IQGAP1 was at 16 hours post-infection and then the levels increased afterwards 
(Figure 3.13). Additionally, the largest number of bacteria that displayed actin tails 
in the control cells was observed using confocal microscopy at 16 hours post-
infection (Supplemental figure 7.2). Thus, B. pseudomallei actin tail formation was 
examined in the next experiments by infecting cells at 48 hours post-transfection and 








Figure 3.12: Assessment of IQGAP1 levels using actin and GAPDH for 
normalisation  
Level of IQGAP1 expression in uninfected siIQGAP1 knockdown cells (grey bar) 
compared with B. pseudomallei infected-siIQGAP1 knockdown cells (white bar) at 24 and 
32 hours post-infection, compared with negative siRNA control-transfected cells (black 
bar), which were taken as 100%. Data represent mean ± SD of two samples from one 
experiment (n=2). 
(a) Band intensity of IQGAP1 expression was quantified and normalised with actin 
expression (Students t-test, p = 0.0299 at 24 hours post-infection and p = 0.0288 at 
32 hours post-infection). 
(b) Band intensity of IQGAP1 expression was quantified and normalised with GAPDH 
expression (Students t-test p = 0.2086 at 24 hours post-infection and p =0.7935 at 
32 hours post-infection).   


























Figure 3.13: IQGAP1 expression in siIQGAP1 knockdown cells after B. pseudo-
mallei infection at different time points 
Percentage of IQGAP1 expression when normalised with GAPDH, and compared with 
negative siRNA control that was set as 100%. The data represent an analysis of single 






 Analysis of actin tail formation in IQGAP1 knockdown and control 
cells 
To further investigate the role of IQGAP1 in actin-based motility of B. 
pseudomallei, the formation of actin tails in Lipofectamine-treated cells (mock 
control) and siIQGAP1 knockdown cells were analysed qualitatively. Initially, a total 
number of 6,847 bacteria were scored manually for the presence of an actin tail, 
2,322 bacteria were analysed in control cells and 4,525 bacteria in siIQGAP1 
knockdown cells. The proportion of bacteria that were associated with actin in 
control cells and siIQGAP1 knockdown cells were similar (Figure 3.14a). Next, the 
bacteria associated with actin were categorised into 4 phenotypes: ‘no tail’ (no actin 
was recruited to the bacterial surface), ‘barcode’ (displayed a pattern of parallel lines 
of varying widths of actin across the bacterium), ‘short tail’ (where the length of the 
actin tail was shorter than the 2 m length of the bacterium), and ‘long tail’ (where 
the length of the actin tail was longer than 2 m) (Figure 3.14b). From this 
categorisation, no significant differences were observed between actin tails formed 
by B. pseudomallei in control cells with those in siIQGAP1 knockdown cells (Figure 
3.14c).  
Then, the bacteria with long actin tails (≥2 m) were classified into a further 
3 types. The first one was called ‘comet tail’ in which the actin was condensed to form 
classic ‘rocket-like’ tails. The second one was ‘thin tail’ in which the width of the actin 
tail was smaller than the width of the bacterium. The last type was ‘loose tail’ which 
showed faint actin staining. The representative images for each actin tail type are 
shown in figure 3.15a. A total of 512 bacteria were analysed in control cells and 781 
bacteria in siIQGAP1 knockdown cells. Figure 3.15b shows the majority of bacteria 
displayed a comet tail (black box), whilst the number of bacteria with thin tails 
showed the smallest proportion (grey box). Although, the number of bacteria with a 
comet tail in normal control cells was greater than in IQGAP1 knockdown cells. 
Conversely, bacteria with a loose tail were present in higher number in siIQGAP1 
knockdown cells than in normal control cells. Next, the images were analysed with 






Figure 3.14: Analysis of B. pseudomallei actin tail formation in control and 
siIQGAP1 knockdown cells from performing of three independent 
experiments. 
(a) Distribution of bacteria associated with or without an actin tail (Students t-test, p = 
0.3452 for bacteria with and without tail, n = 16 for control cells and n = 17 for 
siIQGAP1 cells). 
(b) Confocal micrographs showing a representative image of the different actin tail 
morphology formed by B. pseudomallei (Students t-test, p = 0.4620 for no tail, p = 
0.7745 for barcode, p = 0.5402 for short tails and p = 0.3667 for long tails, n = 16 for 
control cells and n = 17 for siIQGAP1 cells). 
(c) Percentage distribution of bacteria associated with actin tails of each morphology in 
control cells (blue bar) compared to siIQGAP1 knockdown cells (red bar) from 3 






















Figure 3.15: Qualitative analysis of the morphology of actin tail formed by B. 
pseudomallei in control and siIQGAP1 knockdown cells 
(a) Confocal micrograph of HeLa cells infected with B. pseudomallei 10276 showing 
actin tail phenotypes. Scale bar = 10 μm. 



















 IQGAP1 plays a role in determining the actin density and length of 
actin tails formed by B. pseudomallei 
In the previous section, over 2000 bacteria were imaged from each infected 
cell type across 3 biological replicates and scored manually for actin tail morphology. 
The proportion of bacteria with and without actin tails were similar in control cells 
and IQGAP1 knockdown cells. However, the actin tails appeared to have a lower actin 
density in siIQGAP1 knockdown cells. To substantiate this finding, ImageJ software 
was used to measure the length of the actin tail and quantify the actin density by 
measuring the fluorescence intensity along the tail structure. One hundred actin tails 
with the length longer than 2 µm from control and siRNA IQGAP1 transfected HeLa 
cells, across 3 biological replicates, were analysed from maximum intensity 
projection z-stack images that were captured with identical laser settings using an 
LSM710 laser scanning confocal microscope. The data showed a statistically 
significant increase in overall tail length (p = 0.0033, Figure 3.16a), with a 
concomitant decrease in actin density (p = 0.0001, Figure 3.16b), in siIQGAP1 
knockdown cells compared with control cells. RNAi-mediated knockdown of IQGAP1 
expression in Hela cells resulted in a significant increase in the length of actin tails, a 
mean length of 20.5 m compared to a mean length of 14.8 m in control cells (Figure 
3.16a). Although longer in length, the actin density of tails generated in siIQGAP1 
knockdown cells was lower with a mean signal of 1,036 A.U. compared to a mean 
signal of 2,522 A.U. measured for tails in control cells (Figure 3.16b). Taken together, 







Figure 3.16: IQGAP1 affects B. pseudomallei actin tail length and density 
HeLa cells were infected with B. pseudomallei 10276 for 16 hours post-infection before 
fixing. Bacteria, IQGAP1 and actin were stained and images captured by confocal 
microscopy. Length of actin tail and signal intensity were quantified using ImageJ 
software. 100 bacteria from three independent experiments of each sample, control cells 
and IQGAP1 knockdown cells were observed (n=3). 
(a) Scatter plot indicating the length of actin tail formed by individual bacteria 
displaying tail longer than 2 m. The data represent mean ± SEM and asterisks 
denote lengths are significantly different from each other (Unpaired t-test; p = 0 
.0033).  
(b) Scatter plot indicating the intensity of actin recruited by individual bacteria 
displaying tail longer than 2 m. The data represent mean ± SEM and asterisks 
denote actin intensity is significantly different from each other (Unpaired t-test; p = 


















 Expression of IQGAP2 and IQGAP3 in HeLa cells  
The preliminary result showed that IQGAP1 co-localises with the actin tails 
of B. pseudomallei in non-transfected cells and negative siRNA control-transfected 
cells. In contrast, IQGAP1 knockdown cells showed some actin tails of B. pseudomallei 
without any IQGAP1 co-localisation. This suggested that B. pseudomallei was able to 
form an actin tail without IQGAP1. However, an explanation for this observation 
could be that the lack of IQGAP1 expression may be compensated by the expression 
of IQGAP2 and IQGAP3 isoforms in the cells.  
IQGAPs are differentially expressed in tissues. The Human Protein Atlas 
(http://www.proteinatlas.org/) indicates that the mRNAs for the IQGAP2 and 
IQGAP3 genes are expressed in HeLa cells (Supplemental figure 7.3). To test the 
presence of IQGAP2 and IQGAP3 in HeLa cells, Western blot analysis was performed. 
Figure 3.17 shows that IQGAP2 and IQGAP3 are both expressed in HeLa cells. 
Unfortunately, despite testing a wide range of commercially-available antibodies 
against the IQGAP2 and IQGAP3 proteins, none were suitable for confocal 
microscopy analysis. This leaves open the possibility that the IQGAP1-negative tails 
detected in this study may have arisen from the functional compensation of IQGAP1 
by the other IQGAP family members.  
 
 
Figure 3.17: IQGAP2 and IQGAP3 expression in HeLa cells 
The same amount of total HeLa cell lysate was resolved by SDS-PAGE and probed with 
anti-IQGAP1, anti-IQGAP2 (sc-17835), and anti-IQGAP3 (Ab136976) in red and anti-
actin antibodies in green. Using the same sample blotted on the same membrane, to 
detect each protein, the membrane was cut and probed with the specific antibody. To 
detect IQGAP2 and IQGAP3, the membranes were scanned with a higher intensity than 





The work described in this chapter arose from the valuable data set of 30 host 
cellular proteins identified by an affinity approach using bacteria expressing BimA 
under actin polymerising conditions in vitro (Jitprasutwit et al., 2016). From the 
protein list generated previously in our laboratory, IQGAP1 was identified as an 
interesting candidate host protein to study its functional role in B. pseudomallei 
actin-tail formation. Despite many studies on the actin-based motility of other 
intracellular bacterial pathogens, none showed localisation of IQGAP1 in the actin 
tail. Many studies demonstrated that pathogens target IQGAP1 to regulate the host 
cell cytoskeleton to facilitate their infection. In fact, a recent study showed the 
interaction between the OspB Shigella effector and IQGAP1 limits Shigella spreading 
within a cell monolayer (Lu et al., 2015b). In spite of this, subcellular localisation of 
IQGAP1 with the Shigella-actin tail in infected cells was not reported (Lu et al., 
2015b). Taken together, IQGAP1 was selected for investigation in this study because 
IQGAP1 is a novel cellular protein identified in actin-based motility of B. pseudomallei 
and potentially other bacteria that display actin-based motility. 
In this study, confocal microscopy revealed that IQGAP1 is recruited to the B. 
pseudomallei actin tail. Then the localisation of IQGAP1 in B. pseudomallei infected 
cells over a time course was examined. The results showed that at even the earliest 
time point of the study (8 hours post-infection), IQGAP1 co-localised with B. 
pseudomallei actin tails. Similarly, at later time points (16, 24 and 32 hours post-
infection), IQGAP1 was recruited throughout the tail of B. pseudomallei, indicating 
that IQGAP1 is possibly involved in actin-based motility. At 16 hours post-infection, 
the greatest number of bacteria associated with actin tails were observed. It could be 
seen that most of the bacteria displayed a compact (comet-like) actin tail. However, 
the bacteria did not form actin tails with a specific uniform structure. In fact, a 
proportion of bacteria were associated with actin tails composed of loosely bundled 
actin filaments. This observation is in agreement with a recent report by Benanti and 
co-authors (Benanti et al., 2015). The loosely bundled tail is reminiscent of those 
described for certain Rickettsia species reliant on the formin-like Sca2 
autotransporter for actin polymerisation (Haglund et al., 2010). Furthermore, it was 
noticeable that IQGAP1 was recruited in each of the actin tail structures formed by B. 




formation which might lead to a variety of actin tail morphology, possibly using 
IQGAP1 as a scaffold to act in concert to regulate actin-based motility. 
To dissect the role of IQGAP1 in B. pseudomallei actin-based motility, RNAi-
mediated gene knockdown was performed. In this study, conditions of transfection 
were optimised to obtain the greatest level of IQGAP1 knockdown. After adjustment 
of the transfection conditions, IQGAP1 expression was decreased by more than 70% 
as assessed by IQGAP1 immunoblotting. Upon depletion of IQGAP1 by siRNA, it was 
found that the number of bacteria associated with actin tail was similar to those in 
control cells. There is a possibility that IQGAP1 is involved in the number of bacteria 
able to form tails, but the residual levels of IQGAP1 in knockdown cells is enough to 
support tail formation. Nevertheless, when the different actin tail morphologies were 
categorised (no tail, barcode, short and long tails) the number of bacteria with long 
loose tails was greater in IQGAP1 knockdown cells.  To verify this observation, 
confocal images were analysed using ImageJ software. This present study revealed 
the length of actin tails formed by B. pseudomallei in HeLa cells showed a mean of 
14.8 m with the longest of 62 m.  A previous study on actin tail formation of 
Burkholderia species by Benanti and colleagues (2015) observed the length of actin 
tail formed by B. pseudomallei in A549 and Cos7 cells. They showed that the mean 
length of a B. pseudomallei actin tail was approximately 20 m with the longest tails 
of 82 m in A549 cells, and a mean of 15 m with the longest tails of 65 m in Cos7 
cells (Benanti et al., 2015). This different value could be a result of experimental 
methods. Length of B. pseudomallei actin tail formation was observed at 16 hours 
post-infection in this study, whereas the study of Benanti and colleagues (2015) 
examined at 10 hours post-infection. Additionally, there may be significant 
differences in the proteins expressed by these different cell types that are able to 
support actin-based motility. Bacterial factors also should be taken into account 
because B. thailandensis strains engineered to have different BimA orthologues were 
subjects of their study (Benanti et al., 2015). 
Comparison between control HeLa cells and IQGAP1-depleted cells showed a 
significant difference in density and length of B. pseudomallei actin tail.  The 
bacterium formed tails with a lower actin density but a longer tail in cells with 
reduced IQGAP1 expression. These results suggested that IQGAP1 plays role in 




showed a defect in actin tail formation in length and morphology could influence 
motility rate and affected bacterial infectivity. For example, SFG R. perkeri showed 
abnormal actin tails with a shorter actin tail in profilin-depleted cells (Serio et al., 
2010). Although this work demonstrated the localisation of profilin to Rickettsia 
actin tails in mammalian cells, the absence of this host factor in the Rickettsia tail in 
profilin siRNA-treated cells control was not reported (Serio et al., 2010). The 
reduction of profilin in the RNAi cells caused a reduction of motility rate of Rickettsia 
but not L. monocytogenes (Serio et al., 2010). This suggested that host factors are 
exploited by the bacterial pathogens with a specific and distinct role.  
In spite of this, it was evident that B. pseudomallei could still form actin tails 
in the knockdown cells. This may be a result of compensation by the related IQGAP 
proteins IQGAP2 or IQGAP3, which are also expressed in HeLa cells as verified by 
Western blot analysis. This finding disagrees with a previous study that used RT-PCR 
and immunoblotting with specific antibodies and showed the expression of IQGAP1 
and IQGAP3, but not IQGAP2, in HeLa cells (Adachi et al., 2014). A reason for the 
discrepancy may, in fact, be the specificity of antibodies. To verify whether the loss 
of IQGAP1 is compensated by IQGAP2 or IQGAP3 for actin-based motility of B. 
pseudomallei, confocal microscopy of infected cells would be required. However, this 
speculation could not be confirmed because of a lack of specific antibodies available 
for immunostaining to detect IQGAP2 and IQGAP3 in B. pseudomallei infected cells.  
Compensation mechanisms in the IQGAP family would be possible because of the 
conservation of multiple functional domains. Indeed, one report indicated that 
IQGAP3 partially compensates for the functions of IQGAP2 to promote axon 
outgrowth in hippocampal neurons (Wang et al., 2007). However, there is no 
evidence in the literature that the loss of IQGAP1 can be compensated with other 
IQGAPs. From the similarity of domain structure of these proteins and the fact that 
they have common interacting partners, such as actin, it is a possibility that these 
IQGAP2 and IQGAP3 isoforms could compensate for the loss of IQGAP1 in our assay. 
However, this would require further experimentation to investigate. For example, 
double knockdown, suppression of both IQGAP1 and IQGAP2, or both IQGAP1 and 
IQGAP3, and reconstituting IQGAP1-knockdown cells with wild-type IQGAP1 could 




Additionally, the residual IQGAP1 expression in the siIQGAP1 knockdown 
cells may be a reason why the bacteria can still form actin tails, although confocal 
microscopy revealed that there was no IQGAP1 recruitment in some actin tails. An 
approach to understanding whether IQGAP1 plays a role in actin-based motility of B. 
pseudomallei or not could utilise cells derived from IQGAP1 knockout mice (Li et al., 
2000). A study of the role of IQGAP1 in Salmonella cell invasion revealed that IQGAP1 
was required for invasion by regulating actin polymerisation in the phagocytic cup 
(Brown et al., 2007). By using siRNA knockdown, which decreased IQGAP1 
expression by 75%, the percentage of Salmonella Typhimurium SL1344 invasion was 
reduced by 33%. When invasion was tested on mouse embryonic fibroblasts (MEFs) 
from IQGAP1 knock-out mice, the number of intracellular bacteria was significantly 
lower than those in control MEFs, 77% (Brown et al., 2007). A similar finding was 
published showing that IQGAP1-null MEFs were less able to support actin pedestal 
formation by EPEC (Brown et al., 2008). A study of S. flexneri intercellular spreading 
using the MEFs lacking IQGAP1 showed that the area of bacterial spread increased in 
the absence of IQGAP1, suggesting a role for IQGAP1 in restriction of S. flexneri 
spread in cell monolayers (Lu et al., 2015b). However, in our hands, siIQGAP1 
knockdown cells were not useful for studying the intracellular life of B. pseudomallei 
because IQGAP1 knockdown is transient. It should be noted that invasion and 
intracellular survival of B. pseudomallei in IQGAP1-depleted cells in this study were 
not statistically significant difference when compared to control cells (Supplemental 
figure 7.4). Moreover, a monolayer of siIQGAP1 knockdown cells could not be 
obtained to study cell-to-cell spreading. 
Unfortunately, we did not have access to IQGAP1 knockout mice or MEFs. 
When this study was ongoing, the CRISPR-Cas9 technique was a new powerful 
technique to specifically knockout target genes in cell lines. This technique was 







Investigating the role of IQGAP1 in intracellular life of  
B. pseudomallei  
4.1 Introduction 
Several studies have demonstrated the impact of actin-based motility on 
intracellular life of bacterial pathogens.  Particularly, it is important for the cell-to-
cell spread of bacteria. Bacterial mutants incapable of actin-based motility show 
defects in cell-to-cell spread in cultured cells, and are also compromised for virulence 
(Reviewed in Choe and Welch, 2016). The Listeria monocytogenes actA mutant strain, 
that was unable to accumulate actin around individual bacteria, was incapable of 
infecting adjacent cells and demonstrated significant attenuation of virulence 
(Domann et al., 1992, Kocks et al., 1992). Whilst the actA mutant did not show a 
defect in replication within L929 fibroblast cells, its ability to form plaques was 
compromised (Domann et al., 1992). Similarly, a Shigella flexneri icsA mutant that did 
not accumulate F-actin either on the surface or around the bacteria, lost its capacity 
to spread intracellularly and was impaired in plaque formation in confluent 
monolayers of HeLa cells (Bernardini et al., 1989). For R. parkeri both the rickA and 
sca2 mutants exhibited significantly smaller plaque size than wild-type (Reed et al., 
2014). Whilst the rickA mutant was impaired in actin tail formation in the early stage 
of infection (30 minutes post-infection) with no defect in late tail formation at 48 
hours post-infection, the sca2 mutant was partially defective in tail formation in the 
early stage but not able to form an actin tail in the later stage of infection (Reed et al., 
2014). Moreover, the sca2 mutant formed significantly smaller plaques than the rickA 
mutant (Reed et al., 2014), which agreed with the small plaques generated from R. 
rickettsii sca2 mutant (Kleba et al., 2010). These results suggested that Sca2 is 
important in the later stage of Rickettsia infection to facilitate efficient cell spreading 
(Reed et al., 2014). 
In addition to cell-to-cell spread, bacteria can manipulate the host cellular 
protective autophagy pathway using actin-based motility, allowing the bacteria to 
survive and replicate in infected cells. ActA, the bacterial surface protein of L. 
monocytogenes recruits host actin to avoid autophagic recognition (Yoshikawa et al. 




stimulates autophagy by IcsA binding to the autophagy protein Atg5, resulting in 
Shigella uptake by autophagosomes followed by degradation (Ogawa et al., 2005). 
However, Shigella secretes a T3SS effector IcsB which inhibits the IcsA/Atg5 
interaction and prevents the autophagic recognition of the bacterium (Ogawa et al., 
2005). IcsB interacts with Toca-1 which is a host protein required for efficient actin 
tail formation of S. flexneri and for inhibition of recruitment of a marker of autophagy 
(LC3) around intracellular S. flexneri (Baxt and Goldberg, 2014, Leung et al., 2008). 
Moreover, another host cytoskeleton factor known as septin targets and traps 
Shigella by forming septin cages surrounding the bacteria to promote autophagy 
(Mostowy et al., 2010).  
The mechanism of cell-to-cell spread by Burkholderia spp. is different from 
other bacteria that display actin-based motility. Whilst Listeria and Shigella spp. form 
double-membrane protrusions from an infected cell which are then engulfed by the 
adjacent uninfected cells, Burkholderia spp. induce multinucleated giant cell (MNGC) 
formation by fusion of infected cells with the neighbouring cells to mediate spreading 
(Kespichayawattana et al., 2000, French et al., 2011). bimA mutants show a 
significant defect in cell-to-cell spread without visible plaque formation (Sitthidet et 
al., 2011, French et al., 2011, Benanti et al., 2015). Understanding of how B. 
pseudomallei actin-based motility mediates escape from cellular detection and killing 
mechanisms is lacking. A recent study showed a reduction of net intracellular 
replication of a bimA mutant in J774.2 macrophage-like cells (Lazar Adler et al., 
2015). In the same study, the authors also demonstrated that BimA plays a role in 
the virulence of B. pseudomallei since the bimA mutant had a 10-fold increased 
median lethal dose in a BALB/c mouse model of melioidosis compared to the wild-
type B. pseudomallei 10276 (Lazar Adler et al., 2015). This finding agrees with our 
own unpublished observations that a bimA mutant shows impaired intracellular 
survival, a lack of plaque formation in A549 cell monolayers, reduced virulence in a 
mouse model of infection (Figure 1.3 in Chapter 1) and reduced virulence in Galleria 
mellonella.  
The results described in chapter 3 demonstrated that IQGAP1 play a role in 
actin tail formation of B. pseudomallei. To elucidate the role of IQGAP1 in B. 
pseudomallei intracellular life, IQGAP1 knockout cells were generated by CRISPR-




can be programmed to cleave specific DNA target sites in living cells and organisms. 
This technique is adapted from the CRISPR-Cas systems that are found in bacterial 
and archaeal genomes as immune mechanisms to degrade foreign nucleic acid by 
inducing sequence-specific DNA double-stranded breaks (DSBs). The type II CRISPR-
Cas from Streptococcus pyogenes has been widely used for targeted genome editing. 
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) is a region in 
bacterial genomes required for pathogen defence by incorporating a variable 
sequence from the foreign genetic element. CRISPR locus contains a cluster of genes 
including nucleases called Cas9 (CRISPR-associated protein 9) which recognises the 
target DNA via Watson-Crick base pairing and cleaves the target creating a DSB to 
prevent proliferation and propagation of invading genetic elements (Cong et al., 
2013).  
To modify the genome with high precision, a guide RNA (gRNA), also known 
as a single guide RNA (sgRNA), can be designed to define the genomic target to be 
modified, where the protospacer-adjacent motif (PAM) flanks the 3′ end of the DNA 
target site. Once a DSB has been created, it can be repaired via either the Non-
Homologous End Joining (NHEJ) pathway or the Homology-Directed Repair (HDR) 
pathway. NHEJ pathway is rapidly activated to repair DSBs, but it generates random 
mutations with either nucleotide insertions or deletions (InDels) at the DSB site. 
These mutations on the target DNA result in changes in the amino acid sequence, in-
frame or frameshift mutations. Premature stop codons can be introduced within the 
open reading frame (ORF) causing a loss-of-function mutation within the targeted 
gene. In contrast, the HDR pathway is less efficient but more accurate. The DSB can 
be repaired by introducing a specific mutation as a donor template that contains the 
desired mutation, insertion or modification, flanked by segments of DNA identical to 
the original DNA sequence at the DSB. The desired mutation is generated through 
recombination. The DSB is processed to create a 3’ overhang and then the invasion 
of the 3’ single-stranded DNA displaces one strand of the homologous donor DNA 
duplex. The invasive strand pairs with another strand before synthesis of new DNA 
using the homologous DNA sequence as a template to repair the DSB (Reviewed in 





In this chapter, the first aim was to permanently disrupt IQGAP1 gene 
function by creating a HeLa IQGAP1 knockout cell line without regard for specific 
mutation. Thus, the NHEJ repair pathway was utilised to generate random loss-of-
function mutations. Having generated an IQGAP1 knockout cell line, the impact of 





 Optimisation of double nickase plasmid transfection 
In this study, a commercial double nickase plasmid was employed to generate 
IQGAP1 knockout cells.  The plasmid provided by the manufacturer (Santa Cruz 
Biotechnology) incorporates 20-bp sgRNAs designed to target exon 13 of the Homo 
sapiens IQGAP1 gene, which consists of a total of 39 exons (Gene ID: 8826, Genomic 
Sequence: NC_000015.10). The guide sequences were analysed by nucleotide BLAST 
using ‘Human genomic plus transcript’ search set to test the specificity of the sgRNAs 
to IQGAP1. Each sgRNA is followed by PAM 5-NGG-3 site which is a prerequisite for 
Cas9 cleavage.   
From the NCBI Reference Sequence of the Homo sapiens IQGAP1 gene 
(NM_003870.3), the sgRNAs target the opposite strand, at base 1474-1493 and 1465-
1446. Thus, the distance between the PAM-distal 5 ends of the sgRNA pair was 8 bp, 
which created 42 bp 5- overhangs (Figure 4.1). The offset of +8 bp was in the range 
of an optimum gap (0-20 bp) between sgRNA pairs to allow for specific Cas9-
mediated double nicking of the genomic DNA mimicking a DSB (Ran et al., 2013). The 
expected consequence of double-strand break-mediated InDels is the production of 
a stop codon or nonsense mutation leading to a premature mRNA which is marked 
for degradation and the protein cannot be expressed. 
The double nickase plasmids used in this study consists of a pair of plasmids 
each encoding a Cas9n (D10A) nuclease and sgRNA which is chimeric between crRNA 
and tracrRNA targeting opposite strands of the human IQGAP1 locus. In the pair, one 
plasmid contains a GFP marker for monitoring transfection efficiency and another 
one contains a puromycin-resistance gene for selection.  In addition, each plasmid 
contains the U6 RNA polymerase III promoters for sgRNA expression. Two nuclear 
localisation signals (NLSs) that efficiently target Cas9 to the nucleus were included 
(Cong et al., 2013). A chicken β-actin hybrid (CBh) promoter controls Cas9n and 
puromycin resistance gene expression. A small sequence encoding a 2A-peptide, 
which is a self-cleaving peptide, was also included to produce two individual proteins 
from one transcript allowing the production of Cas9 and either puromycin resistance 







Figure 4.1: Double nickase mediates a DNA double-strand break within the 
target DNA  
Schematic illustrating DNA double-stranded breaks generated from a pair of sgRNA that 
was designed for the human IQGAP1 locus targeting within exon 13. The distance 
between the 5-ends of the guide sequence is 8 bp. The pair of sgRNA-Cas9n complexes 




HeLa cells were used to generate IQGAP1 knockout cells using the 
commercial double nickase plasmids described earlier. Lipofectamine® 2000 reagent 
was used for delivery of the plasmid into HeLa cells. For a successful transfection, the 
amount of Lipofectamine was optimised. Firstly, a control plasmid (pECFP-C1) 
expressing cyan fluorescent protein (CFP) was utilised to determine the optimum 
amount of transfection reagent to use in this cell line. One day before transfection, 
HeLa cells were cultured on a coverslip in a 6-well plate to obtain 70-90% confluency 
on the day of transfection. The same amount of plasmid (2.5 g) was tested with four 
concentrations of Lipofectamine 2000 reagent by adding 0, 6, 9, and 12 l into the 
reaction. The plasmid and transfection reagent were mixed and diluted in the Opti-
MEM medium before transfection. A negative control of HeLa cells cultured in Opti-
MEM (without plasmid or Lipofectamine) was also included in the experiment, 
providing a baseline of cell viability of non-treated cells. CFP expression was 
observed after 24 hours post-transfection. Actin was stained in red with Alexa Fluor® 
568 phalloidin. Cells with CFP expression were visualised under a confocal 
microscopy. The result in figure 4.2 shows there were no CFP-expressing cells in 
either cell treated with only Opti-MEM or plasmid without transfection reagent. The 
number of CFP-expressing cells increased with higher amounts of Lipofectamine, 
although the presence of cell debris was found because of the cytotoxic effect of the 
transfection reagent. From this experiment 12 l of Lipofectamine® 2000 reagent 






Figure 4.2: Optimisation of HeLa cell transfection 
HeLa cells were transfected with pECFP-C1 with varying amounts of Lipofectamine 
2000: 6, 9 and 12 L. The cyan fluorescent protein expression was observed under a 
confocal microscope, compared with the negative controls which were Lipofectamine-





 Generation of IQGAP1 knockout cell lines  
Knockout of IQGAP1 in this study was conducted in HeLa cells using the 
commercial double nickase plasmid. The overview of this experiment is shown in 
figure 4.3. In brief, HeLa cells were seeded in a 6-well plate one day before 
transfection. To monitor transfection efficiency, a cover slip was included in an extra 
well. The cells were approximately 70-90% confluent on the day of transfection. 
Then, 2.5 µg of the double nickase plasmids were delivered into the cells using 12 µl 
of Lipofectamine 2000. At 24 hours post-transfection, the transfected cells on the 
coverslip were observed for GFP expression under a fluorescence microscope. GFP-
expressing cells indicate the cells were transfected with the plasmid successfully. 
However, the transfected cells could contain only one plasmid encoding GFP or both 
two plasmids encoding GFP and the puromycin resistance gene. After that, the cells 
containing the plasmid encoding puromycin resistance were selected by adding 
puromycin on day 3 of transfection and incubating for 2 days. In this step, the cells 
that contain only one plasmid encoding GFP are not resistant to puromycin, causing 
rapid cell death of this population of cells. Following this step, any viable cells could 
contain only one plasmid encoding puromycin resistance or both plasmids. To 
generate IQGAP1 knockout cell lines by CRISPR Cas9-mediated genome editing, the 
cells must contain both plasmids to induce a DSB. Single clonal cell lines of the 







Figure 4.3: Overview of experiments for genome editing using a pair of double 
nickase plasmids 
HeLa cells were transfected with a pair of sgRNA and Cas9n expressing plasmids using 
Lipofectamine. At 24 hours, the cells were observed for GFP expression to indicate the 
transfection efficiency. Cells harbouring both plasmids, or one plasmid that contains the 
puromycin resistance gene, were selected by adding puromycin at 3 g/ml for 2 days. 





In this study, after transfection of IQGAP1 double nickase plasmid for 24 
hours, the cells plated onto a coverslip were washed and fixed with 4% PFA/PBS for 
further staining and observation of GFP expression. DNA staining with DAPI allowed 
all cells to be visualised. The efficiency of transfection was observed from GFP-
expressing cells under a fluorescence microscope. Figure 4.4b shows a number of 
cells expressed GFP indicating transfection of double nickase plasmid into HeLa cells 
was successful despite low efficiency, compared with the control in figure 4.4a. 
Bright field images showed a small number of cells with brighter round shape 
indicating some cytotoxicity in both transfected and control cells (Figures 4.4c and 
4.4d).  
From this observation, the transfected cells were further subjected to 
puromycin selection. The cells were incubated with 3 g/ml puromycin for 2 days. 
This step was conducted twice to ensure that all non-transfected cells died. The 
viable cells were expanded and then dissociated from the transfected wells. To 
obtain a single clonal cell line after puromycin selection, the media was replaced with 
fresh media without puromycin and the viable cells were allowed to expand for 4 
days. Then, the cells were trypsinised and counted before performing a serial 
dilution into 96-well plates. The isolated cells were incubated at 37 C in a CO2 
incubator until colonies developed.  The round colonies radiating from a central 
point, representing a single clonal cell line, were kept and expanded for validation by 






Figure 4.4: GFP-expression in HeLa cells after transfection with double-nickase 
plasmid using Lipofectamine® 2000 
HeLa cells were transfected with 2.5 g of the double nickase plasmid and 12 l of 
Lipofectamine. After 24 hours, the cells were washed and fixed with 4% PFA/PBS before 
staining with DAPI. 
(a) 20X fluorescence images of non-transfected cells (Lipofectamine-treated cells) 
control. 
(b) Expression of GFP was detectable under a fluorescence microscope (40X) in HeLa 
cells transfected with double nickase plasmid.  
(c) 100X bright field images of non-transfected HeLa cells. 





















 Screening of IQGAP1 knockout cells  
After isolation of clonal cell lines by serial dilution, individual clones were 
validated by immunoblotting for IQGAP1.  Cell pellets from each clone were washed 
with PBS twice before lysis to obtain a total protein that was subjected to Western 
blot analysis.  The commercial antibody used for detection of IQGAP1 was raised 
against amino acids 314-422 of human IQGAP1 encoded by exons 10 to 12. Since the 
gRNA for editing targets exon 13 (encoding amino acids 443-495 of human IQGAP1), 
this antibody should detect both native and any truncated IQGAP1 isoforms as well 
as the absence of full-length IQGAP1. 
From a total of 17 clones, the cell lysates were subjected to SDS-PAGE and 
immunoblotting probed with anti-IQGAP1 and anti-actin which was used as a loading 
control. Three clones (clone C3, G12 and H5) showed an absence of IQGAP1 at the 
expected size of 190 kDa (Figure 4.5a). From this preliminary result, only these 
clones were passaged and expanded to obtain a higher number of cells and screened 
a second time. From figure 4.5b, it was clear that all selected clones could not express 
IQGAP1. In addition to the immunoblotting result, the selected clones were plated on 
a coverslip in a 24-well plate to observe cell morphology and IQGAP1 expression by 
confocal microscopy.  The images in figure 4.6 show that IQGAP1 was expressed 
ubiquitously in the cytosol and cell membrane in the control cells, whilst all the 
edited clones showed the absence of IQGAP1 expression. Moreover, the cellular 
morphology of these selected clones was similar to the wild-type control cell. Taken 
together, this suggested that IQGAP1 gene editing was successful using CRISPR Cas9 
technique. The selected IQGAP1 knockout clones were further characterised by 






Figure 4.5: Screening and validation of IQGAP1 knockout cells using 
immunoblotting 
HeLa cell lysates were subjected to SDS-PAGE and immunoblotting using rabbit anti-
IQGAP1, and goat anti-actin antibodies which were used as a loading control. 
(a) Screening of IQGAP1 knockout cells was examined by Western blotting. HeLa cell 
lysates were resolved by 4-15% SDS-PAGE. Western blot was probed with anti-
IQGAP1 (red) and anti-actin (green) antibodies.   
(b) The lack of IQGAP1 expression in selected clones was confirmed by 8% SDS-PAGE 


















Figure 4.6: Validation of IQGAP1 knockout cells by immunofluorescence 
microscopy  
Representative confocal laser scanning micrographs of HeLa cells, wide-type (WT) 
control cell and selected clones, C3, G12 and H5. F-actin (green) was stained with Alexa 
Fluor 488-conjugated phalloidin and nuclei was stained with DAPI (blue). IQGAP1 (red) 
was stained with a rabbit polyclonal antibody and detected with anti-rabbit Ig-Alexa 






 Validation of IQGAP1 knockout cells 
 To characterise the genotype of these edited cells, primers for amplification 
of the region flanking exon 13 of the human IQGAP1 gene were designed from the 
Reference genome sequence (NC_000015.10). Figure 4.7a shows the position of exon 
13 on the human IQGAP1 gene, target sites of sgRNAs and the sequencing primers.  
Genomic DNA (gDNA) was extracted from WT HeLa cells using 
phenol/chloroform/isoamyl alcohol before precipitation with ethanol. The gDNA 
pellet was re-suspended in TE buffer and subjected to PCR amplification using a high-
fidelity DNA polymerase. Firstly, the annealing temperature to amplify the region 
from control cell gDNA was titrated from 56 – 67 C to avoid nonspecific priming. 
The result in figure 4.7b shows one specific band of PCR product at the expected size 
of 410 bp, at all annealing temperatures tested. The amplicons were extracted from 
the gel and purified before sequencing using the primers used for amplification. The 
sequencing result was blasted against the human genome to confirm that the product 
was derived from the IQGAP1 gene (Supplemental figure 7.5). Figure 4.7c shows a 
Sanger sequencing chromatogram indicating the site of gRNAs targeted on exon 13. 









Figure 4.7: PCR-based protocol for identifying mutations induced by CRISPR-
Cas9 in HeLa cells 
(a) Schematic diagrams showing sequence viewer of Homo sapiens chromosome 15, 
GRCh38.p7 Primary Assembly (NCBI Reference Sequence: NC_000015 in the range: 
90388241..90502243) (top panel). Pink dashed lines indicate sequenced regions 
containing exon 12 and exon 13. sgRNAs target exon 13. A pair of primers (blue 
arrows) were designed to prime outside exon 13 of the RefSegGene human IQGAP1, 
to detect mutations in the target site. 
(b) PCR products amplified from genomic DNA extracted from HeLa cell WT control cell 
using the primers flanking the target region with varying annealing temperatures. 
The expected size of amplicons was 410 bp.  
(c) Sanger sequencing chromatogram of purified PCR products around the sgRNA 
binding site. The target of sgRNAs are indicated in red and orange boxes, and PAMs 

















To validate mutations in the knockout cell lines, the region flanking the target 
for Cas9n editing at exon 13 of the RefSeq IQGAP1 sequence was amplified by PCR. 
Genomic DNA from three individual clonal populations was extracted and used as a 
template. The amplicons were analysed on an agarose gel. After gel electrophoresis, 
PCR products from the clones revealed different sizes and patterns indicative of the 
expected error-prone mutations at the target site following NHEJ-mediated repair 
(Figure 4.8). In clone C3, there was only one band present on the agarose gel that 
migrated faster than the product from the control cells. This suggested that a deletion 
had been engineered by the CRISPR/Cas9 technique. To confirm this deletion, the 
PCR band from the gel was extracted and the DNA sequenced. The result of the 
sequencing trace showed multiple sequence peaks at the same location with an 
ambiguous sequence read (Figure 4.9a). This indicated a mixed population of 
mutated alleles in clone C3. Analysis of PCR products of this clone was repeated.  The 
PCR product was subjected to an extended period of gel electrophoresis to separate 
out any similarly sized DNA products. The result revealed two smaller bands that 
were excised from the gel and subjected to sequencing (Supplemental figure 7.6), 
which confirmed the mixed population of this clone. For clone G12, there were three 
distinct PCR product amplicons present on the gel, this also indicated a mixed 
population in this clone. Each band was excised from the gel and purified for 
sequencing and showed mutation had occurred either by insertion or deletion 
(Supplemental figure 7.7). From clone H5, the size of the PCR product was larger than 
the control, representing an insertion mutant. The result of Sanger sequencing of 
clone H5 showed the addition of nucleotide bases with single peaks, indicating this 






Figure 4.8: Validation of IQGAP1 knockout cell lines by PCR  
Genomic DNA extracted from non-transfected control cells (WT) and clonal IQGAP1 KO 
isolates (clone C3, G12 and H5). For the negative control, the PCR reaction was set up 
identically to the experimental PCR, but without template DNA. PCR products amplified 
using primers upstream and downstream of exon 13 of IQGAP1. The amplicons were 
analysed on a 2% agarose gel. 
 
 
Figure 4.9: Sanger sequencing analysis of clone C3 and H5 
Chromatograms from Sanger sequencing of purified PCR products using primers from 
the flanking regions of exon 13 of human IQGAP1. 
(a) Chromatogram of clone C3 (Yellow highlights the areas of mixed sequence) 











Sanger sequencing of all PCR products from the 3 selected clones 
demonstrated gene editing at the target site in all cases. Two of them showed a mixed 
population, only cell line H5 was clonal and was further analysed for protein 
expression. The genomic DNA sequencing result of the exon 13 region of clone H5 
showed 10 substituted nucleotides and 128 inserted nucleotides in the region. The 
resulting translated protein was predicted using an online tool 
(http://www.expasy.org/). The predicted consequence of this mutation generated a 
truncated protein with 40 new amino acids and a premature stop codon (Figure 
4.10). This protein mutation can be described by the Human Genome Variation 
Society (HGVS) nomenclature (den Dunnen et al., 2016) as pAla453Leufs*41 and 





Figure 4.10: Validation of IQGAP1 KO cells by sequencing 
Nucleotide and deduced amino acid sequences of exon 13 of human IQGAP1 from WT 
and from the mutant clone H5 are aligned. The nucleotide sequence is shown in the top 
lines and its deduced amino acid sequence in the single letter code is shown below. 
Nucleotide mutations are highlighted and the asterisk in the red box indicates the first 






 Lack of IQGAP1 was confirmed by immunoprecipitation 
The predicted truncated protein of clone H5 is very likely to yield a non-
functional protein sequence. To detect the truncated protein that may be produced 
in the knockout cell line, immunoprecipitation was performed. The antibody that 
was used to isolate IQGAP1 from the precleared lysates of control and knockout cells 
was raised against human IQGAP1 recognising amino acids 314-422. The predicted 
amino acid sequence of IQGAP1 from knockout cells showed the mutation occurs 
downstream of amino acid 453, which indicated that this antibody would be capable 
of recognising and immunoprecipitating both normal and truncated IQGAP1 from 
cell lysates.  The antigen-antibody complexes were captured with Protein A agarose 
beads and then washed extensively to remove non-specific binding proteins. 
Immunoprecipitates were resolved by SDS-PAGE and stained with Coomassie blue. 
From figure 4.11a, the endogenous IQGAP1 was immunoprecipitated from the 
control lysates at the expected molecular weight of full-length IQGAP1 at 190 kDa. In 
addition, there was another band with a higher molecular weight that was isolated 
from the control cell lysate.  In order to verify this band, 1/10 of the same 
immunoprecipitated sample was subjected to Western blot analysis probing with the 
anti-IQGAP1 antibody. The result revealed that both protein bands were specific to 
the antibody, representing the monomer and dimer of IQGAP1 respectively (Figure 
4.11b). This finding supports a previous study that showed native IQGAP1 comprises 
two subunits of 190 kDa each subunit (Bashour et al., 1997). This also agreed with 
the study of Ren and colleagues that demonstrated oligomerisation of purified 
IQGAP1 using gel filtration chromatography (Ren et al., 2005).  
In the knockout cell lysate, the full-length IQGAP1 was not isolated after 
precipitation (Figure 4.11a). The absence of IQGAP1 in the knockout cell was 
confirmed by Western blot analysis using the same anti-IQGAP1 antibody used for 
immunoprecipitation (Figure 4.11b). Moreover, it was unable to detect any distinct 
lower molecular weight protein in this knockout cell line, compared to the negative 
controls. This finding was proved by increasing the total protein of knockout cells 
(10-fold) and demonstrating a lack of truncated IQGAP1 protein from the knockout 
cells (Supplemental figure 7.8).  This showed that clone H5 completely lacked 
expression of IQGAP1 and it was used for further experiments to determine the role 







Figure 4.11: Immunoprecipitation of IQGAP1 from control and knockout cells 
Precleared HeLa cells lysates were incubated with anti-IQGAP1 antibody and 
immunoprecipitated with protein A-Sepharose beads. After washing, the proteins were 
separated on a 4-12% Bris-Tris gel electrophoresed in MOPS buffer. Immunoprecipitates 
were analysed by Coomassie blue staining and immunoblotting. WT: Lysate of control 
HeLa cells; KO: Lysate of knockout cells (clone H5). 
(a) Coomassie blue staining  














 Role of IQGAP1 in invasion of HeLa cells by B. pseudomallei  
In the previous chapter, the role of IQGAP1 in B. pseudomallei actin-based 
motility was studied in siIQGAP1 knockdown cells. It showed the impact of IQGAP1 
on actin tail formation. However, there were no differences in invasion and 
intracellular replication of B. pseudomallei between control cells and siIQGAP1 
knockdown cells. In this chapter, IQGAP1 knockout cells were used to validate these 
findings. Firstly, IQGAP1 knockout cells (clone H5) were subjected to a B. 
pseudomallei invasion assay. Control cells or IQGAP1 knockout cells were infected 
with B. pseudomallei 10276 at MOI of 130. After infection for 30 minutes, the media 
containing the bacteria was removed and replaced with fresh media supplemented 
with kanamycin to kill the extracellular bacteria. The infected cells were further 
incubated at 37 C supplemented with 5% CO2. At 2 hours post-infection, the infected 
cells were washed with PBS twice before lysis with Triton X-100. Released bacteria 
were serially diluted and colonies counted following plating on LB agar plates. The 
number of bacteria recovered from the infected cells was calculated as the number 
of colony forming units per millilitre (CFU/ml).  To determine the percentage of 
invasion, the following equation was used: 
 
(number of intracellular bacteria at 2 hours post-infection/ number of 
bacteria added) × 100  
 
 The result showed the bacterium was able to invade both control HeLa cells 
and IQGAP1 knockout cells at a similar efficiency, 0.00025% for control cells and 
0.00034% for knockout cells. Although the number of recovered bacteria in the 
IQGAP1 knockout cells was slightly higher than those in the control cells, there was 
no significant statistical difference (Student's t-test, p = 0.1699) as shown in figure 
4.12a.  Similarly, when the cells were infected with a higher MOI of 260, there was no 
statistical difference of B. pseudomallei invasion between control and IQGAP1 
knockout cells (Supplemental figure 7.9). In a previous study of B. pseudomallei 
10276 invasion, HeLa cells were infected at MOI of 10 and showed a percentage of 
internalisation of about 0.5 (Stevens et al., 2003). The effect of multiplicity of 




bacteria were recovered when a low MOI rather than a high MOI was used (Francis 
and Thomas, 1996). However, in this study the recovery of bacteria could not be 
detected after 2- hours post-infection when using a low MOI (data not shown). From 
this observation, a high MOI (more than 100) was used in all experiments of B. 
pseudomallei infection HeLa cells in this study. A low invasion efficiency of B. 
pseudomallei in epithelial cells was found in a recent study that showed a low 
percentage of invasion of a clinical isolate of B. pseudomallei into A549 cells 
(0.000125-0.0002%) over a range of MOIs at 1 hour post-infection (Vellasamy et al., 
2016).  
It was hypothesised that this variability in bacterial invasion could be 
attributed to experimental conditions. To validate the invasion assay in this study, 
Salmonella invasion was performed using the IQGAP1 knockout cells. Whilst a 
previous study showed invasion efficiency of Salmonella enterica serovar 
Typhimurium SL1344 was reduced by 75% in IQGAP1-null MEFs (Kim et al., 2011a). 
When the H5 IQGAP1 knockout cells were infected with a spontaneous nalidixic acid 
resistant mutant of S. Typhimurium ST4/74 nalR in this study, it showed no 
difference in the percentage of invasion between IQGAP1 knockout cells and control 
cells (Figure 4.12b). Using this invasive pathogen as the control for the invasion assay 
implied that this experiment requires further optimisation. However, it is also 








Figure 4.12: Percentage of invasion by B. pseudomallei and Salmonella 
Typhimurium strain ST4/74 in control HeLa cells (WT) and IQGAP1 knockout 
cells (KO) 
(a) The cells were infected with B. pseudomallei at MOI of 130. Error bars represent 
standard errors of the mean for experiments performed in triplicate (n=3, Students 
t-test, p = 0.1699). 
(b) HeLa cells were infected with S. Typhimurium strain ST4/74 at MOI of 
approximately 15. After infection for 30 minutes, cells were incubated in 50 g/ml 
gentamicin. At 2 hours post-infection, infected cells were lysed and the number of 
intracellular bacteria quantified. Data are expressed as the percentage of invasion 
calculated as follows: (the number of recovered bacteria/the number of bacterial 
inoculum) x 100 showing mean ± SEM from six separate experiments (n=6, 














 IQGAP1 is essential for intracellular survival of B. pseudomallei  
To assess the ability of bacteria to replicate in IQGAP1 knockout cells, the 
number of intracellular bacteria was determined at 6 and 24 hours after B. 
pseudomallei infection. Figure 4.13 shows the number of bacteria in control cells 
increased dramatically over time, but the numbers of intracellular bacteria only 
slightly increased over this period of time in IQGAP1 knockout cells. The number of 
viable bacteria at 6 hours post-infection in the control HeLa cells and IQGAP1 
knockout cells was similar (Student's t-test, p = 0.052). On the other hand, a 
significantly higher number of bacteria were recovered from control cells after 24 
hours post-infection, compared to IQGAP1 knockout cells (Student's t-test, p = 
0.0301). This finding was confirmed by doubling the number of bacteria used to 
infect the cells and it showed a similar trend (Supplemental figure 7.9). Investigation 
of intracellular survival of this bacterium was also performed at a later point. At 48 
hours post-infection, however, there was significant cell death in the control cells (as 
determined by LDH release assay) making it impossible to determine the actual 
number of viable bacteria at this time point (Supplemental figure 7.10).  Thus, 
intracellular survival of B. pseudomallei in HeLa cells in vitro was only examined until 
24 hours post-infection. Collectively, these results suggested that a lack of IQGAP1 








Figure 4.13: Intracellular survival of B. pseudomallei in control HeLa cells (WT) 
and IQGAP1 knockout cells (KO) 
HeLa cells were infected by B. pseudomallei 10276 at MOI of 130. Intracellular bacteria 
were counted after lysing infected cells at 6 and 24 hours post-infection. The data of the 
number of recovered bacteria at 2 hours post-infection from figure 4.12 is also included. 
Asterisks indicate significant differences (Unpaired t-test; p<0.05) between control cells 
and knockout cells. Error bars represent standard errors of the mean for experiments 
performed in triplicate (n = 3, Student's t-test, p = 0.052 at 6 hours post-infection and 







 Analysis of actin tail formation in IQGAP1 knockout and control cells  
The use of siIQGAP1 knockdown cells in chapter 3 suggested that IQGAP1 
plays a role in controlling the length and actin density of B. pseudomallei actin tails. 
In this chapter IQGAP1 knockout cells were utilised to transcend the limitation of 
residual IQGAP1 in the siIQGAP1 knockdown cells. From three independent 
experiments, a total number of bacteria in control cells and IQGAP1 knockout cells, 
4,301 and 1,586 respectively, were examined at 16 hours post-infection for tail 
formation.  The bacteria were categorised into two groups. The first group included 
the bacteria without a tail but which may still have recruited actin to the bacterial 
surface (termed ‘barcode’), and those that were not associated with actin at all. The 
second group included bacteria with a tail, whether a short or long actin tail. This 
analysis showed a similar proportion of B. pseudomallei formed actin tails in control 
cells and IQGAP1 knockout cells (Figure 4.14a).  
The same data was re-classified into four phenotypes: first, bacteria that were 
not associated with actin at all; second, bacteria that were associated with actin 
recruitment but not displaying an actin tail (barcode); third, bacteria displaying a 
short actin tail; fourth, bacteria displaying a long actin tail. Interestingly, as shown in 
figure 4.14b, the proportion of bacteria that were not associated with actin at all is 
greater in IQGAP1 knockout cells at 49.04% (Student's t-test, p = 0.011), whilst 
bacteria that demonstrated a barcode morphology is greater in control cells at 49.5% 
(Student's t-test, p = 0.0018). However, there was no statistically significant 
differences in the group of B. pseudomallei that displayed a short or long tail 
(Student's t-test, p = 0.9790 and 0.5835, respectively) in control cells and IQGAP1 
knockout cells. Representative images of confocal micrographs in figure 4.14c shows 
the noticeably higher number of bacteria associated with actin in control cells. 
Additionally, it is noticeable that B. pseudomallei showed the barcode phenotype of 
parallel lines of varying widths of actin across the bacterium in control cells (Figure 
4.14d), albeit at higher levels in knockout cells. This phenotype is reminiscent of 
septin-cages that entrap Shigella during host cell infection, where the septin rings 
were detectable next to actin around the bacterium in cage-like structures that 
restrict motility and cell-to-cell spread, and ultimately leads to elimination of the 





Figure 4.14: Qualitative analysis of the morphology of actin tails formed by B. 
pseudomallei in control and IQGAP1 knockout cells 
(a) Distribution of bacteria associated with (short or long tail) or without an actin tail 
(no actin or barcode distribution of actin). 
(b) Percentage distribution of bacteria in each category in control cells (blue bar) 
compared to IQGAP1 knockout cells (red bar). Data represents mean  SEM (n = 3 
Student's t-test, p = 0.011 for no actin, p = 0.0018 for barcode, p = 0.9790 for 
short tails and p = 0.5835 for long tails). 
(c) Representative confocal micrographs of control HeLa and IQGAP1 knockout cells 
infected with B. pseudomallei. Bacteria were stained red, filamentous actin was 
stained in green. Scale bar = 10 µm. 
(d) Representative confocal micrographs showing Hela cells infected with B. 
pseudomallei showing the barcode phenotype. Bacteria were stained red, 






















In the previous chapter, B. pseudomallei displayed an actin tail that was 
significantly longer but less actin dense in siIQGAP1 knockdown cells, compared with 
the control cells. To verify this finding, 100 bacteria displaying a tail with a length 
longer than 2 m were selected randomly in each cell type for analysis. Actin tail 
length and density were measured and processed using ImageJ software. By using 
identical laser settings between B. pseudomallei infected control cells and IQGAP1 
knockout cells, images were captured and analysed from maximum intensity z-
projections of the stacked cell images. The results showed that the bacteria form an 
actin tail in control cells was longer than those in IQGAP1 knockout cells, with a mean 
length of 13.1 μm and 8.3 μm respectively (Figure 4.15a). However, actin density of 
B. pseudomallei actin tails measured by the fluorescence intensity in control cells was 
similar with those in IQGAP1 knockout cells (Students t-test, p = 0.1945) (Figure 
4.15b). Comparison with the finding in Chapter 3, actin tail formation of B. 
pseudomallei in IQGAP1 knockout cells did not follow the trend previously observed 
in siIQGAP1 knockdown cells. In fact, the proportion of bacteria displayed a short or 
long actin tail and bacteria did not display an actin tail (no actin recruitment and 
formed barcode morphology), compared with the control cells was consistent 
between in siIQGAP1 knockdown cells and in IQGAP1 knockout cells. Although, the 
greater number of bacteria with no actin association was observed only in IQGAP1 
knockout cells, but not in siIQGAP1 knockdown cells. Conversely, the number of 
bacteria displayed barcode phenotype was shown in the control cells more than in 
IQGAP1 knockout cells, but this finding was not found in the siIQGAP1 knockout cells. 
Taken together, it could be suggested that the IQGAP1 may be not essential to 
induce the formation of B. pseudomallei actin tail. Despite that, the results 
demonstrated that IQGAP1 is involved in the organisation of the architecture of the 









Figure 4.15: IQGAP1 affects B. pseudomallei actin tail length but not the density 
of the actin tail 
HeLa cells were infected with B. pseudomallei 10276 WT for 16 hours post-infection 
before fixing. Bacteria, IQGAP1 and actin were stained and images captured by confocal 
microscopy. The length of the actin tails and signal intensity were quantified using 
ImageJ software. 100 bacteria from three independent experiments of each sample, 
control cells (WT) and IQGAP1 knockout cells (KO) were observed (n=3). 
(a) Scatter plot indicating the length of actin tail formed by individual bacteria 
displaying a tail longer than 2 m. The data represent mean ± SEM and asterisks 
denote lengths that are significantly different from each other (Unpaired t-test; p = 
0 .001).  
(b) Scatter plot indicating the intensity of actin in tails formed by individual bacteria 
displaying a tail longer than 2 m. The data represent mean ± SEM (Unpaired t-test; 
p = 0 .1945).   
                                                                     










   




 IQGAP1 affects MNGC formation by B. pseudomallei 
B. pseudomallei can spread directly to neighbouring cells by inducing the 
formation of a multinucleated giant cell (MNGC) which is promoted by actin-based 
motility. From the effect of IQGAP1 on actin tail formation, it was hypothesised that 
IQGAP1 could be a factor to support MNGC formation by B. pseudomallei. MNGC 
formation could not be assessed in siIQGAP1 knockdown cells because the cells could 
not form full monolayers, hence the IQGAP1 knockout cells were used to investigate 
MNGC formation in this chapter. 
To assess MNGCs induced by B. pseudomallei in IQGAP1 knockout cells, cells 
were infected with the bacterium and incubated for 16 hours before fixing and 
staining, and quantification of the number of MNGCs. Infected cells were stained with 
phalloidin for F-actin and nuclei were stained with DAPI. To locate infected cells, the 
bacteria were stained red with mouse anti- B. pseudomallei LPS antibody followed by 
anti-mouse-Alexa568. MNGCs were defined as cells containing 3 or more nuclei. In a 
field of view, only nuclei of infected cells were quantified and used to calculate the 
percentage of MNGC formation as follows:  
 
(number of nuclei within multinucleated giant cells/ total number of nuclei 
in the field of view) × 100. 
 
 Figure 4.16a shows representative images of B. pseudomallei infected cells at 
16 hours post-infection leading to MNGC formation in control HeLa cells (WT) and 
IQGAP1 knockout cells (KO). It is clear that the number of bacteria in control cells 
was greater than in IQGAP1 knockout cells, which agrees with the previous result of 
intracellular survival (Figure 4.13). Despite the lower number of bacteria in 
knockout cells, MNCG formation could be detected. On average, MNGC formation in 
control cells was 41% whilst in knockout cells, the bacteria induced MNGC at a much 
lower frequency of only 4.8% (Figure 4.16b). MNGC was monitored at later time 
points but MNCGs could not be detected in IQGAP1 knockout cells even at 72 hours 








Figure 4.16: B. pseudomallei induced MNGC formation in control (WT) and 
knockout cells (KO) 
HeLa cells were infected with B. pseudomallei 10276 WT at MOI of 130 for 16 hours post-
infection before fixing. Bacteria, IQGAP1 and actin were stained and images captured by 
confocal microscopy.  
(a) Confocal micrographs showing a representative image of an MNGC in control cells 
(WT) and IQGAP1 knockout cells (KO). Each colour of the circle represents a group 
of nuclei forming an MNGC. 
(b) The percentages of MNGC formation in cells represent the mean ± SEM for 
experiments performed in triplicate (n=3) and asterisks indicate significant 
differences (Unpaired t-test; p<0 .0001) between the control cells (WT) and IQGAP1 















 Defective plaque formation by B. pseudomallei in IQGAP1 knockout 
cells 
The ability of B. pseudomallei to spread from cell-to-cell can be quantified by 
assessing the formation of plaques in a cell monolayer. This assay could not be 
performed in siIQGAP1 knockdown cells because these cells could not form a robust 
monolayer. To evaluate the role of IQGAP1 in plaque formation by B. pseudomallei, 
IQGAP1 knockout cells were used.  
HeLa cells were infected with B. pseudomallei at MOI of approximately 100 
and incubated for 24 hours before fixing and staining with crystal violet. At 24 hours 
post-infection, in control cells, the bacteria formed 24 plaques per well of a 24-well 
plate on average from 3 independent replicates. In contrast, there was no visible 
plaque formation in IQGAP1 knockout cells (Figure 4.17a). To confirm this 
phenotype, the infected cells were further incubated and observed for plaque 
formation at 48 and 72 hours post-infection. The results showed that the bacteria 
formed larger plaques over time in control cells (Figure 4.17b). However, the number 
of plaques could not be quantified at these time points because the plaques merged, 
thereby hindering accurate quantification. On the other hand, there was no visible 
plaque formation detected in B. pseudomallei infected IQGAP1 knockout cells even at 
72 hours post-infection. At the later time points of infection, it is presumed that the 
number of intracellular bacteria decreased. The number of intracellular bacteria in 
B. pseudomallei infected IQGAP1 knockout cells were observed under a microscope 
and showed a very low number of bacteria at 48- and 72- hours post-infection, in 
agreement with this assumption (Supplemental figure 7.11). Collectively, IQGAP1 is 
assumed to play a role at a late stage of the B. pseudomallei intracellular life cycle, 






Figure 4.17: Plaque formation by B. pseudomallei in control (WT) and IQGAP1 
knockout cells (KO) 
HeLa cells were infected with B. pseudomallei 10276 at MOI of approximately 100. Plaque 
formation was observed by crystal violet staining.  
(a) The total number of plaques formed at 24 hours post-infection in each well of a 24-
well plate was counted. Data represent mean  SEM for experiments performed in 
triplicate and asterisks indicate significant differences (n=3, Unpaired t-test, p = 
0.0147) between groups.  
(b) Representative images of the infected cell monolayers after infection with B. 
pseudomallei for 24, 48 and 72 hours and stained with crystal violet showing 














The aim of the work presented in this chapter builds upon the previous 
chapter. It showed that IQGAP1 was present in the actin tail of B. pseudomallei with 
a proposed function to control the length and actin density of tails. To gain insight 
into the impact of IQGAP1 on the intracellular life of B. pseudomallei, IQGAP1 
knockout cells were generated using the CRISPR-Cas9 technique. Transfections of 
siRNAs or CRISPR-Cas9 require optimisation to achieve the highest efficiency. RNAi 
is simple and can be validated by Western blot analysis to obtain a desired 
knockdown level of protein expression.  On the other hand, CRISPR-Cas9 has 
additional steps of selection, clonal expansion and verification. One of the main 
differences between the mechanism to repress gene expression by siRNA and 
remove a gene by CRISPR-Cas9 is their action. Whilst RNAi results in decreases at the 
mRNA level and occurs in the cytoplasm, CRISPR-Cas9 targets at the DNA level in the 
nucleus. Consequently, the effect of RNAi is typically transient for 2–7 days and never 
fully eliminates expression of the targeted gene, whereas CRISPR-Cas9 edits the 
genome causing a permanent effect (Reviewed in Barrangou et al., 2015). With the 
benefits of the CRISPR-Cas9 approach, IQGAP1 knockout cells (clone H5) were 
produced to explore the roles of IQGAP1 in B. pseudomallei intracellular life. Studies 
show that actin-based motility affects bacterial intracellular life and is important for 
cell-to-cell spread (Reviewed in Kuehl et al., 2015). However, it is still under 
investigation how actin-based motility impacts the intracellular life cycle of B. 
pseudomallei. To explore the effect of IQGAP1 in the intracellular life of this 
bacterium, the IQGAP1 knockout cell was subjected to invasion, intracellular 
survival, MNGC and plaque formation assays.  
IQGAP1 is a well-known regulator of Salmonella invasion (Brown et al., 2007, 
Kim et al., 2011a). However, this study showed that IQGAP1 is not required for B. 
pseudomallei invasion into HeLa cells. A very low percentage of B. pseudomallei 
invasion at 0.00025% and 0.00034% in control cells and IQGAP1 knockout cells 
respectively, was detected when the cells were infected at MOI of 130. This low 
percentage of invasion was also found upon infection of another epithelial cell line 
(A549) by a B. pseudomallei clinical isolate (Vellasamy et al., 2016). Due to a very low 




pseudomallei into HeLa cells requires further optimisation to improve the level of 
detection. However, it was questionable whether the invasion assay performed in 
this study is reliable. To examine this, S. Typhimurium ST4/74 nalR was used to infect 
the control or IQGAP1 knockout cells. The result showed a similar level of invasion 
efficiency of Salmonella into these cell types. This finding contradicts the previous 
study that showed a significant reduction (by 33%) of Salmonella invasion in HeLa 
cells with siRNA-mediated suppression of IQGAP1 (decreased ~75%) (Brown et al., 
2007). Moreover, MEFs lacking IQGAP1 also showed a reduction of S. Typhimurium 
invasion by 75% (Kim et al., 2011a). However, when the MEFs lacking IQGAP1 were 
infected with Shigella, the number of internalised bacteria in the cells were greater 
than in control cells but with no statistical difference (Lu et al., 2015b). An 
explanation for this difference could be the specific mechanism used by these 
pathogens to gain entry into host cells or the origin of the cell types used in these 
experiments.  It is also possible that the conditions used to culture Salmonella in the 
experiment described in this chapter were not optimal for T3SS expression. In future, 
temperature shift of the bacterial culture from 25°C to 37°C may be used to induce 
protein secretion by the Salmonella T3SS in vitro. For example, SopE that contributes 
to the entry process into HeLa cells and co-localises with IQGAP1 and phagocytic 
cups during Salmonella invasion could impact this process (Brown et al., 2007, Wood 
et al., 1996). 
For intracellular survival, it is clear that the number of B. pseudomallei in 
control cells is greater than in IQGAP1 knockout cells at 24 hours post-infection. 
Although the number of bacteria that invaded and survived until 6 hours after 
infection in the knockout cells was slightly higher than in control cells, it was not 
significant. At 6 hours post-infection also mirrors the timing of BimA expression in 
B. pseudomallei infected cells (Jitprasutwit et al., 2016). The decreased number of 
bacteria in IQGAP1 knockout cells at the later time point indicates a defect in 
intracellular survival. The host defence mechanisms that affect the ability of the 
bacterium to survive and replicate include the harsh environment of the endosome 
and autophagy.  After invasion of B. pseudomallei into non-phagocytic cells, the 
bacterium has evolved strategies to escape from the endocytic vesicle and survive in 
the cytosol. Comparison of intracellular growth of B. pseudomallei in control and 




numbers of bacteria. Several studies have demonstrated that B. pseudomallei T3SS 
mutants were able to escape into the cytosol by 6 hours post-infection (Reviewed in 
Allwood et al., 2011). Thus, it is probable that at 6 hours post-infection in this study 
the bacteria can escape from the endocytic vesicles and are free in the cytosol, 
suggesting that IQGAP1 does not impair the ability of the bacteria to escape from the 
vacuoles.  Although this could be confirmed using a chloroquine and kanamycin 
protection assay or by LAMP1-staining. 
In the cytosol, B. pseudomallei exploits host cellular actin to support its 
movement inside the cells and into the adjacent cells. B. pseudomallei was still able 
to form actin tails in IQGAP1 knockout cells, with the same proportion of bacteria 
displaying either a short or long tail, compared to the control cells. However, the 
length of the actin tail in control cells was significantly longer than in IQGAP1 
knockout cells with no difference in actin density. Collectively, this data indicates a 
possible function of IQGAP1 to recruit actin to the bacteria and to promote actin 
polymerisation to form long tails. It should be noted that this finding differs 
significantly from that described in chapter 3 where siRNA mediated knockdown of 
IQGAP1 resulted in longer tails with less actin density. This can be explained by the 
fact that the residual IQGAP1 in siIQGAP1 knockdown cells are sufficient for forming 
a long actin tail. However, the depletion of IQGAP1 affected the structure of the actin 
tails causing a loose tail instead of a compact tail. On the other hand, in this chapter, 
a lack of IQGAP1 led to a shorter B. pseudomallei tail with no effect on actin density. 
This suggests that other unknown host factors may be involved in B. pseudomallei 
actin tail formation. 
Actin-based motility is the ability of bacteria to propel themselves inside the 
cytoplasm and facilitate cell-to-cell spread by actin polymerisation. In addition, this 
motility promotes the avoidance of cellular innate immune responses. B. 
pseudomallei induces the fusion of cells for spreading from infected cells to 
neighbouring uninfected cells leading to MNGC formation. In this study, B. 
pseudomallei infected IQGAP1 knockout cells showed a significant defect in MNGC 
formation compared to control cells at 16 hours post-infection. This phenotype was 
confirmed by plaque assay which represents MNGC cell death and is a visual readout 




fusion by B. pseudomallei in IQGAP1 knockout cells is supported because there was 
no visible plaque formation even up until 72 hours post-infection. Whereas in control 
cells a number of plaques could be detected at 24 hours post-infection which 
increased in size over time.  This result could be expected given the rapid decrease 
in number of intracellular bacteria in IQGAP1 knockout cells. In the next chapter, the 
interaction between IQGAP1 and BimA was explored and the importance of IQGAP1 






Expression and purification of IQGAP1 
to study its interaction with BimA 
5.1 Introduction 
Burkholderia actin-based motility requires BimA to mediate actin assembly 
at the bacterial pole. In order to understand what host cell proteins may be involved 
in this process, the bacterium was engineered to constitutively express BimA and 
IQGAP1 was identified as a potential interacting partner using an affinity approach 
(Jitprasutwit et al., 2016). In chapter 3, confocal microscopy revealed that IQGAP1 
was recruited to B. pseudomallei actin tails in infected cells. In IQGAP1-depleted cells, 
the role for this protein in controlling the length and actin density of the actin tails 
was demonstrated. Moreover, a defect in intracellular survival of this bacterium was 
found in HeLa cells lacking IQGAP1 (chapter 4). A number of pathogen-derived 
IQGAP1 interaction partners were identified previously, with roles that seem to be 
specific for different pathogens (Reviewed in(Kim et al., 2011b). For example, a T3SS-
translocated effector protein, SseI, which plays a role in maintaining a long-term 
infection of S. enterica serovar Typhimurium in mice and is required to inhibit cell 
migration of primary macrophages and dendritic cells in vitro, has been identified as 
an IQGAP1 binding partner (McLaughlin et al., 2009). SseI binds directly to IQGAP1 
in vitro and co-localises with IQGAP1 and actin at the cell periphery of bone marrow-
derived macrophages during Salmonella infection (McLaughlin et al., 2009). 
Enteropathogenic E. coli (EPEC) also targets IQGAP1 through the translocated 
intimin receptor (Tir) of the T3SS which manipulates the actin cytoskeleton by 
associating with calmodulin to induce actin pedestal formation (Brown et al., 2008). 
Localisation of IQGAP1 with actin was revealed at the site of EPEC adhesion and an 
in vitro assay showed a direct interaction between IQGAP1 and Tir (Brown et al., 
2008). Another novel T3SS effector protein in E. coli, Ibe (IQGAP1-binding effector), 
also interacts with IQGAP1 to induce pedestals and actin-rich membrane ruffles 
(Buss et al., 2009). 
IQGAP1 is a scaffold protein with multiple roles including regulation of the 
cell cytoskeleton. Previous studies have shown that IQGAP1 directly binds and 




enhances actin assembly in vitro via the Arp2/3 complex and N-WASP (Le Clainche 
et al., 2007, Bensenor et al., 2007). It has been proposed that IQGAP1 regulates actin 
polymerisation by capping the barbed end of actin filaments (Pelikan-Conchaudron 
et al., 2011). In this chapter, the role of IQGAP1 in BimA-mediated actin 
polymerisation has been studied. BimA is located at the pole of B. pseudomallei, binds 
monomeric actin and stimulates actin polymerisation in vitro in a manner 
independent of the cellular Arp2/3 complex (Stevens et al., 2005a, Sitthidet et al., 
2010, Benanti et al., 2015). It is possible that IQGAP1 is recruited to the bacterial 
actin tail in infected cells either through a direct interaction with BimA or through its 
interaction with cellular actin. It is also possible that IQGAP1 augments BimA-
mediated actin polymerisation. In this chapter, the interaction between IQGAP1 and 
BimA was examined. To determine if BimA can directly bind IQGAP1, an in vitro pull-
down assay was performed with purified proteins. A yeast two-hybrid system 
approach was also utilised. In addition to protein-protein interaction assays, the 
ability of IQGAP1 to stimulate BimA-mediated actin polymerisation in an in vitro 






 pMAL-IQGAP1 cloning for expression of MBP-IQGAP1 
To test whether there is a direct interaction between IQGAP1 and BimA, 
recombinant plasmids encoding full-length and truncated IQGAP1 were constructed 
by PCR cloning. Primers were used to amplify either full-length, the N-terminus or 
the C-terminus of IQGAP1 at the expected size (approximately 5,000 bp, 2,400 bp and 
2,500 bp respectively) using HeLa cell cDNA as template (Figure 5.1a). A positive 
control for amplification from the cDNA template was also included showing 838 bp 
fragments of the β–actin gene, whereas the absence of cDNA template was used as a 
negative control (Figure 5.1a). The PCR fragments were cloned into the pGEM-T Easy 
vector and transformed into E. coli XL-1 blue cells. And then, the fragments were sub-
cloned into pMAL-p2X vector which is designed for protein expression in the 
periplasm to facilitate disulphide bond formation for correct folding of proteins. 
Using these vectors, IQGAP1 proteins were expressed as C-terminal MBP fusion 
proteins (Fig. 5.1b).  
After identification of positive clones, the plasmid DNA was extracted and 
sequenced. Amino acid sequences of Homo sapiens IQGAP1 (NP_003861) and 
translation of the cloned genes were aligned using a web tool, Clustal Omega 
(https://www.ebi.ac.uk/Tools/msa/clustalo/). The full-length IQGAP1 (encoding 
aa1-1657) had 99% identity to the reference sequence, with substitutions of K201T 
(lysine was replaced by threonine at amino acid position 201) and D1244G (aspartic 
acid was replaced by glycine at amino acid position 1224). The N-terminus of IQGAP1 
(encoding aa1-808) showed 99% identity with the reference IQGAP1 sequence with 
M185T and N299D substitutions (methionine was replaced by threonine at amino 
acid position 185 and asparagine was replaced by aspartic acid at amino acid 
position 299), while the C-terminal IQGAP1 (encoding aa809-1657) showed 100% 
identity to human IQGAP1 (Figure 5.2). The different positions of the mutations on 
each fragment suggested they had arisen from using the polymerase mix (Advantage 
2 Kit; Clontech) that contained Taq DNA polymerase and a minor amount of a proof-
reading polymerase to amplify the products, rather than the variation of IQGAP1 
sequence. However, these mutations are located outside of the important conserved 
domains and were presumed to have negligible effect on IQGAP1 activity. These 







Figure 5.1: IQGAP1 cloning  
(a)  PCR product of full-length IQGAP1 (5,002 bp), IQGAP1 N-terminal half (2,444 bp) 
and IQGAP1 C-terminal half (2,578 bp) were separated by 1% agarose gel 
electrophoresis. Positive control for cDNA template showing 838 bp fragments of β 
–actin. No cDNA template used as a negative control (-ve).  







Figure 5.2: Schematic diagram of IQGAP1 constructs illustrating any 
differences in amino acid composition compared to the Homo sapiens IQGAP1 
sequence (Accession number: NP_003861) 
Known domains that interact with cellular proteins are highlighted. CHD; calponin 
homology domain, WW; polyproline binding region, IQ; calmodulin-binding IQ motifs, 
GRD; Ras GTPase-activating protein-related domain, RGCT; RasGAP C-terminus. 
Numbers indicate amino acid residues. 
 
  




  MBP-IQGAP1 expression and purification  
To express IQGAP1 proteins, pMAL-p2X harbouring the full-length, N-
terminal half and C-terminal half of the IQGAP1 gene were transformed into E. coli 
strain Rosetta 2 (DE3) pLysS that is suitable for expression of eukaryotic proteins 
with rarely used codons in E. coli. After IPTG induction, the recombinant protein from 
each of the constructs could be detected on an SDS-PAGE gel stained with Coomassie 
Blue dye (Figure 5.3). The culture and induction conditions were optimised to obtain 
the best conditions for expression and purification (Supplemental figure 7.12 and 
7.13). Figure 5.3 shows the proteins were in both the soluble (S) and insoluble (P) 
fractions after lysis of induced cells in BugBuster buffer. SDS-PAGE showed several 
additional bands in the purified protein samples, including protein of the expected 
molecular weights of the MBP fusion proteins. Total cell lysate from IPTG-induced E. 
coli cells were analysed by Western blotting with antibodies specific to MBP to 
examine if the proteins were degradation products. Many bands of protein specific 
to anti-MBP could be detected from the expected molecular weight of the fusion 
protein to the size of MBP at 42.5 kDa (Supplemental figure 7.14). This suggested 
that the MBP-fusion proteins may be degraded by bacterial proteases. Another 
possibility for degradation could be protein folding improperly because of a high 
reducing potential in the E. coli cytoplasm. Direct the protein to the periplasm would 
be helpful for folding protein in E. coli. To improve this, the plasmids were 
transformed into E. coli Rosetta-gami B which is supplemented with a plasmid for 
expression eukaryotic proteins that are limited by codon usage of E. coli. Also, this 
engineered E. coli strain lacks neither the proteases reducing degradation of the 
expressed protein nor reductase for enhancing the formation of target protein 
disulphide bonds in the bacterial cytoplasm. However, this strain failed to express 
the IQGAP1-MBP fusion proteins (Supplemental figure 7.15). Therefore, the fusion 
proteins were expressed in E. coli Rosetta 2 (DE3) pLysS since they showed a high 
level of expression. The proteins were induced and purified, typical MBP-IQGAP1 
fusion protein expression and purification profiles are shown in figure 5.3. Soluble 
MBP-fusion protein was bound on amylose resin and then eluted with maltose. The 








Figure 5.3: SDS–PAGE showing purification of MBP-IQGAP1 recombinant 
proteins expressed in E. coli Rosetta 2 (DE3) pLysS after IPTG induction  
M: protein marker, UN: Uninduced cell, IN: Induced cell, P: Pellet of insoluble proteins, S: 







 Pull-down assay  
To detect a direct interaction between BimA and IQGAP1, a pull-down assay 
was performed using GST-BimA54-455 (Sitthidet et al., 2010) immobilised on GSH 
beads or MBP-IQGAP1 proteins; full-length, N-terminus and C-terminus immobilised 
on amylose resin. Comparison between the GST pull-down and MBP pull-down 
method is shown in figure 5.4. For the GST pull-down, purified MBP-IQGAP1 was 
added into the reaction containing GST or GST-BimA immobilised on GSH beads. 
After incubation, unbound proteins were removed from the beads by centrifugation 
and extensive washing. It was assumed that if IQGAP1 interacts with BimA, IQGAP1 
would be eluted from the beads and could be detected by Western blotting using anti-
MBP. In the same way, when IQGAP1 proteins were immobilised on amylose resin, 
BimA could be detected in the pull-down using anti-GST by immunoblotting if BimA 
is indeed an interacting partner of IQGAP1. 
 
 
Figure 5.4: Schematic illustrating the pull-down assays 
(a) GST pull-down assay. The BimA GST-tagged protein was captured by GSH agarose 
beads and incubated with the MBP-IQGAP1 proteins. After washing, if IQGAP1 
interacts with BimA, it could be eluted and subjected to SDS-PAGE. The fusion MBP 
protein can be detected by Western blot using anti-MBP. 
(b) MBP pull-down assay. The fusion MBP-IQGAP1 proteins were immobilised on 
amylose resin and incubated with BimA GST-tagged protein. After washing, if BimA 
interacts with IQGAP1, it could be eluted and subjected to SDS-PAGE. The GST fusion 





1) Pull-down assay using immobilised GST-BimA 
To perform a GST pull-down assay, the MBP-tag fusion proteins were 
produced after IPTG induction. The E. coli cells were harvested and lysed, and soluble 
protein was incubated with amylose resin. After washing, the MBP-tagged proteins 
were eluted with maltose (Figure 5.5a). The amount of eluted proteins was very low, 
and could only be detected by silver staining (Figure 5.5a). GST and GST-BimA54-455 
captured on beads were also produced for the pull-down assay as previously 
described (Sitthidet et al., 2010). The amount of protein on the beads is shown by 
Coomassie blue staining of the protein gel (Figure 5.5a).  
Each MBP-tagged protein was incubated with GST or GST-BimA54-455 
immobilised on GSH beads. After extensive washing and electrophoresis of the GSH 
beads, Western blot analysis revealed that all MBP-tagged proteins, including the 
MBP protein alone were present in both the pull-down with either GST or GST-
BimA54-455 (Figure 5.5b). It indicated that there was non-specific binding between 
MBP and GST proteins or the GSH beads. Thus, the result from the GST pull-down 
was inconclusive. 
 
2) Pull-down assay using immobilised MBP-IQGAP1 
Next, IQGAP1 proteins fused with an MBP-tag were immobilised on amylose 
resin for MBP pull-down assays. SDS-PAGE gel followed by Coomassie blue staining 
in figure 5.6a showed a dominant band of MBP-tagged IQGAP1 proteins at the 
predicted molecular weight. The same amount of eluted GST or GST-BimA54-455 was 
incubated with the MBP-proteins (Figure 5.6a). Similarly, to the situation described 
above, there was evidence of non-specific interaction of the tag proteins either with 
each other or the amylose resin used in the assays. At this point it could not be 
concluded that IQGAP1 and BimA are interacting partners and a separate 







Figure 5.5: Pull-down assay using immobilised GST-BimA 
After IPTG induction, protein was expressed and purified for pull-down assay. FL: MBP- 
full length IQGAP1, N: N-terminal IQGAP1, C: C-terminal IQGAP1, M: Maltose-Binding 
Protein.  
(a) IQGAP1 proteins were eluted from amylose resin and subjected to SDS-PAGE with 
silver staining. GST and GST-BimA were immobilised on GSH beads and subjected to 
SDS-PAGE with Coomassie blue staining. 
(b) GST pull-down assay; IQGAP1 proteins, full-length, N-terminus, and C-terminus 
were added to incubate with GST or GST-BimA that was immobilised on GSH beads. 
After washing extensively, the protein complex was subjected to SDS-PAGE and 















Figure 5.6: Pull-down assay using immobilised MBP-IQGAP1   
(a) After IPTG induction, protein was expressed and purified for pull-down assay. FL: 
MBP- full length IQGAP1, N: N-terminal IQGAP1, C: C-terminal IQGAP1, M: Maltose-
Binding Protein. GST and GST-BimA proteins were eluted from GSH beads whereas 
IQGAP1 proteins were immobilised on amylose resin. Proteins were subjected to 
SDS-PAGE with Coomassie blue staining. 
(b) Eluted samples from the pull-down assays. MBP pull-down assay; GST and GST-
BimA proteins were added to full-length, N-terminus, and C-terminus of IQGAP1 
that was immobilised on amylose resin. After washing extensively, the protein 
complex was subjected to SDS-PAGE and immunoblotting using anti-GST. GST 















 Identification of a direct interaction between BimA and IQGAP1 
using a yeast two-hybrid assay  
The yeast two-hybrid (Y2H) assay is a powerful technique used to study 
protein-protein interactions in yeast cells allowing the detection of the interaction in 
the cellular environment. This system uses the modular nature of eukaryotic 
transcriptional activators that contain a DNA-binding domain (DNA-BD) and an 
activation domain (AD). These domains can be separated and are functionally and 
structurally independent. The DND-BD binds tightly to a DNA sequence called an 
upstream activating sequence (UAS), but does not activate transcription unless the 
AD is close enough to form a functional transcription unit. The reconstitution of the 
transcription factor activates the downstream reporter gene(s). In this study, the 
yeast GAL4 transcriptional activator was used to detect protein-protein interactions. 
A protein of interest (bait) is expressed as a fusion to the GAL4 DNA-BD, whereas 
another protein (prey) is expressed as a fusion to the GAL4-AD.  The fusion proteins 
are expressed under the yeast alcohol dehydrogenase 1 promoter (PADH1) and 
targeted to the yeast nucleus where the interaction occurs.  When the bait protein 
interacts with the prey protein, the AD is brought into close proximity with the DNA-
BD forming an active transcription complex. The interaction is tested in the host 
strain Saccharomyces cerevisiae AH109 that utilises three reporters: ADE2, HIS3, and 
MEL1. The auxotrophic markers; ADE2 and HIS3 allow growth on minimal media or 
synthetically defined (SD) medium formulated to provide the carbon and nitrogen 
sources for the yeast to grow and is supplemented with essential amino acids lacking 
adenine and histidine, respectively. Additionally, α-galactosidase which is a secreted 
enzyme encoded by MEL1 induces blue colonies on X-α-Gal indicator plates 
(Bruckner et al., 2009). 
To perform a Y2H assay in this study, a bait plasmid; pGBKT7 containing the 
TRP1 gene and the GAL4 DNA-BD was fused to amino acids residue 54–455 of BimA. 
This plasmid had been previously constructed in our laboratory.  Yeast cells 
containing this plasmid were selected on minimal medium lacking tryptophan (SD/-
Trp). The prey plasmid; pGADT7 encodes an LEU2 nutritional marker that allows 
yeast to grow on SD media lacking leucine (SD/-Leu) as shown in figure 5.7a. The 
IQGAP1 gene was cloned into the prey plasmid and expressed in-frame with the 




(pGEMT-FL-IQGAP1) with 100% amino acid identity with the reference human 
IQGAP1 sequence. The nutritional selection markers encoded by the bait and prey 
plasmids allow yeast cells harbouring both bait ad prey plasmids to be selected on a 
double dropout media lacking both tryptophan and leucine (DDO or SD/–Leu/–Trp), 
as shown in figure 5.7b. When investigating the protein-protein interaction, the yeast 
cells were selected on a quadruple dropout (QDO/X) which is the SD media lacking 
adenine, histidine, leucine and tryptophan supplemented with X-α-Gal. This 
chromogenic substrate is used for detecting the positive interactions which results 
in formation of a blue yeast colony. To test whether proteins interact, positive and 
negative controls for the protein-protein interaction provided from the Matchmaker 
kit were transformed into S. cerevisiae AH109. A prey plasmid, pGADT7-T that 
encodes simian virus 40 large T-antigen fused with the GAL4-AD was co-expressed 
with pGBKT7-53 which is a bait plasmid that encodes a murine p53 fused with the 
GAL4 DNA-BD, generating the strain AH109 pGBKT7-53 pGADT7-T. These proteins 
are known interacting partners and used to demonstrate the positive interaction by 
the Y2H system. The interaction between the large T-antigen and p53 leads to 
reconstitution of the DNA-BD and the AD activating the transcription of HIS3, ADE2 
and MEL1 genes leading to a blue colony on QDO/X plate (Figure 5.7c).  Whereas the 
negative control yeast strain AH109 pGBKT7-Lam pGADT7-T harbours plasmids 
encoding a fusion of the DNA-BD with human Lamin C (pGBKT7-Lam) and pGADT7-
T.  Due to no interaction between these proteins, the DNA-BD is still bound on the 
UAS but it does not activate transcription because the AD is not close enough to 
activate transcription. Thus, the yeast cell cannot grow on a QDO/X plate (Figure 
5.7c). In addition, -actin was used as a positive control for the interaction with BimA 
(Stevens et al., 2005a). The -actin gene was amplified from HeLa cell cDNA. PCR 
products were amplified and cloned into pGADT7. The resulting plasmids, pGADT7-
IQGAP1 and pGADT7-actin, were extracted from E. coli for sequencing. Using the T7 
promoter primer, the insertion of IQGAP1 and actin was confirmed to be in the 
correct direction and in-frame with the GAL4-AD (Supplemental figure 7.16). The 
plasmid, pGADT7-IQGAP1 or pGADT7-actin, was then transformed using the LiAc/SS 
Carrier DNA/PEG method into S. cerevisiae AH109 that harboured the bait plasmid, 
pGBKT7-BimA. The transformants were isolated on DDO media and then examined 






Figure 5.7: Yeast two-hybrid assay 
(a) Yeast two-hybrid plasmid map shows important features. The ADH1 promoter is 
used to drive expression of the fusion proteins.  A bait plasmid, pGBKT7 carrying 
TRP1 allows growth on minimal media lacking tryptophan (SD/-Trp). The fusion 
protein, GAL4 DNA-BD-BimA was expressed by pGBKT7. The prey plasmid pGADT7 
containing LEU2 allows growth of the yeast on minimal media lacking leucine (SD/-
Leu). The fusion protein GAL4-AD-IQGAP1 was expressed by pGADT7.  
(b) When both bait and prey plasmid are introduced into yeast cells, it can be selected 
on minimal media lacking tryptophan and leucine (DDO). 
(c) An example of protein-protein interactions showing the principle of yeast two-
hybrid. The p53 and large T-antigen were expressed as DND-BD and AD fusion 
proteins, respectively in a yeast two-hybrid assay. The DNA-BD binds to upstream 
activating sequences (UAS). When the AD is close to the site transcriptional 
activation of the reporter genes occurs, consequently, yeast are able to grow and 
turn blue on a media lacking tryptophan, leucine, adenine and histidine 
supplemented with X--gal (QDO/X) plates. Whereas co-expressing T-antigen and 
human Lamin C which is on pGBKT7, yeasts are not able to grow on QDO because 
the proteins do not interact.  












 Yeast strain phenotype on SD media 
To validate the phenotype of S. cerevisiae AH109 harbouring the plasmids, the 
cells were grown on various SD media. On the minimal medium lacking tryptophan, 
only cells containing pGBKT7 are able to grow e.g. cells harbouring pGBKT7-BimA, 
pGBKT7 pGADT7-actin and pGBKT7 pGADT7-IQGAP1, whereas cells that contains 
only pGADT7 (pGADT7-IQGAP1 or pGADT7-actin) cannot grow on this media (Figure 
5.8a). On the other hand, cells harbouring pGADT7 are able to grow on media lacking 
leucine, whilst cells containing only pGBKT7 (pGBKT7-BimA54-455) cannot survive on 
this medium (Figure 5.8a). On DDO medium (SD/-Trp/-Leu), cells must contain both 
bait and prey plasmids to survive. The result in figure 5.8a shows that there was no 
growth of cells containing only one plasmid on DDO medium. Collectively, all yeast 
strains displayed the expected phenotype, thus, these strains were then subjected to 
the Y2H assay. 
 Before testing protein-protein interactions, all strains carrying the vectors 
were tested for auto-activation to determine whether the protein fragments can 
activate the reporters in the absence of any binding partner thereby leading to a false 
positive result. To test this, the empty prey plasmid, pGADT7 was transformed into 
S. cerevisiae AH109 containing the bait protein (AH109 pGBKT7-BimA). The prey 
protein, IQGAP1 and actin, was also examined for false positives in the presence of 
the empty bait vector (pGBKT7). These negative control strains were tested on 
minimal media lacking histidine or adenine to investigate whether or not the HIS3 
and ADE2 reporters are activated. Figure 5.8b shows that S. cerevisiae AH109 
pGBKT7-BimA with the empty prey vector was capable of growing on the minimal 
media lacking histidine. This indicated that BimA is able to induce HIS3 reporter gene 
activity. To eliminate yeast growth as a result of HIS3 reporter leakage, a competitive 
inhibitor of the histidine synthase, 3-amino-1,2,4-triazole (3-AT) was included in the 
media. However, 3-AT could not reduce the background growth of AH109 pGBKT7-
BimA pGADT7, despite use of a high concentration (Supplemental figure 7.17). 
Although BimA showed auto-activation of the HIS3 reporter, the cells carrying 
pGBKT7-BimA could not grow on SD medium lacking tryptophan, leucine and 
adenine. Indeed, any strains tested in this experiment were unable to grow on this 
medium. Thus, the strong ADE2 reporter was utilised for testing the protein-protein 







Figure 5.8:  Yeast strain phenotype on minimal media (SD) lacking essential 
amino acid (s) 
S. cerevisiae AH109 was transformed with pGBKT7 and/or pGADT7 with the fusion 
protein indicated in the figure. The yeast was cultured and a serial dilution was made. 
The cell suspension was dotted on the SD medium and incubated at 30C for 24 hours. 
(a) The minimal SD media lacking tryptophan (-Trp), or leucine (-Leu), or both (-Trp -
Leu) showed the presence of plasmid in yeast cells. 
(b) The minimal SD media lacking tryptophan, leucine and histidine or adenine (-Trp -














 Yeast two-hybrid assay  
S. cerevisiae AH109 carrying both bait and prey plasmids were re-streaked on 
DDO media to isolate single colonies before testing for an interaction. From a single 
colony (after 5 days of incubation), a loop full from a single colony of S. cerevisiae 
AH109 containing both bait and prey plasmids was suspended in 20 µl of water. 
From the suspension, 5 µl was dropped onto the DDO or QDO/X plates. Figure 5.9 
shows the growth of S. cerevisiae AH109 on DDO medium at 24 hours after 
inoculation which confirms that the cells harboured both bait and prey plasmids. To 
test the interaction, growth on QDO/X plates was observed. The result in figure 5.9 
shows that AH109 pGBKT7-BimA pGADT7-actin generates blue colonies on QDO/X 
indicating an interaction between BimA and β-actin. This result is consistent with the 
previous finding that showed rhodamine-labelled actin was rapidly recruited to the 
surface of GST-BimA48-384 coated sepharose beads without additional cellular factors 
(Stevens et al., 2005a). Although introduction of the vector expressing IQGAP1 as an 
activation domain fusion protein into the BimA yeast strain (AH109 pGBKT7-BimA 
pGADT7-IQGAP1) resulted in growth of the yeast strain on QDO media, the colonies 
remained white (Figure 5.9) even after extended incubation of up to 3 days 
(Supplemental figure 7.18). Growth on selective media in the absence of detectable 
α-galactosidase activity indicates that BimA54-455 and IQGAP1 do not directly interact 
with each other.  
The control yeast strains described in section 5.2.4 were also included in the 








Figure 5.9: Yeast two-hybrid interactions  
The pray plasmid expressing actin (pGADT7-actin) or IQGAP1 (pGADT7-IQGAP1) was 
transformed into Saccharomyces cerevisiae AH109 containing pGBKT7-BimA54–455. Cell 
suspensions were inoculated onto SD medium lacking leucine and tryptophan (DDO) to 
confirm the presence of plasmids. In addition, they were inoculated on SD medium 
lacking leucine, tryptophan, adenine and histidine (QDO) supplemented with X-α-Gal 
substrate to test for protein-protein interactions. Plates were observed at 24 hours after 
inoculation.  The interaction controls were S. cerevisiae AH109 harbouring pGBKT7-53 
and pGADT7-T (positive interaction control; +ve) and pGBKT7-Lam and pGADT7-T 






 Verification of protein expression 
The fusion proteins from the Y2H cloning vectors were expressed under the 
yeast alcohol dehydrogenase 1 promoter (PADH1). The full-length ADH1 promoter 
leads to high-level expression of genes in pGADT7 during logarithmic phase of the 
yeast host cells growth. However, transcription is repressed in the late log phase by 
ethanol, which is a by-product of yeast metabolism that is accumulated in the 
medium. On the other hand, the bait vector pGBKT7 contains only a 700-bp fragment 
of the ADH1 promoter which leads to high-level constitutive expression of protein 
without ethanol repression (Reviewed in(Van Criekinge and Beyaert, 1999). 
In addition to the fact that the nucleotide sequencing results of pGADT7-
IQGAP1 and pGADT7-actin showed the DNA insertions were in-frame with the AD 
sequence, the expression of fusion proteins was determined by Western Blot 
analysis. The construction of pGBKT7-BimA54-455 was not generated in this study but 
immunoblotting using the specific antibody to test the actual BimA expression in the 
yeast was performed.  Yeast strains were cultured in DDO medium lacking 
tryptophan and leucine to maintain the two plasmids. Cells were harvested and lysed 
with sample buffer to obtain total protein and subjected to SDS-PAGE and 
immunoblotting. To verify the expression of BimA54-455 by pGBKT7, the protein was 
detected using the GAL4 DNA-BD antibody that binds specifically to the DNA-binding 
domain of the yeast GAL4 protein. Figure 5.10a shows a dominant protein band in 
each strain at a molecular weight consistent with the predicted size of the fusion 
protein.  The approximate size of GAL4 DNA-BD is 22 kDa whilst the BimA54-455 is 
about 40 kDa. As the result, the fusion GAL4 DNA-BD with BimA is about 62 kDa. This 
indicates that BimA54-455 was expressed in-frame with the DNA-BD in S. cerevisiae 
AH109. Figure 5.10 also shows the protein band from the yeast lysate of AH109 
pGBKT7-53 pGADT7-T which is a positive control for the yeast two hybrid 
interaction. The molecular weight of p53 fused in-frame to the GAL4 DNA-BD was 
predicted at 57 kDa, which was also detected using immunoblotting using antibody 
specific to GAL4 DNA-BD domain (Figure 5.10a). 
To determine protein expression in pGADT7, IQGAP1 and actin were 
expressed as GAL4-AD fusion with a hemagglutinin epitope tag (HA-tag) which is 
located between the GAL4-AD and the prey protein. In addition to the GAL4-AD, the 




targeting the protein to the yeast nucleus where the interaction takes place to 
activate transcription. To detect the expression of IQGAP1 and actin in this study, 
anti-HA was used to probe the fusion proteins expressed in the yeast cells. Total 
protein from yeast strain AH109 pGBKT7-53 pGADT7-T was also included and used 
as a positive control for Western blotting to ensure that the antibody recognises the 
GAL4-AD-HA-tagged fusion proteins. Figure 5.10b shows the detection of specific 
proteins at the expected molecular weights in yeast cells strain AH109 pGBKT7-
BimA pGADT7-actin and the control strain, but not in AH109 pGBKT7-BimA 
pGADT7-IQGAP1. GAL4-AD-HA-tagged T-antigen fusion protein is about 89 kDa and 
GAL4-AD-HA-tagged actin fusion protein is about 60 kDa. On the other hand, IQGAP1 
fused with GAL4-AD-HA-tagged with a predicted molecular weight at about 210 kDa 
could not be detected by immunoblotting (Figure 5.10b). A reason for this could be 
the low level of expression as the full-length ADH1 promoter may be repressed by 
the ethanol that accumulated in the late-log phase of culture of the strain. To 
overcome this possibility, the cells were harvested after sub-culture or directly from 
plates, however, the expression of IQGAP1 still could not be detected by Western 
blotting in this study (Supplemental figure 7.19). Another reason for this could be 
that the sensitivity of Western blotting is limited. The protein-protein interactions in 









Figure 5.10: Western blot analysis showing expression of yeast fusion proteins 
in S. cerevisiae AH109 
Overnight cultures of S. cerevisiae AH109 strains containing pGBKT7-BimA pGADT7-
Actin (BimA+Actin), pGBKT7-BimA pGADT7-IQGAP1 (BimA+IQGAP1) and pGBKT7-p53 
pGADT7-T (+ve) were harvested. The whole cell lysates were visualised by SDS-PAGE 
and probed by Western blotting. 
(a) Protein expressed by pGBKT7 strains were detected using antibody specific to the 
GAL4 DNA-BD. Arrows indicate the binding domain fusion proteins. 
(b) Protein expressed by pGADT7 strains were detected using antibody specific to the 
HA-tag. Arrows indicate the fusion proteins.  
  




 Cloning and expression of IQGAP1 in Pichia  
Both in vitro and in vivo techniques failed to detect a direct interaction 
between IQGAP1 and BimA. Despite this, it was hypothesised that IQGAP1 was 
required for actin polymerisation mediated by BimA. To test this, purified IQGAP1 
and BimA were required for an in vitro pyrene-actin assay. Previously, the full-length 
IQGAP1 was expressed in E. coli using pMAL-p2X. However, large-scale production 
of the full-length IQGAP1 could not be performed. It was assumed that stability of the 
plasmid and toxicity of the target protein in E. coli may be factors preventing large 
scale production and purification. To test this, the number of E. coli containing pMAL-
p2X-FL-IQGAP1 after IPTG induction was quantified and it revealed a dramatic 
decrease in bacterial cell number on the LB plate containing the appropriate 
antibiotics compared with cells that had not been induced with IPTG (Supplemental 
figure 7.20). This plasmid instability and toxicity of the IQGAP1 to E. coli likely 
explains the low expression levels.  From this result, the full-length IQGAP1 gene 
from the pMAL-p2X construct was sub-cloned into pPICZ B for expression of the 
protein intracellularly in P. pastoris to generate purified full-length IQGAP1.  The 
plasmids were verified by sequencing to confirm that the IQGAP1 gene was in-frame 
with the polyhistidine (6x-His) tag (Supplemental figure 7.21). The plasmid was 
linearised and then transformed into P. pastoris. There are two different P. pastoris 
recombinant strains. Mut+ strain is capable of metabolising methanol as its sole 
carbon source (same as wild-type strain) and MutS phenotype has a slow growth 
phenotype on methanol medium. One phenotype may have better IQGAP1 
expression than the other. Thus, both strains GS115 (Mut+) and KM117H (MutS) were 
tested for IQGAP1 expression. P. pastoris GS115#15 showed the greatest expression 
of IQGAP1 estimated from GAPDH expression which was used as a loading control 
(Figure 5.11a). This strain was further optimised for a time point that yielded the 
greatest IQGAP1 production and showed IQGAP1 was produced increasingly over 
time until 4 days (Figure 5.11a). Then, the production was scaled up to 4 litres and 
the extracted protein was purified by affinity chromatography. Figure 5.11b shows 
that non-specific proteins were eluted from the Ni column and a protein of the 
expected molecular weight of IQGAP1 could not be detected, although it could be 
detected using Western blotting (Figure 5.11b). Thus, the amount of IQGAP1 was 








Figure 5.11: IQGAP1 expression and purification in Pichia 
(a) Western blot probed with anti-IQGAP1 and anti-GAPDH as a loading control for 
screening of IQGAP1 expression in Pichia strains, GS115 (Mut+) and KM117H (MutS). 
(b) P. pastoris GS115#15 was selected for optimisation showing the greatest of IQGAP1 
expression after 4 days of induction. 
(c) IQGAP1 fused with 6xHis protein expressed in Pichia was affinity purified from 4 
litres culture. Anti-IQGAP1 antibodies specifically recognised the full-length 
IQGAP1-6xHis protein by immunostaining of Western blots of samples from induced 
cell lysates, M: molecular weight marker, T: Total protein, Ins: Insoluble protein, FT: 
Flow through, E: Elutions. 
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 Purification of N-IQGAP1 
Since the full-length IQGAP1 could not be produced in a large-scale in either 
E. coli or P. pastoris, E. coli harbouring pMAL-p2X-N-IQGAP1 (described in section 
5.2.2) was used for protein expression. From 4 litres of induced E. coli culture, MBP-
N-IQGAP was purified by affinity chromatography. Figure 5.12a shows the protein 
was expressed and was bound on the amylose resin.  The MBP-tag can be cleaved 
from the fusion protein using FactorXa, which is a site-specific endo-protease 
recognising a sequence that is introduced on the plasmid between sequence coding 
for MBP and the target protein. After digestion, the fused protein was cleaved 
efficiently resulting in N-IQGAP1 and MBP at the expected size (Figure 5.12a). 
FactorXa cleavage was performed with the fusion protein bound to the matrix. The 
digested protein was washed out and collected. Each fraction of proteins was tested 
for IQGAP1 protein by dot blot using anti-IQGAP1. Positive fractions were pooled and 
subjected to SDS-PAGE followed by Coomassie blue staining. Figure 5.12b shows the 
purified N-IQGAP1 protein that was used for a pyrene-actin polymerisation assay.  
 
Figure 5.12: Purification of N-IQGAP1 
(a) SDS–PAGE followed by Coomassie staining showing purification of MBP-N-IQGAP1 
protein expressed in E. coli Rosetta 2 (DE3) pLysS after IPTG induction.  Proteins 
were extracted from uninduced cells, soluble protein, insoluble proteins and the 
protein bound to amylose resin after elution. The eluted MBP-N-IQGAP1 protein was 
treated with FactorXa to cleave the MBP-tag off. 
(b) SDS–PAGE followed by Coomassie staining showing the purified N-IQGAP1 used for 
pyrene-actin assay in this study. The protein was obtained from the on-column 
cleavage by FactorXa.  




 Cloning and expression of BimA54-470  
To study actin polymerisation in vitro, purified BimA was required. A recent 
study showed that the full passenger domain located at the C-terminus of BimA is 
important for oligomerisation and is required for full actin polymerisation activity 
(Benanti et al., 2015). In this study, BimA from amino residue 54 to 470 that includes 
the passenger domain and extends through the trimeric coiled coil region was 
produced. To amplify nucleotide sequence encoding BimA54-470, pME-6032 
harbouring full-length BimA from B. pseudomallei 10276 (Stevens et al., 2005b) was 
used as template for amplification. The PCR fragment was cloned into pET-21b(+) to 
generate BimA54-470-6x-His. E. coli strains containing the plasmid were screened by 
PCR and then subjected to sequence analysis.  The plasmid was transformed into E. 
coli Rosetta 2 (DE3) pLysS for protein expression and the transformants were 
screened for BimA54-470 expression in a pilot experiment by Western blotting using 
antibody specific to BimA48−384 (Stevens et al., 2005a) (Supplemental figure 7.22). 
Then a clone was selected for large-scale production (1 litre) and protein isolated by 
affinity purification. Figure 5.13a shows that proteins were eluted from the matrix, 
however the dominant band was not the expected size, it was bigger than the 
predicted molecular weight of the fusion protein (~44 kDa). To detect the His-tagged 
BimA protein, one of the elution fractions was further examined by immunoblotting 
using anti-BimA and anti-6xHis. Figure 5.13b revealed that the His-tagged BimA 
protein could be detected in the elution fraction after purification. Since the yield was 






Figure 5.13: BimA54-470-6xHis expression and purification 
(a) SDS–PAGE followed by Coomassie staining showing purification of BimA54-470-6xHis 
recombinant protein expressed in E. coli Rosetta 2 (DE3) pLysS after IPTG induction. 
Sol: Soluble protein, Ins: Insoluble proteins, FT: Flow-through, A1-A6: Gradient 
elution fractions. 
(b) The same samples in (a) were subjected to immunoblotting using anti-BimA and 
anti-His. The positive controls for each antibody are GST-BimA54-455 and a 6His tag 





















To produce MBP-tagged BimA54-470, the gene from pET-21b(+)-BimA54-470 was 
sub-cloned into pMAL-p2X. The plasmids containing the BimA54-470 insert were 
screened by PCR. A clone was selected for sequencing to confirm the MBP-tag was 
in-frame with BimA54-470. Then a pilot scale protein expression and purification was 
performed. Figure 5.14a shows that expression of MBP-BimA54-470 was induced and 
the soluble protein was bound to the amylose resin. The protein band after elution 
showed a dominant band of MBP-BimA, although the size of protein was not as 
expected. A reason for this may be the hydrophobicity of BimA causing the fusion 
protein to migrate faster than the predicted molecular weight (~88 kDa). To 
determine if the induced protein was BimA, the eluted fraction was subjected to 
Western blot analysis using anti-BimA. The result showed only one band specific to 
BimA having a molecular weight as same as the dominant band that shown in SDS-
PAGE gel (Figure 5.14b in Panel 3). This suggested that MBP-BimA54-470 was 
expressed in E. coli successfully showing a reasonable amount of protein that was 
enough for downstream purification. 
An initial trial of the pyrene-actin polymerisation assay using purified MBP 
protein alone showed a high level of background nucleation activity, compared to 
control (actin alone) reactions that were used as a baseline for nucleation activity 
(Supplemental figure 7.23). Thus, we determined that the MBP-tag would need to be 
removed from the MBP-BimA fusion protein before using BimA in the actin 
polymerisation assay. Cleavage of MBP-BimA54-470 by FactorXa was examined using 
a web tool (http://web.expasy.org/ peptide_cutter/) first. This tool confirmed that 
there is one FactorXa recognition site within the predicted MBP-BimA54-470 protein 
sequence between the MBP and BimA proteins. This allows the cleavage of MBP after 
MBP-BimA purification. However, when MBP-BimA was digested with FactorXa, the 
molecular weight of the resulting protein products was not as expected. Figure 5.14b 
shows two bands of digested proteins with molecular weight at approximately 40 
and 25 kDa. The molecular weight of MBP is about 42 kDa and the predicted 
molecular weight of BimA54-470 is about 40 kDa. Immunoblotting with BimA 
antibodies revealed that the smaller band of the digested protein was BimA (Figure 
5.14b). It was hypothesised that there was an additional unpredicted site for the 
FactorXa protease on BimA. To test this, GST-BimA54-455 expressed and purified from 




FactorXa cleavage. Additionally, electrophoretic profiles of the BimA fragment was 
analysed in the absence of denaturing agents (Native-PAGE), a procedure commonly 
used for molecular mass determination of hydrophobic proteins. Surprisingly, both 
MBP-BimA and GST-BimA proteins showed evidence of proteolysis of the BimA 
portion of the fusion proteins (Figure 5.14c). Thus, MBP-BimA54-470 could not be used 
for BimA purification because FactorXa cleavage also cut BimA at an additional 









Figure 5.14: Generation of the recombinant fusion protein MBP-BimA54-470 
 (a) SDS–PAGE followed by Coomassie staining showing purification of MBP-BimA54-470 
recombinant protein expressed in E. coli Rosetta 2 (DE3) pLysS after IPTG induction.  
 UN: Uninduced cell, T: Total whole cell lysate from induced cell, Sol: Soluble protein, 
INS: Insoluble proteins, FT: Flow-through, R: Protein bound to amylose resin, E: 
Eluted protein. 
(b) The MBP-BimA54-470 was digested with and without FactorXa (1) and then were 
subjected to SDS–PAGE followed by Western blot using anti-MBP (2) and anti-BimA 
(3). 
 (c) Native–PAGE followed by Coomassie staining showing eluted MBP-BimA54-470 and 
GST-BimA45-544 proteins digested with FactorXa or treated with only buffer.  





















 Purification of GST-BimA54-455 
A recombinant BimA54-470 could not be generated in this study at sufficient 
quantities for the pyrene assay. The previous BimA protein from amino residues 54 
to 455 fused with GST (Sitthidet et al., 2010) was used instead. Proteins (GST and 
GST-BimA) were expressed and purified by affinity chromatography from one litre 
cultures of induced E. coli Rosetta 2 (DE3) pLysS harbouring pGEX-BimA54-455 or 
pGEX-4T-1. After elution and dialysis, proteins were subjected to SDS-PAGE with 
Coomassie blue staining. As shown in figure 5.15, the proteins were purified and then 




Figure 5.15: SDS-PAGE of recombinant GST and GST-BimA54-455 proteins 
GST and GST-BimA54-455 were purified by affinity chromatography on a GSTrap™ 4B 
column. After elution from the column using reduced glutathione and then dialysis, the 






 The effect of IQGAP1 on BimA-mediated actin polymerisation 
IQGAP1 is a scaffold protein that binds actin filaments directly (Mateer et al., 
2002) and crosslinks the actin filament through oligomerisation (Fukata et al., 1997). 
BimA also interacts with actin monomers directly (Stevens et al., 2005a) and 
enhances the rate of actin polymerisation in vitro (Stevens et al., 2005a, Benanti et 
al., 2015). It was hypothesised that IQGAP1 was required for maximal BimA-
dependent actin polymerisation. In this study purified N-IQGAP1 (which contains the 
domain required for F-actin binding) was tested with GST-BimA54-455 to study the 
effect of IQGAP1 on BimA-mediated actin polymerisation. The kinetics of actin 
polymerisation can be observed using pyrene-conjugated actin (Cytoskeleton). 
Enhanced fluorescence occurs over time when pyrene monomers are incorporated 
into filaments (Stevens et al., 2005a).   
Pyrene-actin polymerisation assays were performed in three independent 
experiments with a total of 6 reactions using 1 µM actin containing 200 nM of GST 
protein or GST-BimA54-455 in the presence or absence N-IQGAP (50 nM). Fluorescence 
data was collected every minute for up to 1 hour. During the linear phase of 
polymerisation, rates of fluorescence units per second were calculated. G-actin alone 
in the polymerisation buffer was used as a negative control for the spontaneous actin 
polymerisation, compared to those with the GST or N-IQGAP1 alone. The actin 
polymerisation rate of GST or N-IQGAP1 alone was similar (Figure 5.16) which is the 
same rate of G-actin alone (Supplemental figure 7.24). This suggested that GST and 
N-IQGAP1 do not have polymerising activity on its own. Moreover, the rate of 
polymerisation by GST was not enhanced by addition of N-IQGAP1 (Figure 5.16). On 
the other hand, the rate of BimA-mediated polymerisation markedly increased up to 
18.5 units per second in average, compared to the controls which were about 5.8 
units per second. The stimulation of actin polymerisation by BimA agreed with our 
previous studies (Sitthidet et al., 2010, Stevens et al., 2005a). Interestingly, addition 
of N-IQGAP1 in the reaction containing BimA54-455 increased the polymerisation rate 
significantly to 21.50 units per second (p = 0.0026). This indicates that N‐IQGAP1 










Protein Polymerisation rate  
(Mean  SEM; n = 3) 
p value compared to the reaction 
of GST-BimA + N-IQGAP1 
GST-BimA+N-IQGAP1 21.05  0.16 n/a 
GST-BimA 18.50  0.35 0.0026464* 
GST+N-IQGAP1 5.77   0.12 0.0000002* 
GST 5.87  0.14 0.0000002* 
N-IQGAP1 5.85  0.21 0.0000006* 
 
 
Figure 5.16: N-IQGAP1 enhances BimA-mediated actin polymerisation  
Emission of fluorescence due to polymerisation of pyrene-labelled actin monomers by 
N-IQGAP1 and GST-BimA54–455 proteins (red line) was increased compared with GST-
BimA54–455 alone (blue lines). While GST alone (orange lines), N-terminal IQGAP1 alone 
(black line) or GST and N-IQGAP1 (green line) showed spontaneous actin 
polymerisation. The graphs show the mean emission levels of fluorescence over time 
from three independent replicates in one assay. The rise in fluorescence units per second 
during the linear phase of polymerisation was calculated as rates of polymerisation 
showing the mean rates of fluorescence units per second ± SEM in the table below. 
Asterisks denote a significant difference in the rate of polymerisation compared to the 








BimA, which is located at one pole of the bacterium, was identified as a 
bacterial factor required for actin-based motility of B. pseudomallei (Stevens et al., 
2005a). A host cellular protein, IQGAP1, was isolated from splenic lysates using an 
affinity approach using bacteria constitutively expressing BimA (Jitprasutwit et al., 
2016). In this study, it was shown that IQGAP1 is present throughout the length of 
the actin tails of bacteria. It is possible that BimA interacts with IQGAP1 directly and 
is required for efficient actin tail formation by B. pseudomallei. To determine whether 
or not there is a direct interaction between these proteins, MBP pull-down and GST 
pull-down assays were performed. However, as demonstrated in this chapter, the 
results of the pull-down assays were inconclusive. It is possible that the interaction 
between IQGAP1 and BimA might require other host cellular proteins. Additionally, 
other bacteria factors that are regulated by the same VirAG two-component system 
might mediate the interaction (Schell et al., 2007). To test this, the fusion proteins 
could be investigated in experiments including lysates prepared from bacteria 
expressing BimA, with or without other host cellular proteins in splenic lysate. 
However, attempts to express and purify full length IQGAP1 proteins both in E. coli 
and P. pastoris were not successful in this study and would need further optimisation 
and troubleshooting. 
Y2H was utilised to detect an interaction between IQGAP1 and BimA in vivo 
within the yeast cells. This system is very sensitive and the expressed proteins are 
more likely to be in their native conformations because they are produced in the 
eukaryotic cells intracellularly. However, this may lead to false positives because of 
high sensitivity. Thus, the multiple reporter systems in the yeast strain AH109 were 
selected to minimise false positives for testing the interaction between BimA and 
IQGAP1. The amino acid residues 54–455 of the BimA protein were expressed fused 
with the DNA-BD as the bait protein, whereas IQGAP1 was cloned in-frame with the 
AD as the prey protein. Additionally, β-actin was expressed and used as a positive 
control for a host cell protein that interacts with BimA.  
To test for an interaction between the two proteins of interest, S. cerevisiae 
AH109 pGBKT7-BimA54-455 pGADT7-IQGAP1 and AH109 pGBKT7-BimA54-455 




but lacking leucine, tryptophan, adenine, and histidine (QDO/X), along with the 
control for interaction; AH109 pGBKT7-p53 pGADT7-T (positive control) and AH109 
pGBKT7-Lam pGADT7-T (negative control). Plates were observed after 24 hours and 
up until 72 hours and showed that the yeast strain carrying pGBKT7-BimA54-455 and 
pGADT7-actin produced blue colonies. This strong interaction was comparable with 
the positive interaction control between the p53 and large T-antigen, and is 
consistent with the previous result described by Stevens and colleagues (2005b). On 
the other hand, yeast strain AH109 pGBKT7-BimA54-455 pGADT7-IQGAP1 resulted in 
growth on QDO/X media; however, the colonies remained white even after 3 days of 
incubation.  This is similar to the AH109 pGBKT7-Lam and pGADT7-T strain, 
representing a negative control for the Y2H assay. The growth of yeast strain AH109 
pGBKT7-BimA54-455 pGADT7-IQGAP1 also implied that the fusion proteins were 
expressed although IQGAP1 expression could not be detected by Western blotting in 
this study. Only genuine positive interactions activate all reporters. Thus, this 
suggested that BimA54–455 and IQGAP1 do not interact directly with each other.  
In spite of the fact that IGAP1 does not interact with BimA directly, it was 
reasonable to hypothesise that IQGAP1 functions as a stabiliser for actin 
polymerisation by BimA. The previous studies demonstrated that BimA interacts 
with monomeric actin directly (Stevens et al., 2005a, Stevens et al., 2005b, Sitthidet 
et al., 2010). Also, BimA polymerises actin in a concentration-dependent manner, 
although this process is Arp2/3-independent (Benanti et al., 2015, Stevens et al., 
2005a). In fact, a recent publication demonstrated that BimA mimics cellular 
Ena/VASP proteins with the ability to nucleate actin, elongate filaments at their 
barbed ends, and bundle the filament promoting actin polymerisation (Benanti et al., 
2015). IQGAP1 has been recognised as a regulator of the cytoskeleton showing 
important roles in organising the actin cytoskeleton (Reviewed in Watanabe et al., 
2015). IQGAP1 binds directly to filamentous actin and cross-links the filaments into 
bundles (Bashour et al., 1997, Fukata et al., 1997, Mateer et al., 2002).  The binding 
site of the filamentous actin on IQGAP1 was demonstrated to be on the amino-
terminal CHD domain (Fukata et al., 1997). However, the domains that are involved 
in the function of cross-linking by oligomerisation are unclear, it has been reported 
that this function is encoded between amino acids 216 - 683 (Fukata et al., 1997) or 




oligomerisation of IQGAP1 is important for its function of bundling or stabilising the 
actin filaments without any actin-related proteins. Further investigations also found 
that IQGAP1 stimulates branched actin filament assembly, thereby promoting 
Arp2/3-dependent actin polymerisation by binding to N-WASP (Bensenor et al., 
2007, Le Clainche et al., 2007) with the barbed end capping activity which is located 
on the C-terminus of IQGAP1 (Pelikan-Conchaudron et al., 2011). Despite the fact that 
the exact mechanism of actin assembly regulation by IQGAP1 is still controversial, it 
is agreed that IQGAP1 is in an auto-inhibited conformation where the N-terminal 
domain of IQGAP1 interacts with the C-terminal region to stimulate Arp2/3-
dependent actin assembly (Le Clainche et al., 2007, Pelikan-Conchaudron et al., 
2011). 
 To determine the effect of IQGAP1 on BimA-mediated actin polymerisation, 
purified proteins were required for the pyrene assay. Although the full-length 
IQGAP1 could not be produced in this study, it is proposed that N-IQGAP1 containing 
the CHD domain and parts of the IQ motif with the capacity of F-actin binding and 
oligomerisation are enough to determine its function. Also, the purified BimA54-470 
which the passenger domain was extended through the trimeric coiled coil that 
mediates oligomerisation for full activity (Benanti et al., 2015), could not be 
produced in this study. The region of BimA encoding residues 54 to 455, that lacks 
the signal peptide and transmembrane domain, and fused with GST-tag from the 
previous study exhibited an ability to enhance the rate of pyrene-actin monomer 
polymerisation (Sitthidet et al., 2010). Thus, to investigate the effect of IQGAP1 on 
BimA-mediated actin polymerisation, the N-IQGAP1 and GST-BimA54-455 proteins 
were used in the pyrene assays. In this assay, BimA54-455  enhanced the rate of actin 
polymerisation, compared with the GST protein, consistent with the previous studies 
(Benanti et al., 2015, Sitthidet et al., 2010, Stevens et al., 2005b). It is noticeable that 
the reaction containing GST alone or N-IQGAP1 alone or the combination between 
GST and N-IQGAP1 showed an initial lag phase. After that, there is a phase of rapid 
filament elongation, during which subunits add quickly onto the ends of the 
nucleated filaments. On the other hand, the reaction containing only GST-BimA54-455 
lacked the lag phase, which indicated BimA54-455 enhanced the nucleation rate which 
is a characteristic of actin nucleators. Whereas the nucleation rate in the reaction 




GST-BimA54-455, the rate of elongation was enhanced with increasing concentrations 
of F-actin in reaction. This suggested that N-IQGAP1 may function as a stabiliser of 
the actin filaments stimulated by BimA. To confirm this finding, further experiments 
are required, for example, by varying the concentration of N-IQGAP1 and including 
full-length IQGAP1. A previous study showed the concentration-dependent effects of 
IQGAP1, full-length and several N-terminal fragments of IQGAP1 on actin assembly 
(Bensenor et al., 2007). The full-length IQGAP1 showed the higher rate of actin 
polymerisation in the presence of the Arp2/3 complex and N-WASP (Bensenor et al., 
2007). A reason for this could be the barbed end capping activity located on the C-
terminal end of IQGAP1 (Pelikan-Conchaudron et al., 2011).  
In conclusion, this chapter provides the first evidence that IQGAP1 enhances 
BimA-mediated actin polymerisation in vitro, despite no evidence of a direct 







6.1 Impact of this study 
The main objective of this study was to explore the mode of action and 
functional significance of IQGAP1 in the intracellular life of Burkholderia 
pseudomallei. This facultative intracellular bacterial pathogen has evolved 
mechanisms to harness the power of actin polymerisation for propelling itself inside 
the cytosol and providing the driving force for cell membrane protrusion into 
neighbouring cells. This process requires a putative Type V secreted protein, BimA 
that is located at one pole of the bacterial cell where actin nucleation occurs and the 
actin tail is formed (Stevens et al., 2005a). B. pseudomallei BimA influences 
intracellular survival, intercellular spread (Sitthidet et al., 2011) and virulence in 
mice (Lazar Adler et al., 2015 and our own unpublished data). However, the 
molecular mechanism by which it recruits and activates cellular factors to assemble 
actin is not fully understood. From valuable preliminary data obtained in our 
laboratory, IQGAP1 was one of 30 host proteins identified as a candidate host cell 
protein involved in BimA-mediated actin polymerisation. Many of the host cell 
candidate factors are common to both the actin-rich tails of L. monocytogenes and B. 
pseudomallei. However, IQGAP1 is a novel protein uniquely associated with the actin 
tails of B. pseudomallei (Jitprasutwit et al., 2016).   
This present study revealed the localisation of IQGAP1 in B. pseudomallei-
infected HeLa cells by confocal microscopy.  This is the first demonstration of the 
presence of IQGAP1 in the actin tail of a bacterial pathogen. Additionally, siRNA-
mediated IQGAP1 knockdown indicated a role for IQGAP1 in regulating B. 
pseudomallei actin tail morphology. This result is validated by the finding that the 
rate of BimA-mediated in vitro actin polymerisation could be enhanced by the N-
terminal domain of this scaffold protein IQGAP1. This implies that the function of 
IQGAP1 is in the stabilisation of the actin filaments. Although, a direct interaction 
between IQGAP1 and BimA could not be detected in this present work. 
 The role of IQGAP1 in B. pseudomallei actin-based motility was investigated 
using IQGAP1 knockout cells generated using a CRISPR-Cas9 system. Interestingly, 




intracellular survival, MNGC and plaque formation. Additionally, this thesis discloses 
the actin barcode morphology formed by this bacterium which is similar to septin 
cages-like structure in Shigella. Septin localises next to the actin around the surface 
of the bacteria, which is then targeted for autophagy and this protein restricts actin 
tail formation and cell-to-cell spread (Mostowy et al., 2010). In contrast, an 
incomplete septin ring was detected around the actin tail and body of Listeria 
suggesting that this bacterium avoids septin cage-like formation and escapes 
autophagy (Mostowy et al., 2010). Whilst septin prevents actin tail formation in 
Shigella, in this study the number of B. pseudomallei with this septin cage-like 
structure was decreased dramatically in IQGAP1 knockout cells, in which the number 
of viable bacteria was very low. This implies that IQGAP1 is involved in this structure 
and impacts the intracellular survival life B. pseudomallei. 
   
6.2 Future work 
 Actin-based motility of B. pseudomallei in IQGAP1 knockdown cells 
and IQGAP1 knockout cells 
B. pseudomallei is still able to form actin tails in both siIQGAP1 knockdown 
cells (Chapter 3) and IQGAP1 knockout cells (Chapter4).  There is a contradiction 
between the data in chapter 3 and chapter 4. B. pseudomallei formed a longer and 
less actin dense tail in siIQGAP1 knockdown cells but formed a shorter tail with 
similar of actin density in IQGAP1 knockout cells, compared to the control cells. It 
should be noted that the control cells between these groups are different, 
Lipofectamine-treated cells were used as a control for the knockdown experiments, 
whereas non-treated cells were used as a control for the studies in the knockout cells. 
This can be explained by the different percentage of bacteria that displayed tails in 
these control cells. The proportion of B. pseudomallei displaying a tail in 
Lipofectamine-treated cells was 58% but in non-treated control cells only 34% of 
bacteria showed a tail, despite observing cells at the same time post-infection (16 
hours post-infection). However, the results in the IQGAP1 knockdown and knockout 
system showed a similarity in the proportion of bacteria displaying actin tails and 
those without an actin tail. Both experiments showed that there was no difference 




morphology) and with actin tail (short and long tails). This result may suggest that 
these cells could be comparable and agree that B. pseudomallei does not require 
IQGAP1 to induce or initiate actin polymerisation.   
The ability of B. pseudomallei to form actin tail in either the siIQGAP1 
knockdown cells or IQGAP1 knockout cells suggested that other host proteins 
participate in B. pseudomallei actin tail formation. Moreover, the function of IQGAP1 
could be compensated by IQGAP2 or IQGAP3 isoforms. Although this study showed 
the expression of IQGAP2 and IQGAP3 detected by Western blotting was very low, 
compared with the level of IQGAP1. Further experiments to examine the presence of 
IQGAP2 or IQGAP3 in the actin tail of B. pseudomallei infected siIQGAP1 knockdown 
cells and IQGAP1 knockout cells using specific antibodies are needed to confirm this 
hypothesis.  
Figure 6.1 shows a possible activity of IQGAP1 involved in B. pseudomallei 
actin tail formation. After B. pseudomallei BimA initiate actin polymerisation and the 
actin filaments are formed, IQGAP1 works with other unknown protein(s) to stabilise 
the actin filaments producing a compact comet tail, showing intense actin density 
when stained with fluorescently-labelled phalloidin. In siIQGAP1 knockdown cells, 
the remaining IQGAP1 is limited causing the actin filament to be looser and longer 
than those in control cells. In contrast, the ability to form a proper long actin tail is 
defective in IQGAP1 knockout cells, where the other host cell factor(s) may play a 
role in B. pseudomallei actin tail formation to result in a short actin tail. 
 
 
Figure 6.1: A possible function 
of IQGAP1 on actin filaments. 
Schematic representation of 
possible actin filament 
organisations in the HeLa control 
cells, siRNA-mediated IQGAP1 
knockdown cells and IQGAP1 




The proportion of bacteria displaying tails (short and long tails) were similar 
between the control cells and the IQGAP1 knockout cells. Likewise, there was no 
difference in the number of bacteria with short and long tails between the control 
cells and the siIQGAP1 knockdown cells. Interestingly, within the group of bacteria 
that did not display tails, the number of bacteria with actin association in a barcode 
morphology was greater in the non-treated control cells, compared to the IQGAP1 
knockout cells. Conversely, the number of bacteria without actin recruitment in the 
IQGAP1 knockout cells was greater than those in the non-treated control cells. 
However, this outcome was not found in the IQGAP1-depleted cells. The remarkable 
effect from the knockout cells could be more pronounced than in the knockdown 
cells. The remained IQGAP1 protein in the knockdown system may sufficient to 
partially induce the actin formation. In contrast, IQGAP1 is absent in the knockout 
cells. This could affect the downstream pathway if IQGAP1 may interact with others 
for proper actin-based motility of B. pseudomallei. Thus, comparison the results from 
these methods between knockdown and knockout system can be challenging. 
Particularly, studies on actin-based motility which is a rapid dynamic and highly 
complex process needs careful investigation. Live cell imaging by real-time video 
microscopy could be used for elucidating the stages of actin tail formation more 
precisely. However, this is a limitation to the study of B. pseudomallei which must be 
performed in the containment level 3 laboratory. Thus, a time course study is an 
alternative way to study this bacterium.  
Collectively, both siRNA-mediated knockdown and CRISPR-Cas9 knockout of 
IQGAP1 demonstrate a role of IQGAP1 in B. pseudomallei actin-based motility and the 
intracellular life cycle of this bacterium. 
 
 Intracellular life of B. pseudomallei in IQGAP1 knockout cells 
The main drawback of using siRNA-mediated knockdown cells in mammalian 
cells is that the suppression of gene expression is transient. This study showed that 
IQGAP1 expression recovered after transfection causing a difficulty in distinguishing 
the effects of IQGAP1 on intracellular survival at the later time points. Moreover, the 
study of plaque formation was also problematic because it requires a cell monolayer. 




50% confluence which could not be used to study cell-to-cell spreading in this 
knockdown system. Thus, studies on intracellular life of B. pseudomallei in the 
siIQGAP1 knockdown cells were only conducted until 16 hours post-infection 
because the expression of IQGAP1 decreased until this time point before recovery.  
The role of IQGAP1 in B. pseudomallei invasion was not seen in this study 
whilst IQGAP1 participates in invasion of host cells by other bacteria. However, at 16 
hours post-infection, when the level of IQGAP1 expression in siIQGAP1 knockdown 
cell was lowest, an impact of IQGAP1 in controlling actin tail length and actin density 
of B. pseudomallei was demonstrated.  Bacterial actin tail architecture affects 
bacterial motility and impacts its pathogenesis. From the findings in siIQGAP1 
knockdown cells, it was interesting to further understand the molecular basis of 
IQGAP1 function on B. pseudomallei infection. The CRISPR-Cas9 tool was utilised to 
knockout IQGAP1 in HeLa cells. To enhance specificity, double nickase plasmids were 
successfully used to generate the knockout cells. The single clone of IQGAP1 
knockout cells, Clone H5, is an insertion mutant that causes a frameshift mutation 
introducing premature stop codons within the IQGAP1 gene. Eukaryotes evolved 
mechanisms to degrade this abnormal protein leading to loss of gene function. In this 
present study, Western blotting, immunofluorescence staining, and 
immunoprecipitation were used to validate the lack of IQGAP1 as well as the 
predicted truncated protein in this clone.  
A bacterial invasion assay was performed to confirm the previous finding in 
siIQGAP1 knockdown cells. A low number of bacteria was recovered from the 
infected cells and showed similar number of bacteria in control and IQGAP1 
knockout cells. Indeed, the bacteria could invade into IQGAP1 knockout cell readily 
but there was no statistical difference with the control cells. It was questionable 
whether the protocol to examine the invasiveness in vitro is repeatable. To test this, 
the invasive pathogen Salmonella was used to test the experimental conditions used 
in this study.  Previous studies showed a defect of Salmonella Typhimurium SL1344 
invasion into mouse embryonic fibroblasts (MEFs) derived from IQGAP1 knockout 
mice (Brown et al., 2007, Kim et al., 2011a). In this study, Salmonella Typhimurium 
4/74 was used to infect the IQGAP1 knockout HeLa cells and the result was 
inconsistent with the previous studies. Variability could be attributable to 




of the bacteria inoculated, the growth phase of bacteria, and the cell types as well as 
the maturity of cell line. This indicated that the protocol for this assay requires 
adjustment. Additionally, the percentage of invasion obtained for B. pseudomallei 
was relatively low. Alternative methods such as evaluation of the number of 
intracellular bacteria by confocal microscopy can be applied. 
 Despite the low number of bacteria recovered at 2 hours post-infection, the 
number of intracellular bacteria increased at 6 hours after infection in both control 
cells and IQGAP1 knockout cells but with no statistical difference. After that, the 
number of bacteria dropped dramatically in IQGAP1 knockout cells, whereas the 
growth of intracellular bacteria in control cells increased gradually at 24 hours post-
infection. To further understand this phase of infection, additional time points before 
24 hours post-infection may be required. However, the viability of bacteria was 
observed at 16 hours post-infection where actin tail formation was examined.  
It was clear that the number of bacteria in IQGAP1 knockout cells was lower 
than in control cells at 24 hours post-infection. The increased number of bacteria in 
control cells can be explained by the ability of B. pseudomallei to spread to the 
adjacent cell obtaining more nutrients to replicate and subvert host immune 
responses. In contrast, the number of viable bacteria was reduced at the later time 
point in IQGAP1 knockout cell. A hypothesis for this is that the bacteria is killed by 
cell defence mechanisms, for example autophagy since the bacteria is trapped inside 
the cells.  An assay using a protein marker of the autophagosomal membrane, LC3 
conversion and turnover assays for monitoring autophagy could be performed to 
prove this. Additionally, it is evident that the number of B. pseudomallei with barcode 
morphology in control cells was greater than those in IQGAP1 knockout cells, 
whereas the greater number of bacteria without actin association (no actin 
recruitment at all) were observed in IQGAP1 knockout cells. The barcode feature that 
was revealed in this study is similar to Shigella that is trapped in septin cage-like 
structure and targeted to autophagy. However, there is no evidence of septin cages 
in B. pseudomallei. Staining of septins, which are a family of cytoskeletal proteins that 
play a role in cytokinesis in mammalian cells, can be performed in B. pseudomallei 




Moreover, the percentage of MNGC formation was approximately 10-fold less 
than those in control cells. Consequently, B. pseudomallei showed a defect in plaque 
formation in IQGAP1 knockout cells even after extended incubation times until 72 
hours post-infection. This result agreed with the decrease in intracellular survival of 
bacteria in IQGAP1 knockout cells. A summary of the findings of the role of IQGAP1 
in the intracellular life of B. pseudomallei in control and IQGAP1 knockout cells is 
depicted in figure 6.2. 
The defect of B. pseudomallei intracellular survival in IQGAP1 knockout cells 
is one of the most striking results from this present study demonstrating the role of 
IQGAP1 in intracellular life of B. pseudomallei.  This finding could be more convincing 
by restoring IQGAP1 in the knockout cells to rescue the B. pseudomallei ability to 
survive inside host cells. Full-length or some individual domains of IQGAP1 cDNA 
constructs could be transfected into the IQGAP1 knockdown cells to determine which 
domains of IQGAP1 are needed. 
 
Figure 6.2: Possible fates of B. pseudomallei in HeLa control cells, compared to 
IQGAP1 knockout cells.  




 Investigation of the interaction between IQGAP1 and BimA 
To study protein-protein interactions, the proteins of interest should be 
active and functionally in a native conformation. It can be difficult to express a 
protein in heterologous expression systems, especially target protein with inherent 
properties such as size and hydrophobicity. Choosing alternative expression systems 
or host strains can improve yield. However, purity of protein is also important to 
study the activity of proteins. A cell-free translation system may be an option for 
expressing troublesome proteins, although yield may be low. 
The pull-down and yeast two-hybrid assays failed to demonstrate a direct 
interaction between IQGAP1 and BimA. The pulldown assays were compounded by 
the fact that the tagged-proteins bound non-specifically to the capture resin. 
Furthermore, the lack of a direct interaction in the Y2H assay may have been due to 
the undetectable levels of IQGAP1 fusion protein in the yeast. To overcome these 
caveats and definitively determine whether BimA and IQGAP1 directly interact with 
one another, Förster resonant energy transfer (FRET) could be used to study 
interactions within cells.  
Despite the lack of evidence of a direct interaction of BimA with IQGAP1, this 
thesis shows the importance of N-IQGAP1 on BimA-mediated actin polymerisation. 
To complete this work, examination of the full-length IQGAP1 or individual domains, 
as well as including other host cellular factors, using the pyrene-actin polymerisation 
assay should be performed. Additionally, investigating the effects of IQGAP1 on actin 
depolymerisation would be interesting for a better understanding of this molecular 
mechanism. 
 
6.3 Closing statement 
B. pseudomallei causes a severe and fatal disease called Melioidosis, an 
emerging infectious disease with an expanding global distribution and with high 
mortality rates in the endemic areas. Particularly, this bacterial pathogen is classified 
as a bioterrorism agent because this agent is believed to be transmitted through the 
air and there is no available vaccine. Moreover, it is difficult to treat with antibiotics, 
thus, development of new therapeutic strategies is essential. Discovery of IQGAP1, 
which is a novel protein involved in B. pseudomallei actin-based motility in this study, 




suppress the target key protein that bacteria use to survive intracellularly could 
prevent the progress of disease which could improve management for treatment of 
severe sepsis.  
Indeed, a preliminary observation in this study showed the presence of IQGAP1 
in the actin tail of bacteria expressing BimA of another virulent Burkholderia species, 
B. mallei and also in the actin tail of an avirulent species, B. thailandensis (Figure 6.3). 
This implies that IQGAP1 is a common target protein that Burkholderia spp. exploit 
for actin tail formation. It is hypothesised that IQGAP1 may be used for actin-based 
motility in other pathogens with alternative mechanisms. Studying intracellular life 
of B. pseudomallei is essential not only to gain knowledge of the pathogenesis of actin-
based motility but also to provide a better understanding of cell biology, both of 






Figure 6.3: Localisation of IQGAP1 in HeLa cells infected with bacteria 
expressing BimA of B. mallei and B. thailandensis. Arrows indicate IQGAP1 is 
recruited into an actin tail. 
(a) B. pseudomallei 10276 pDM4 :: BimA (pME- BimAma) infected HeLa cells at 16 hours 
post-infection B. pseudomallei expressing BimAma was stained blue, actin was 
stained green and IQGAP1 was stained red. Scale bar = 10 µm. 
(b) B. thailandensis E30 pBHR4-gros-RFP infected HeLa cell at 16 hours post-infection. 
B. thailandensis expressed red fluorescent protein, actin was stained blue and 
IQGAP1was stained green. (The plasmid is a kind gift from Richard Titball, 
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7.1 Bacterial strain and yeast strains, plasmids and antibodies used in 
this study 
Table7.1: Bacterial strain, yeast strain used in this study 
Strain Description Source/Reference 
Burkholderia pseudomallei 
strain 10276 (NCTC 10276) 
Isolated from a British 
seaman suffering from the 
chronic form of melioidosis 
Maegraith and 
Leithead (1964) 
Salmonella  enterica serovar 
Typhimurium 4/74 
Nalidixic acid-resistant (NalR) Jones et al. (1988) 
E. coli Strains   
E. coli  XL-1 blue cloning Agilent 
Technologies 
E. coli  XL10-gold Site-directed mutagenesis Agilent 
Technologies 
E. coli Rosetta 2 (DE3) 
pLysS,  
Protein expression Novagen 
E. coli Rosetta 2 (DE3) pLysS 
pGEX-4T-1 
Strain expresses GST protein  Sitthidet et al. 
(2010) 
E. coli Rosetta 2 (DE3) pLysS 
pGEX-BimA 
Strain expresses residues 54 
to 455 of B. pseudo-mallei 
10276 BimA fused with GST  
Sitthidet et al. 
(2010) 
Saccharomyces cerevisiae   
AH109 Ade–, His–, Leu–, Trp–  Clontech 
AH109 pGBKT7-53 
pGADT7-T 
Control for positive 
interaction 
Clontech 
AH109 pGBKT7-Lam  
pGADT7-T 
Control for negative 
interaction 
Clontech 
Pichia pastoris strains   
GS115  Methanol-utilising strain 
(Mut+), His–, Mut+ 
Invitrogen 
GS115/ Albumin  Control for MutS phenotype  Invitrogen 
GS115/pPICZ/lacZ  control for Zeocin™ 
resistance in Pichia and Mut+ 
phenotype, His– 
Invitrogen 










pECFP-C1 Mammalian expression vector with cyan 
fluorescent protein tag, KanR 
Clontech 
Double nickase 
plasmid (cat no. sc-
400597-NIC) 
A pair of plasmid encoding a D10A 
mutated Cas9 nuclease and target human 
IQGAP1 for knockout gene expression  
Santa Cruz 
Biotechnology 
pGEM-T Easy Cloning vector, AmpR  Promega 
pGEM-T-FL-IQGAP1 pGEM-T containing full-length IQGAP, 
AmpR 
This study 
pGEM-T-N-IQGAP1 pGEM-T containing N-terminal IQGAP, 
AmpR 
This study 
pGEM-T-C-IQGAP1 pGEM-T containing C-terminal IQGAP, 
AmpR 
This study 
pGEM-T-IQGAP1 pGEM-T containing full-length IQGAP, 
AmpR 
This study 
pWhitescript Control for site-directed mutagenesis Agilent 
Technologies 
pMAL-p2X Bacterial expression vector containing an 





pMAL-p2X encodes full-length IQGAP1 





pMAL-p2X encodes full-length IQGAP1 aa 





pMAL-p2X encodes full-length IQGAP1 aa 
809-1657 fused with an N–terminal MBP, 
AmpR 
This study 
pPICZ B Pichia expression vectors  
containing C–terminal 6xHis tag, ZeoR 
Thermo Fisher 
Scientific 
pPICZ B-IQGAP1 pPICZ B encodes full-length IQGAP1 
fused with an C–terminal 6xHis tag, ZeoR 
This study 
pME6032-BimA pME6032 contains the intact bimA from 
B. pseudomallei 10276, TetR 
Stevens et al., 
(2005a) 
pET-21b (+) Bacterial expression vector containing an 




pET-21b (+) encodes BimA aa 54-470 




pMAL-p2X encodes BimA aa 54-470 
fused with an N–terminal MBP, AmpR 
This study 
pGBKT7 BD Yeast expression vector encoding an in-
frame GAL4 DNA binding domain and c-
Myc tag, Trp+, KanR 
Clontech 
pGBKT7-BimA54-455 pGBKT7 encodes the Gal4 DNA-BD fused 
with BimA aa 54-455, and myc tag, Trp+, 
KanR 
Terence Field/  
Jitprasutwit et 
al., (2016) 








pGBKT7-BimA54-455 pGBKT7 encodes the Gal4 DNA-BD fused 
with BimA aa 54-455, and myc tag, Trp+, 
KanR 
Terence Field/  
Jitprasutwit et 
al., (2016) 
pGADT7 AD Yeast expression vector encoding an in-
frame GAL4 activating domain and HA 
tag, Leu+, AmpR 
Clontech 
pGADT7-IQGAP1 pGBKT7 encodes the GAL4-AD fused with 
IQGAP1 and HA tag, Leu+, AmpR 
This study 
pGADT7-actin pGBKT7 encodes the GAL4-AD fused with 








Table 7.3 Primers used in this study 




























































of IQGAP1 for 































Amplify BimA54-470 This study 
BimA470-SacI ATCCGCGAGCTCGGAATC
ATCGTCAGCGCGGTCGC 
Amplify BimA54-470 This study 
F802IQ GGCTAAGCAGGACAAAA
TGACA 
IQGAP1 Sequencing  This study 
    




Table 7.3 Primers used in this study (continued) 





IQGAP1 Sequencing This study 
F3323IQ CAGACAGGAGAGGCAAG
CAA 













pGADT7 Sequencing Clontech 
3AD  AGATGGTGCACGATGCA
CAG 
pGADT7 Sequencing  Clontech 
M13F  TGTAAAACGACGGCCAG
T 














































of IQGAP1 of 
human origin 
WB (1 µg/ml) 
IF (2 µg/ml) 
IP (4 µg per 1 mg 




-Actin   
(goat polyclonal) 
C-terminus of 
actin of human 
origin 











mapping to an 
internal region 
of IQGAP2 of 
human origin 








WB (1: 500)  Abcam (ab136976) 
-MBP 
 (mouse monoclonal) 
Maltose binding 
protein  










(His x 6) fusion 
protein 








0.5 µg/ml (Stevens et al., 
2005a) 
-Pseudomonas 
mallei LPS  
(mouse monoclonal) 
LPS of P. mallei 
and B. 
pseudomallei 
2 µg/ml Abcam (ab10011) 
-Rabbit 680 (goat) Rabbit IgG WB (1:10,000) Cell signalling 
(5366) 
-Mouse 680 (goat) Mouse IgG WB (1:10,000) Cell signalling 
(5470) 
-Mouse 800 (goat) Mouse IgG WB (1:10,000) Cell signalling 
(5257) 
-Rabbit 568 (goat) Rabbit IgG IF (1:200) Molecular Probes 
(A10036) 
-Mouse 568 (goat) Mouse IgG IF (1:200) Molecular Probes 
(A11004) 
    













-Mouse 405  
(goat) 
Mouse IgG IF (1:200) Molecular Probes 
(A31553) 
-Goat 0.1 mg 
(donkey) 
Goat IgG WB (1:20,000) LI-COR 
(92632214) 




7.2 Determination of optimal working dilution for IQGAP1 staining in 
HeLa cells 
A series of dilutions in a titration experiment was performed using dilutions of 
1:50 and 1:100 of primary antibody using a goat polyclonal antibody and a rabbit 
polyclonal antibody. The secondary antibodies were diluted at 1:500 and 1:200. 
Using 1:100 of rabbit polyclonal antibody and detected with 1:200 of the anti-rabbit 
Ig-Alexa Fluor 568 shows the best staining with low background and specific to 
IQGAP1 in the cytoplasm and the cell membrane where an overlap in the 
fluorescence signals in yellow was observed (Figure 7.1). 
 
 
Figure 7.1: IQGAP1 localises with actin tails of B. pseudomallei   
Representative confocal laser scanning micrographs of uninfected HeLa cells. F-actin 
(green) was stained with Alexa Fluor 488-conjugated phalloidin. IQGAP1 (red) was 
stained with a goat polyclonal antibody or a rabbit polyclonal antibody and detected with 





7.3 B. pseudomallei displayed actin tails in HeLa cells at different 
points after infection 
To study actin tail formation by B. pseudomallei, HeLa cells were infected with 
B. pseudomallei for 8, 16, 24 and 32 hours and cell staining to examine the number of 
bacteria formed actin tail using confocal microscopy. Figure 7.2 shows at 16 hours 
post-infection, the number of bacteria that displayed actin tails in HeLa cells was 
largest compared to another time points. From this observation, B. pseudomallei 




Figure 7.2: Actin tail formation by B. pseudomallei in control cells at 8, 16, 24 
and 32 hours post-infection 
Confocal micrographs of HeLa cells infected with wild-type B. pseudomallei 10276. 
Bacteria were stained with anti-LPS antibody in blue and actin was stained in green. 




7.4 Expression level of IQGAP isoforms 
To inspect expression level of IQGAP2 and IQGAP3 in HeLa cells, the Human 
Protein Atlas program (https://www.proteinatlas.org/) was utilised. From the 
information provided, HeLa cell at the early passages was extracted for total RNA has 
been analysed by RNA-seq to estimate the transcript abundance of each protein-
coding gene reported as values of TPM (Transcript Per Million). Figure 7.3 shows 
RNA expression overview generated by the Human Protein Atlas program. 
Transcripts for IQGAP1, IQGAP2 and IQGAP3 in HeLa cell show TPM values are 102.7, 
4.8 and 36.4 respectively.  
 
 
Figure 7.3: RNA expression overview with cell lines sorted generated by the 
Human Protein Atlas program. 




7.5 Invasion and intracellular survival of B. pseudomallei in siIQGAP1 
knockdown cells 
HeLa cells and siIQGAP1 knockdown cells were infected with B. pseudomallei 
at MOI of 130. At 2 hours post-infection, the infected cells were lysed to examine the 
invasion efficiency of B. pseudomallei. At 24 hours post-infection, the intracellular 
bacteria were recovered to investigate the number of viable bacteria inside the cells. 
Figure 7.4 shows percentage of invasion and intracellular survival of B. pseudomallei 




Figure 7.4: Percentage of invasion by B. pseudomallei and the number of 
bacteria in control HeLa cells and siIQGAP1 knockdown cells  
(a) At 2 hours post-infection, infected cells were lysed, and the number of intracellular 
bacteria quantified. Data are expressed as the percentage of invasion calculated as 
follows: (the number of recovered bacteria/the number of bacterial inoculum) x 100 
showing mean ± SEM from three separated experiments (n=3). 
(b) Intracellular bacteria were counted after lysing infected cells at 6 and 24 hours post-
infection. The data of the number of recovered bacteria at 2 hours post-infection 
from figure 7.4a is also included. Error bars represent standard errors of the mean 
for experiments performed in triplicate (n=3).  
(a) 




     
 





7.6 Sequencing result of PCR product from control HeLa cells 
Genomic DNA extract from WT HeLa cells was subjected to PCR amplification 
using a pair of primers designed for the region flanking exon 13 of the human IQGAP1 
gene. One band of PCR product at the expected size was extracted from the gel for 
sequencing using the primers used for amplification. Figure 7.5 shows high quality 
of Sanger sequencing chromatogram of the amplicons and the sequencing result that 
was blasted against the human genome using Homo sapiens (human) Nucleotide 
BLAST (https://blast.ncbi.nlm.nih.gov/Blast.cgi). From BLAST analysis, it 
demonstrated that the product share 100% identity with human IQGAP1 gene. 
 
Figure 7.5: Nucleotide sequencing result of PCR product from genomic DNA of 
HeLa cells (WT)  aligned to Homo sapiens IQGAP1 gene 
(a) Sanger sequencing chromatogram of purified PCR products from genomic DNA of 
HeLa WT control cells around the sgRNA binding site at exon 13 (red) showing 
nucleotide alignment with Homo sapiens IQGAP1 database (yellow box). The 
product was sequenced using two primers indicated in blue boxes to cover the 
editing sites. 
(b) The sequencing result was blasted against to Homo sapiens nucleotide.  
(a) 

















7.7 Sequencing result of PCR product from clone C3 
Genomic DNA extract from clone C3 editing cells was subjected to PCR 
amplification using a pair of primers designed for the region flanking exon 13 of the 
human IQGAP1 gene. A large band of PCR product at the smaller size than those from 
WT cells was shown. An extended time of agarose gel electrophoresis was performed 
to separate the product with similar size. Two smaller bands were revealed and 
extracted for sequencing. Sequencing result in Figure 7.6 indicated this clone was 
mixed and two of them showed the deletion mutation when alignment with the wild-
type sequence.  
 
 
Figure 7.6: Nucleotide sequencing result of PCR product from genomic DNA of 
clone C3 aligned to Homo sapiens IQGAP1 gene 
Sanger sequencing chromatogram of purified PCR products from genomic DNA of clone 
C3 around the sgRNA binding site. C3U, C3M and C3L was the separated bands. Orange 




7.8 Sequencing result of PCR product from clone G12 
PCR product from genomic DNA of clone G12 using a pair of primers designed 
to flank the targeted region on the human IQGAP1 gene showed three distinct PCR 
bands. Each band was excised from the gel and purified for sequencing. Figure 7.7 
shows mutation had occurred either by insertion (G12U) or deletion (G12M and 
G12L) when alignment with wild-type sequence. 
 
 
Figure 7.7: Nucleotide sequencing result of PCR product from genomic DNA of 
clone G12 aligned to Homo sapiens IQGAP1 gene 
Sanger sequencing chromatogram of purified PCR products from genomic DNA of clone 
G12 around the sgRNA binding site. G12U, G12M and G12L were separated by agarose 
gel electrophoresis. Alignment with wild-type (WT) sequence of IQGAP1 gene shows 
error-prone mutations. Grey box indicates insertion and orange boxes indicates deletion 





7.9 Immunoprecipitation confirms lacking IQGAP1 in Clone H5 
knockout cells 
Ten-fold increase of total cell lysate extracted from clone H5 IQGAP1 knockout 
cells, compared to those from wild-type cell, was used for immunoprecipitation to 
confirm the absence of IQGAP1 in this clone. After precipitation, Western blot 
analysis using antibody specific to IQGAP1 was unable to detect any distinct protein 
band in this knockout cell line, compared to the negative controls. This suggested 




Figure 7.8: Immunoprecipitation of IQGAP1 from control and clone 5 knock-
out cells 
Precleared HeLa cells lysates were incubated with anti-IQGAP1 antibody and 
immunoprecipitated with protein A-Sepharose beads. After washing, the proteins were 
separated and immunoprecipitates were analysed by Coomassie blue staining and 
immunoblotting. WT: Lysate of control HeLa cells; KO: Lysate of knockout cells (clone 
H5). Right panel shows Coomassie blue staining and left panel shows Western blot 




7.10 Invasion and intracellular survival of B. pseudomallei in HeLa 
control cells and IQGAP1 knockout cells using a high MOI  
To study the effect of lacking IQGAP1 in HeLa cells in B. pseudomallei invasion 
and intracellular survival, a high MOI at 260 was used to infect the cells.  Despite of a 
high MOI, percentage of B. pseudomallei invasion into both cells, control and IQGAP1 
knockout cells was similar (Figure 7.9a).  However, the decrease number of bacteria 
was found in the IQGAP1 knockout cell at 24 hours post-infection with a similar trend 
in the experiment using MOI at 130, compared those in control cell (Figure 7.9b). 
Although, the number of bacteria at 24 hours post-infection when using MOI at 260 
was lower than those at 6 hours post-infection, the similar number of bacteria was 
recovered at 6 and 24 hours post-infection when using MOI at 130. A higher number 
of bacteria infected to cells could cause cell cytotoxicity and caused cell death. This 
could be challenging to determine the actual number of viable bacteria at the later 




Figure 7.9: Percentage of invasion by B. pseudomallei and the number of 
bacteria in control HeLa cells (WT) and IQGAP1 knockout cells (KO) using MOI 
at 260 
(a) At 2 hours post-infection, infected cells were lysed and the number of intracellular 
bacteria quantified. Data are expressed as the percentage of invasion showing mean 
± SEM from two experiments (n=2, p =0.01138). 
(b) Intracellular bacteria were counted after lysing infected cells at 6 and 24 hours post-
infection. The data of the number of recovered bacteria at 2 hours post-infection 
from figure 7.9a is also included. Data are expressed as the percentage of invasion 
showing mean ± SEM from two experiments (n=2, p = 0.3757 at 6 hours post 
infection and p = 0.0144 at 6 hours post infection).  
(a)                  (b) 




7.11 Cell cytotoxicity after B. pseudomallei infection 
Investigation of intracellular survival of this bacterium was studies at 48 
hours post-infection. At this time point the number of bacteria decresed and 
fluctuated wildly between experiments in both wild-type control cell and IQGAP1 
knockout cells (data not shown). LDH release assay was utilised to investigate cell 
cytotoxicity. Figure 7.10 shows percentage of cytotoxicity increased at 48 hours post-
infection. This implied that the cells were leaked, and the intracellular bacteria were 
released which would be killed in culture media containing the antibiotics.  This 
could be a reason why the number of recovered bacteria was varied and low in the 





Figure 7.10: Cytotoxic effect of B. pseudomallei infection 
Cytotoxic effect of B. pseudomallei infected HeLa cells at 24 hours and 48 hours post 
infection. The percentage of cytotoxicity was calculated from OD 490 nm measuring LDH 
release from cells into the supernatant. The value of maximum LDH released from 
uninfected cells (Max) taken as 100%. Data shown are mean  SD representative of 





7.12 Low numbers of bacteria in IQGAP1 knockout cells at later time 
points  
At the later time points of infection, the actual number of bacteria in infected 
cells could not be obtained because of cell cytotoxicity. It is presumed that the 
number of intracellular bacteria decreased following the trend observed at 24 hours 
post-infection. To confirm this, intracellular bacteria in B. pseudomallei infected 
IQGAP1 knockout cells were observed under a microscope. Figure 7.11 shows a very 
low number of bacteria that were stained in red at 48- and 72- hours post-infection. 
Whereas a higher number of bacteria in control cells was noticeable. Some bacteria 
were also localised with actin, which was stained in green, could be seen in yellow in 
the infected wild-type control cells. 
 
 
Figure 7.11: Number of B. pseudomallei in HeLa wild-type control cells and 
IQGAP1 knockout cells at 48 and 72 hours post-infection. 
Confocal micrographs of HeLa cells infected with wild-type B. pseudomallei 10276. 
Bacteria were stained with anti-LPS antibody in red, nuclei were stained with DAPI 




7.13 Optimisation of MBP-IQGAP1 expression 
From a small-scale production of MBP-IQGAP1, it showed a low level of protein 
expression. Additionally, the induced proteins were formed in insoluble fractions 
accumulated in inclusion bodies. To improve this, optimisation of the culture and 
induction conditions were performed. Figure 7.12 and 7.13 show the conditions used 
for expression of the full-length, and N-terminus and C-terminus of IQGAP1, 
respectively, to obtain a high level of protein expression in soluble form. The 
overnight culture was induced by IPTG directly or was sub-culture before induction. 
Concentrations of IPTG and temperature of induction were also optimised.  
 
 
Figure 7.12: SDS–PAGE showing expression of MBP-FL-IQGAP1 recombinant 
proteins expressed in E. coli Rosetta 2 (DE3) pLysS after IPTG induction  
Asterisk indicates the best condition for expression the soluble protein used in this study. 







Figure 7.13: SDS–PAGE showing expression of MBP-IQGAP1 recombinant 
proteins expressed in E. coli Rosetta 2 (DE3) pLysS after IPTG induction  
Un: Uninduced cell, Ind: Induced cell, S: Soluble proteins and Ins: Insoluble proteins 
Asterisk indicates the best condition for expression the soluble protein used in this study. 
(a)  Expression of MBP-N-IQGAP1 recombinant protein.  
(b)  Expression of MBP-C-IQGAP1 recombinant protein.  


















7.14 Degradation of MBP-IQGAP proteins 
Yields of MBP-IQGAP1 produced by E. coli were poor.  It was hypothesie that 
the proteins were expressed but were degraded by bacterial proteases or protein 
folding improperly. Western blotting with antibodies specific to MBP was performed 
to prove this. Figure 7.14 shows protein bands specific to anti-MBP from the 
expected molecular weight of the fusion protein, indicated in the square brackets, to 
the size of MBP (42.5 kDa). This result supports the induced MBP-IQGAP1 proteins 
by E. coli were degraded. 
 
 
Figure 7.14: MBP-IQGAP1 proteins was degraded during production. 
After IPTG induction, protein was expressed by E. coli Rosetta 2 (DE3) pLysS. Total cell 
lysate from E. coli carrying MBP- full length IQGAP1, N-terminal IQGAP1, C-terminal 







7.15 IQGAP1 expression in E. coli strains 
Due to a low yield of MBP-FL-IQGAP1in E. coli strain Rosetta 2 (DE3) pLysS was 
concerned, the plasmid encoding MBP-FL-IQGAP1 was transformed into E. coli 
Rosetta-gami B for enhancing the quantity and quality of the fusion protein. Figure 
7.15 shows there was no induced proteins after IPTG induction from E. coli Rosetta-
gami B and derivatives, compared to those from E. coli strain Rosetta 2 (DE3) pLysS. 
Whereas the induced protein band could be detected from the expression in the E. 
coli strain Rosetta 2 (DE3) pLysS, MBP-FL-IQGAP1 was not detected from the 
induced cells of E. coli Rosetta-gami B. 
 
 
Figure 7.15: SDS–PAGE showing the expression of MBP-FP-IQGAP1 
recombinant proteins expressed in E. coli Rosetta 2 (DE3) pLysS, E. coli Rosetta-
gami B and derivatives after IPTG induction  
Protein marker was load in the first lane, UN: Uninduced cell, 8: IPTG induced at room 






7.16 Sequencing result of IQGAP1 and actin on pGADT7  
To test the interaction between IQGAP1 and BimA, IQGAP1 gene was cloned 
into pGADT7 and expressed as a prey protein. Also, -actin gene was amplified and 
cloned into the same plasmid. Actin was used as a positive control for the interaction 
with BimA. The insertion of IQGAP1 and actin need to be in-frame with the GAL4-AD 
for testing the interaction.  Figure 7.16a shows the sequence of pGADT7. With the 
same frame of the GAL4-AD for construction of a fusion protein, a hemagglutinin 
(HA) epitope tag was also expressed as a fusion. Using the T7 sequencing primer, the 
insertion of IQGAP1 and actin were expressed in-frame with HA tag in the correct 
direction and in-frame with the GAL4-AD as shown in Figure 7.16b and 7.15c, 
respectively.  
 
Figure 7.16: Alignment of amino acids encoding IQGAP1 and actin on pGADT7   
(a)  Sequence of pGADT7 showing GAL4-AD and a hemagglutinin (HA) epitope tag were 
expressed in-frame.  
(b)  Sanger sequencing chromatogram of the PCR products from pGADT7-IQGAP1. The 
red lines indicate reading frame number were in-frame with the HA tag shown in 
the cyan arrow. 
(c) Sanger sequencing chromatogram of the PCR products from pGADT7-actin. The red 
lines indicate reading frame number were in-frame with the HA tag shown in the 
cyan arrow.   














7.17 High concentration of 3-AT  
S. cerevisiae AH109 pGBKT7-BimA with the empty prey vector was capable of 
growing on a SD/-His plate indicated that the expression the HIS3 reporter gene was 
activated by BimA. To a lesser extent of this activity, 3-amino-1,2,4-triazole (3-AT) 
was supplemented to SD/-His plates using concentration from 2.5 – 15 mM. Yeast 
cells containing pGBKT7-BimA was diluted and plated on the media using the same 
dilution. Figure 7.17 shows growth of AH109 pGBKT7-BimA pGADT7 on the negative 
control plate (SD/-His without 3-AT) was similar to those on plates containing 3-AT, 
despite use of a high concentration. Although 3-AT could not reduce the background 
growth of AH109 pGBKT7-BimA pGADT7 on a SD/-His plate, the interaction of BimA 




Figure 7.17: Yeast strain AH109 pGBKT7-BimA pGADT7 phenotype on minimal 
media (SD) lacking histidine supplemented with 3-AT  
S. cerevisiae AH109 was transformed with pGBKT7-BimA pGADT7 and cultured. A serial 
dilution was made and plated on the SD/-His medium with/without 3-AT and incubated 




7.18 Yeast two-hybrid assay after 2-days incubation 
Yeast two-hybrid assay was utilised in this study to examine the interaction 
between BimA and IQGAP1.  Growth on selective media lacking tryptophan and 
leucine (DDO) showed that yeasts harbouring both bait and prey proteins. Blue 
colour of yeast colonies on selective media in the absence of tryptophan, leucine, 
histidine, adenine supplemented with X--Gal (QDO/X--Gal) indicates the direct 
interaction between proteins. AH109 pGBKT7-BimA pGADT7-actin was able to grow 
and turned the colonies to blue on QDO/X-α-Gal plates demonstrating the direct 
interaction between BimA and actin, agreed with the previous finding (Stevens et al., 
2005a). On the other hand, white colonies of AH109 pGBKT7-BimA pGADT7-IQGAP1 
with the slow growth on QDO/X-α-Gal medium implied that IQGAP1 and BimA did 
not interact with each other directly. This observation was guaranteed by extending 
incubation of up to 3 days. Figure 7.18 shows the yeast colonies expressing BimA and 
IQGAP1 were still white after incubation for 2 and 3 days.  
 
Figure 7.18: Yeast two-hybrid interactions  
The pray plasmid expressing actin (pGADT7-actin) or IQGAP1 (pGADT7-IQGAP1) was 
transformed into S. cerevisiae AH109 containing pGBKT7-BimA54–455. Cell suspensions 
were inoculated onto DDO and QDO/X-α-Gal plates and incubated for 2 and 3 days. The 
interaction controls were S. cerevisiae AH109 harbouring pGBKT7-53 and pGADT7-T 
(positive interaction control; +ve) and pGBKT7-Lam and pGADT7-T (negative 




7.19 Validation of IQGAP1 expression by pGADT7  
Studying of protein-protein interaction using yeast two-hybrid system, 
IQGAP1 was cloned into pGADT7 to express with HA epitope tag under the ADH1 
promoter. The protein expression was validated using Western blot analysis. Figure 
7.19 shows the immunoblotting using anti-HA and anti-GADPH that used as a loading 
control. Due to accumulation of ethanol during logarithmic growth of the yeast host 
cells, the full-length ADH1 promoter in pGADT7 may be repressed. To minimise this 
effect, the total protein from the yeast strains was extracted by either scrapping the 
yeast colonies directly from plates or sub-culturing the yeast strains before 
harvesting. Colonies from plates after incubation for 24 hours were collected for total 
protein extraction. Alternatively, the overnight culture was transferred into fresh 
medium to an OD600 = 0.5 and incubated at 30°C for 3 hours with shaking before 
harvesting. Despite this, only a faint band of actin was shown but IQGAP1 expression 




Figure 7.19: Western blot analysis showing expression of yeast fusion proteins 
in S. cerevisiae AH109 
S. cerevisiae AH109 strains containing pGBKT7-BimA pGADT7-Actin (BimA+Actin) and 
pGBKT7-BimA pGADT7-IQGAP1 (BimA+IQGAP1) were harvested. The whole cell lysates 





7.20 Plasmid instability and toxicity of the IQGAP1 to E. coli 
Although MBP-IQGAP1 was expressed by the expression vector pMAL-p2X, a 
low expression levels or no expression at all was encountered, especially in a large-
scale production. This could be caused by toxicity of the target protein. To investigate 
this, the E. coli containing pMAL-p2X-FL-IQGAP1 cells were plated on LB agar plates 
before IPTG induction. Figure 7.20 shows the number of E. coli colonies on LB plates 
indicating the number of all viable cells and E. coli cells carrying the plasmid could 
able to form colonies on LB plates with antibiotics. However, the lower numbers of 
E. coli with a small size on LB plates supplemented with IPTG only (without 
antibiotics) may imply that E. coli had lost the plasmid, or the plasmid may be 
unstable during the expression. Also, there was no colony of the E. coli strain on LB 
agar supplemented with antibiotics and IPTG. This indicated that the target protein 
may be toxic to the E. coli causing cells death after protein expression. 
 
 
Figure 7.20: Growth of E. coli on LB agar plates supplemented with or without 
antibiotics and IPTG. 
A cultures of E. coli Rosetta 2 (DE3) pLysS containing pMAL-p2X-FL-IQGAP1 was diluted 
and plated on a LB agar plate (a), LB agar plate supplemented with 100 µg/ml ampicillin 
and 34 µg/ml chloramphenicol (b), LB agar plate supplemented with 1mM IPTG without 
antibiotics (c), and LB agar plate supplemented with antibiotics and 1mM IPTG (d). 
  












7.21 Cloning of IQGAP1 with C-terminal 6xHiS-tag in-frame fusion 
The entire coding sequence of the human IQGAP1 was cloned into the yeast 
expression vector pPICZ B. To express the full-length of IQGAP1 fused with His-tag 
in P. pastoris, the insert was sequenced. A sequencing primer targeting on 3AOX1 
site was used to confirm the correct in-frame sequence with a His-tag (Figure 7.21a). 
Figure 7.21b showed the sequencing result at the 3-end of the IQGAP1 insertion 
were in-frame with the fusion protein. 
 
 
Figure 7.21: Comparison of the amino acid sequence of IQGAP1 expressed by 
pPICZ B in P. pastoris 
(a)  Sequence of pPICZ B for expression in P. pastoris indicating a His-tag in the cyan 
rectangle at the 3-end from the multi-cloning sites. 
(b) Sanger sequencing chromatogram of the PCR products at the 3-end of pPICZ B-
IQGAP1. The amino acid sequence translated from the sequencing result was aligned 
with the IQGAP1 gene showing the correct in-frame sequence with a His-tag 
indicated in cyan arrow.  















7.22 Validation of BimA expression by Western blot analysis 
To express and purify BimA, BimA54-470 was cloned into the expression vector 
pET-21b(+). BimAwith His-tag fusion was produced in E. coli Rosetta 2 (DE3) pLysS 
and tested by immunoblotting using antibody specific to BimA48−384 (Stevens et al., 
2005a). Figure 7.22 shows the protein band specific to anti-BimA was induced, 





Figure 7.22: Western blot analysis showing expression of BimA in E. coli 
Rosetta 2 (DE3) pLysS 
Total proteins from E. coli Rosetta 2 (DE3) pLysS strains with and without IPTG induction 
were subjected to Western blotting. detected using antibody specific BimA48−384 for 
protein expression. 
M: Protein molecular weight marker 
1: Total cell lysate of uninduced cell of E.coli Rosetta2 (DE3) pLysS containing pET21b 
(+) 
2: Total cell lysate of induced cell of E.coli Rosetta2 (DE3) pLysS containing pET21b (+) 
3: Total cell lysate of induced cell of E.coli Rosetta2 (DE3) pLysS containing pET21b (+)-
BimA54-470 
4: Total cell lysate of induced cell of E.coli Rosetta2 (DE3) pLysS containing pET21b (+)-
BimA54-470 





7.23 MBP shows a baseline of nucleation activity 
To study the ability of IQGAP1 to stimulate actin polymerisation. Purification 
of IQGAP1 fused to maltose-binding protein (MBP) was performed.  A preliminary 
experiment of pyrene-actin polymerisation assay supplemented with MBP was 
tested. Figure 7.23 shows the purified MBP increased actin polymerisation rate 
dramatically, compared to the GST protein which showed a similar rate with actin 
alone.  With a high level of background nucleation activity of MBP, this fusion protein 






Figure 7.23: MBP shows a baseline of nucleation activity   
Emission of fluorescence due to polymerisation of pyrene-labelled actin monomers by 
MBP (purple line) was increased compared with the reaction containing GST (orange 






7.24 Rate of actin polymerisation of G-actin alone 
Pyrene assay is a biochemical kinetic assay for measuring the changes in 
fluorescence intensity when pyrene-labelled monomeric actin is polymerised or 
depolymerise. This assay is very sensitive to small differences in concentration of 
actin filaments presented in the reaction. Thus, the reaction containing only actin 
alone was run on the same day when performing the experiments to ensure there is 
not extensive of actin filament. Working stock of actin was prepare freshly and tested 
before initiating test with proteins of interest. Due to the reaction with actin alone 
was perform independently from the test reactions, the data was not included in the 
Figure 5.16. Fluorescence data was collected every minute for up to 1 hour. During 
the linear phase of polymerisation, rates of fluorescence units per second were 
calculated (Figure 7.24).  Rate of actin polymerisation of G-actin alone in the 
polymerisation buffer was similar to those with the GST or N-IQGAP1 alone as shown 
in the Chapter 5. 
 
 
p value compared to the reaction of actin alone  
Polymerisation rate of actin = 6.41  0.14 units/sec (n= 3) 
N-IQGAP1 GST GST + 
N-IQGAP1 
GST-BimA GST-BimA + 
N-IQGAP1 
0.7387173 0.6009689 0.9639274 0.0000043* 0.0000002* 
 
Figure 7.24: Rate of actin polymerization using actin alone  
Emission of fluorescence due to polymerisation of pyrene-labelled actin monomers by 
actin alone. Three independent replicates were tested in one experiments and the graphs 
show the mean emission levels of fluorescence over time. The rise in fluorescence units 
per second during the linear phase of polymerisation was calculated as rates of 
polymerisation showing the mean rates of fluorescence units per second ± SEM in the 
table. Asterisks denote a significant difference in the rate of polymerisation compared to 
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